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Abstract 
It is widely accepted that the Maillard reaction, specifically the development of 
Advanced Glycation End-products (AGEs) in vivo, is linked to the pathogenesis of 
diabetic secondary complications. The same diseases that occur in old age are 
similarly thought to develop as a function of the accumulation of AGEs. This thesis 
presents an in vitro investigation into glycation by fructose (fructation) and 
discusses the potential for in vivo fructation. The contribution of in vivo fructation 
to degenerative diseases is unknown, largely because assays for glycation 
underestimate, or do not detect, fructation (Ahmed N& Furth A. J. 1992, Clin. 
Chem. X8,1301-1303). 
In vitro radiolabelling illustrates that incorporation of fructose into protein, 
through the Maillard reaction, is more swift than glucose. The development of 
AGE-fluorescence reflects the incorporation of the two sugars, i. e. higher upon 
fructation. 
A novel colorimetric assay for glycation (including fructation), based on the 
reaction of 2,4-dinitrophenylhydrazine (DNPH) with protein-bound carbonyl 
groups, is presented. The DNPH assay detects compounds that are intermediates 
in post-Amadori, or post-Heyns reactions, and precede development of 
fluorescence. The production of the protein-bound carbonyl intermediates is 
largely dependent on the presence of lipid and free metal. The same group of 
compounds are probably the principle site of action of aminoguanidine, which 
blocks the production of AGEs. 
An in vitro model is presented, to show how protein glycated in one part of the 
body, can long after maintenance of euglycaemia, become covalently cross-linked 
to a second protein. Lysozyme was glycated with low concentrations of fructose, 
111 
or using short periods of fructation, and the free fructose removed. The fructated 
lysozyme was subsequently incubated in sugar-free buffer with native ß- 
lactoglobulin and produced a 32kD heterodimer of the two covalently cross-linked 
proteins. 
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1. Introduction 
The work described in this thesis concerns the Maillard reaction as it occurs in vivo 
with particular emphasis on the monosaccharide fructose. The Maillard reaction is 
a non-enzymatic reaction between the carbonyl group of reducing sugars and 
primary amines eventually producing Advanced Glycation End-products or 
AGEs. There are two halves to the Maillard reaction (see Fig. 1.1. ). I have used the 
term glycation to define the initial half of the reaction, i. e. both the formation of 
the Schiffs base and the subsequent rearrangement to Amadori product, if the 
hexose was an aldehyde, or Heyns product if the hexose was a ketone. The 
chemistry of glycation is well understood it is the latter half of the Maillard 
reaction, that I have termed post-Amadori or post-Heyns reactions, that is poorly 
understood. The lack of knowledge of the post-Amadori or post-Heyns reactions, 
both at theoretical and practical levels is because of the large number of variations 
of possible post-Amadori or post-Heyns reactions and their products. This thesis 
describes the results and conclusions of a series of experiments designed to 
elucidate post-Amadori or post-Heyns reactions. 
protein 
sugar 
Schiffs 
, 
Amadori 
base product 
glycation 
Advanced Glycation 
End-products 
post-Amadori reactions 
some of which are metal and lipid catalysed 
Fig. 1.1. Schematic outline of the Maillard reaction. Please note that the 
diagram has been simplified and the name Amadori could be substituted with 
Heyns to allow further definition. 
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Glycation occurs on primary amino groups, i. e. terminal a-amino groups or the e- 
amino group of lysine; this makes it distinct from enzymatic glycosylation which 
occurs on the side groups of serine, threonine, asparagine, hydroxylysine and 
hydroxyproline residues. Glycation is non-enzymatic, it is a chemical reaction with 
a rate that is dependent on the concentration of the substrates, the temperature and 
the pH [133,. 1,2]. In vitro, temperature is an important consideration of the 
Maillard reaction because it affects it in two ways; the first concerns the general 
rule of doubling the rate of a chemical reaction for every 10°C rise. The second 
consideration concerns the proportion of the sugar that is in the reactive acyclic 
(aldehyde or ketone) form of the monosaccharide, glucose for example has a four 
fold increase in its aldehyde form between 20°C and 60°C [3]. To avoid problems 
with varying rate of reaction due to different temperatures used in different 
experiments the work presented in this thesis (unless otherwise stated) was carried 
out at 37°C, the physiological temperature of humans. 
The time scale of discovery of the various parts of the Maillard reaction is very 
long. Schiff in 1900 first described the equilibrium between sugars, primary 
amines and what we know now as Schiffs base [4]. The reaction as a whole is now 
known as the Maillard reaction because in 1912,1916 and 1917 Maillard showed 
that, upon heating, reducing sugars reacted at various rates with different amino 
acids to produce darkly coloured compounds [reviewed in 2]. It was Amadori in 
1931 who showed that the Schiffs base of aldehydes rearranged to form what we 
know now as Amadori product, see figure 1.2. [5]. Ramsey et a1,1933 showed that 
proteins produced similar products to amino acids upon heating with reducing 
sugars, but it was Mohammed et al, 1949 who showed it was the free amino 
groups of the proteins that took part in the reaction [6 and 7]. In 1967 Heyns et al 
2 
reported a similar rearrangement reaction, to Amadori, of Schiffs base of ketones, 
to form what are now known as Heyns products [8]. 
The Maillard reaction is very important to the food industry because it affects 
nutrient availability, flavour, aroma and colour of cooked or stored foods 
[reviewed in 212]. During storage of foods with a high sugar content, such as milk 
(bovine milk contains an average of 0.13M lactose), free amino acids react with the 
sugar and because these products are indigestible it reduces the amino acids 
available to the nutrient pool [207,9 and 212]. The reaction of sugars with free 
amino acids during cooking is important for the production of the coloured and 
volatile compounds responsible for the colour, aroma and flavour of foods, for 
example the aroma and colour of bread and meat or the bitterness of coffee [212, 
10]. Some of the Maillard products produced by cooking protein-rich foods, 
especially meat and fish are very potent mutagens and carcinogens [212 and 11]. 
3 
-HA 
%'1 
HC 
H-C--OH 'OH+ 
ý ý 
/ýx C=N+HR 
/-A 
ÄH C- 
11 Immonium ion --11 
Schiffs base 
Amadori Product 
H2- NHR 
HO-Cý 
O 
C 
Schiffs base 
HCcNHR 
i H-ý-OH 
ý 
-HA 
H+ 
HC± NHR 
A 
H-CC-OH 
-C-OH 
Carbonium ion 
Fig. 1.2. Two possible routes for Amadori rearrangement, taken from Figs. 2 
and 3 of the review by Gottschalk (1966) [131. 
Eneaminol + HA 
H2CI -NHR 
C=0 04 - 
HC-NHR 
i 
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1.1. The Maillard reaction in vivo 
It was Maillard in 1912 who first postulated upon the significance of the reaction 
occurring in vivo. Glucose is present in circulation normally at a fasting rest 
concentration of about 5mM, but after a meal rises as a function of the amount of 
carbohydrate ingested. The hormones glucagon and insulin maintain euglycaemia; 
glucagon prevents hypoglycaemia by mobilising glycogen while insulin prevents 
hyperglycaemia by increasing uptake and utilisation of glucose. High loads of 
glucose result in hyperglycaemia because it takes time for the control by insulin to 
take place; the degree and duration of hyperglycaemia experienced is a measure of 
glycaemic control and can be tested by an oral glucose tolerance test (OGTT). An 
OGTT consists of drinking a solution of 50g glucose (75g in USA) while at rest, 
after an overnight fast and subsequent measurement of the blood glucose 
concentration at various times up to two hours after ingestion; the test is used as 
the basis for diagnosis of diabetes mellitus (which is hereafter referred to as 
diabetes). 
Figure 1.1.1. shows the results of a typical OGTT on a range of people as they age; 
the lowest line on the graph is typical of a 20 year old individual and shows a 
small rise in blood glucose, due to the oral load, that returns to normal within 
about two hours. As people age their sensitivity to insulin decreases and even 
though they produce more insulin, upon an OGTT their blood glucose rises higher 
and takes longer to return to basal levels. The top line on the graph is typical of a 
mild age-onset diabetic who responds poorly to the insulin that they do produce, 
i. e. the hyperglycaemia rises quite high and takes longer than 2 hours to return to 
basal levels. Type 1 diabetics also exhibit the same sort of curve as type 2 but 
produce much higher hyperglycaemia (20-40mM), due to the lack of insulin rather 
5 
than insensitivity to it. The gradual increase in insensitivity to insulin with age is 
why for many years type 2 diabetes was called age onset diabetes; up to 50% of the 
population in the USA is clinically or sub-clinically diabetic at age 70 [161. 
This thesis is concerned with the long term changes caused by the slight 
hyperglycaemia ever present in conventionally treated diabetics. If type 1 diabetes 
goes untreated, the impaired uptake of glucose, caused by the lack of insulin, 
accelerates triacylglycerol hydrolysis, fatty acid oxidation and ketone body 
formation. Ketones are acidic so ketosis (the build up of ketones) puts a strain on 
the buffering capacity of the blood and kidneys. The kidneys try to control ketosis 
by excreting protons which increases the blood pH, but also causes a loss of 
sodium and potassium ions along with inorganic phosphate and water; producing 
overall, the classic symptoms of diabetes, i. e. thirst and decreased blood volume. 
Ketosis is a serious condition that can lead to coma and death, so type 1 diabetics 
control their blood glucose by administration of insulin. 
Insulin is the dominant hormone over its antagonist glucagon, thus administration 
of too much insulin can suppress the blood glucose level below normal (called 
hypoglycaemia). Hypoglycaemia is dangerous because the brain is dependent on 
glucose for its energy supply and this condition can result in various the 
symptoms: - mood swings, sweating, change in pallor, a strong bounding pulse, 
shallow breathing and if left untreated will lead to coma, brain damage and even 
death. The constant daily danger of hypoglycaemia has meant that conventional 
insulin treatment has tried to produce a glucose concentration that was slightly 
above normal but not so high as to cause ketosis; this of course leads to a higher 
rate of glycation than occurs in a non-diabetic. 
Measurement of the amount of glycated protein (as a percentage of the total 
amount of that protein) indicates the degree of glycaemic control a diabetic has 
6 
had over the life-span or half-life of that protein. The methods commonly used in 
routine clinical laboratories for assessment of glycaemic control are glycated 
haemoglobin and the serum fructosamine assay, the various methods used to 
detect glycation are discussed in greater detail in section 1.4. The Maillard reaction 
is however important in vivo for another reason; the build up of AGEs is directly 
proportional to the development of diabetic secondary complications and also to 
normal ageing. 
7 
time after 50g oral load of glucose (mins) 
Fig. 1.1.1. Typical results of an oral glucose tolerance test (OGTT) on a range of 
people. The top curve is that of a mild type 2 diabetic followed by (in decreasing 
order) 50,40,30 and 20 year old individuals. 
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1.2. Diabetic secondary complications 
Insulin stimulates enhanced uptake of glucose, a lack of or insensitivity to insulin 
results in hyperglycaemia which in turn leads to an enhanced rate of glycation. 
The body controls the basal glycation, which occurs in everyone as an unfortunate 
side effect of using glucose as an energy source, by protein turnover. There is 
evidence of enhanced rates of such protein turnover stimulated by macrophages 
that detect the modified protein [17 and 18]. For many years hyperglycaemia was 
known to be a major risk factor for the development of diabetic secondary 
complications, but a connection between direct cause and effect was unproven and 
contentious. The diabetes control and complications trial (DCCT) in America has 
conclusively shown that hyperglycaemia is indeed the major risk factor in 
development of diabetic secondary complications [19]. It is the development of 
AGEs that is intimately connected with diabetic secondary complications; they 
have been shown, by a variety of methods, to increase in atherosclerosis, 
nephropathy, neuropathy and retinopathy as a function of age and to increase 
during the progression of these same diseases as diabetic secondary complications 
[20,21,22,23,24,25,26,27,28,29 and 30]. 
Excellent reviews of diabetic secondary complications are by Yki-Järvinen (1992) 
and Nathan (1993) and only brief descriptions are necessary here [22 and 31]. A 
number of the diabetic secondary complications described here involve thickening 
of endothelial basement membranes The thickening of the basement membranes is 
caused by tissue remodelling by the surrounding cells; such tissue remodelling 
could be initiated by macrophages responding to immunoglobulins trapped 
within the membrane or by direct recognition of an AGE modified protein [17,18 
and 215]. Interestingly the endothelial cells of murine coronary vasculature 
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endocytose labelled-AGE-albumin, that was in general circulation, and transcytose 
it to the abluminal surface, i. e. the basement membrane side. The accumulation of 
such labelled-AGE-albumin was reported to occur principally in the liver, lung, 
kidney, intestine and heart of mice into which it had been intravenously injected. 
The receptor for the AGE (RAGE) was reported to also occur in smooth muscle, 
mesangial cells and some neurons [2151. 
Retinopathy is a form of blindness caused by the formation of new capillaries 
over the retina that prevent light from reaching it. New capillaries are formed 
because the existing capillaries are blocked by the thickening of their basement 
membrane and increased platelet aggregation which restricts the supply of oxygen 
to the retina [22 and 32]. 
Corneal clouding and lens cataracts are due to a loss of order of the collagen 
fibrils or crystallin proteins respectively. The loss of regular protein packing is 
either due to AGE-cross-links between the proteins or an alternative theory holds 
that a build up of sorbitol causes osmotic pressure to disrupt the packing; the 
production of sorbitol is discussed on page 42 et sequa [33]. 
Nephropathy is a gradual loss of kidney function due to thickening of the 
glomerular and tubular basement membranes and a decrease in their heparan 
sulphate proteoglycan content. The kidneys gradually lose their ability to act as an 
ultrafilter and cannot retain protein, this is partly overcome but also exacerbated 
by increased glomerular filtration rate and renal plasma flow. The disease's main 
histological feature is proteinuria [22,21 and 34]. 
Neuropathy or impaired nerve conduction is associated with depletion of 
myoinositol and decreased sodium/ potassium ATPase activity, which means the 
nerve takes longer than normal to recover from an impulse. Activation of the 
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sorbitol pathway during hyperglycaemia depletes myoinositol and causes the 
characteristic changes in neuropathy [27,33,22 and 341. 
Macrovascular disease that includes arteriosclerosis, atherosclerosis and 
thrombosis are due to AGE-cross-linking, thickening of circulatory vessel 
basement membrane, deposition and modification of serum proteins (e. g. 
lipoproteins) into the membrane, altered blood viscosity and impaired endothelial 
dependent relaxation [21,35,36,37,22 and 23]. 
Secondary infections occur at a higher incidence in people who suffer from 
hyperglycaemia because of impaired neutrophil adhesion, chemotaxis and 
phagocytosis due to glycation of complement protein 3. Secondary infections of 
peripheral regions occur with increasing regularity with progression of peripheral 
vascular disease. The increased oxidative stress that the disease causes can 
exacerbate secondary complications that are already present in the diabetic 
individual and lower their quality of life [22]. 
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The risk factors associated with diabetes mellitus in America shown in the table 
below are quoted from Na than, (1993) 131]; 
Complication percentage risk of a 
diabetic developing the 
complication 
ratio of incidence of 
complication compared 
to non-diabetics 
visual impairment 14 - 
blindness 16 20 
renal failure 22 25 
stroke 10 2-3 
amputation 12 40 
myocardial infarction 
(heart attack) 
21 2-5 
median survival after 
diagnosis of IDDM 
36 years 
median age at death 
(IDDM) 
49 years 
Note that IDDM is an abbreviation for insulin dependent diabetes mellitus. 
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1.2.1. Insulin therapy 
Conventional insulin treatment consists of monitoring blood glucose 
concentrations on a daily basis and two daily insulin injections. The diabetes 
control and complications trial (DCCT) in America has shown that a strict insulin 
regime (i. e. at least 4 glucose checks which are used to self dose more than 3 
insulin injections per day) does significantly reduce the risk of secondary 
complications, compared to conventional treatment. The achievement of the lower 
risk is by the very tight glycaemic control; i. e. the prevention of hyperglycaemia 
and thus excess glycation. Such a strict regime is not without its problems, apart 
from the inconvenience of so many checks and injections there is a3 fold higher 
risk of hypoglycaemia and a tendency to gain weight [19,38 and 391. The first year 
of the strict regime after switching from conventional treatment has been reported 
to be problematic for diabetics with existing complications, e. g. retinopathy [40]. 
The strict insulin therapy reduces the rate of glycation considerably but not the 
progression of already glycated proteins to AGEs and thus secondary 
complications. In the patients studied it would appear that it takes one to two 
years before the build up of AGEs is limited by lowering the rate of glycation, 
such an occurrence would not, however, explain the initial exacerbation of the 
complications [39 and 401. One explanation could be that the free glucose and 
glucose-protein adducts (intermediates to AGE formation) compete for reaction 
with lysine residues on other proteins, e. g. sites of glycation and AGE-cross- 
linking are the same. Therefore reducing the mean glucose concentration with the 
strict insulin therapy allows more cross-linking of glycated protein (the 
concentration of which may only fall slowly) to newly formed proteins. AGEs 
produced in vivo at a faster rate, in such a manner, would lead to exacerbation of 
diabetic secondary complications. If this hypothesis is true it implies that glycation 
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actually inhibits AGE formation and in the absence of free sugar post-Amadori or 
post-Heyns reactions should proceed at a faster rate; Eble et al (1983) reported just 
such an effect for polymerisation of RNase in vitro [185]. 
Continuous subcutaneous infusion is another method for administration of insulin. 
Lauritzen et al (1983) reported that this produced a near normal basal glucose 
concentration of 6mM, but that this was not enough to prevent progression of 
proliferative retinopathy in patients with simple retinopathy [41]. Lauritzen's 
study was carried out for up to a year which may have not been long enough to 
allow turnover of AGE-proteins and subsequent remission of the diseases. 
Alternatively the insulin therapy by this method was not strict enough to reduce 
the rate of AGE formation to below the rate of their removal. 
The exacerbation of diabetic secondary complications, caused by a high rate of 
AGE formation upon maintenance of euglycaemia, could be prevented by 
administration of compounds that would inhibit post-Amadori or post-Heyns 
reactions. Such administration could cease after the first year of a strict insulin 
regime when the rate of glycation decreases to a level that the body can dear by 
protein turnover, as indicated by the studies described above [39 and 40]. 
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1.3. Production of Advanced Glycation End-products (AGEs) 
Figure 1.1. illustrates post-Amadori or post-Heyns reactions as a series of steps 
leading to production of AGEs, this is, however, an over-simplification of these 
reactions. There are probably many parallel multistep post-Amadori or post- 
Heyns reactions producing a wide variety of AGEs. The term AGE is itself a broad 
definition of a range of properties, e. g. fluorescence, chromophores, cross-linking 
and protein fragmentation. There is also evidence that these measures of AGEs 
may themselves be intermediates in the production of more AGEs; e. g. the 
production of brown pigmentation in food at the same time as a decrease in 
fluorescence [1731. Figure 1.3.1. illustrates the state of current knowledge of the 
AGEs produced from Amadori product. 
3-deoxyglucosone 
protein 
protein *-- 
0 
amino 
acids 
Fig. 1.3.1. 
represents 
7or 
(metal 
catalysed 
oxidation 
I 
ITS and visible 
chromophores 
__ý 
fluorescence ` 
(e. g. pentosidine) 
ý... ýý non-fluorescent 
cross-links 
ý--> CML, CMhL 
free radicals 
Summary of post-Amadori reactions as we know them now. AP 
Amadori product, CML carboxymethyllysine and CMhL 
carboxymethylhydroxylysine. 
15 
The characterisation of post-Amadori or post-Heyns reactions would be useful for 
the rational design of compounds to inhibit formation of diabetic secondary 
complications. The most ideal solution for the prevention of diabetic secondary 
complication is to achieve stable euglycaemia such as exists in people without 
diabetes; however glycation of proteins that have a long half-life, or not even 
turned over at all, will eventually lead to the AGE formation that occurs in 
everyone, increasing as a function of age [23,26,29 and 30]. If the Maillard 
reaction in vivo was interrupted and halted it could delay the onset of some of the 
diseases associated with old age, this is of course assuming that diabetic secondary 
complications are signs of accelerated ageing. There is also a case for such 
therapeutic interruption to inhibit advancement of diabetic secondary 
complications during the first year of strict insulin therapy in patients who were 
previously conventionally treated [40,39 and 41]. 
The next part of this section of the thesis is a brief description of the types of AGE 
illustrated in figure 1.3.1. 
1.3.1. Fluorescence 
The fluorescence produced as a result of glycation (AGE-fluorescence) has a very 
broad excitation and emission range, 300-400nm and 370-500nm respectively, 
probably because of the large number of compounds produced, which is further 
reflected by the variety of specific wavelengths quoted in the literature [10]. With 
the production of many similar fluorophores there is, inevitably, overlap of 
excitation and emission wavelengths and thus quenching. Apart from isolation of 
individual fluorophores by HPLC the literature suggests two sorts of approach to 
the problem. The first is to find which wavelength in the 300-400nm region that 
absorbs the most; excite at that wavelength and then scan at higher emission 
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wavelengths to find the maximum intensity; these two wavelengths are then used 
as the basis of the measurement. The second approach is to use the maximum 
fluorescence wavelengths of a known AGE biomarker, such as pentosidine, 
pyralline or furoyl-furanyl-imidazole (FFI), see figure 1.3.1.1. for their structures. 
The fluorescence wavelengths used in this thesis have tried to tackle the problems 
outlined above by using two sets of wavelengths. The first set corresponds to those 
of pentosidine as reported by Dyer et al (1991); i. e. excitation at 328nm and 
emission at 378nm, called pentosidine-linked fluorescence in this thesis [46]. The 
second set are those of the maximum of serum albumin after glucation or 
fructation as reported by Suarez et al (1989); i. e. excitation at 350nm and emission 
at 420nm, this I have termed albumin-specific fluorescence [14]. The problem with 
the first approach is that fluorescence does not necessarily derive directly from 
glycation alone, other fluorophores can occur under oxidative conditions (with or 
without the presence of saccharides). Products of lipid peroxidation, pyridium 
cross-links and tyrosine oxidation products are all fluorophores that will interfere 
with the assay of AGE-fluorescence [45]. 
Pentosidine [a] Pyralline [b] Furoyl-furanyl-imidazole [c] 
ribose 
N HN NN 
iii 
arginine (H2)3 
H (CH2)4 
lysine 
R 
R"/CRiý 
Fig. 1.3.1.1. Structures of some putative AGE biomarkers. The references in 
square brackets are; [a] = [42], b= [43] and c= [44]. R stands for the rest of the 
lysine residue and protein. 
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Pentosidine has been detected in vivo but in vitro forms less than 1% of AGE-cross- 
links detected and is thus only a minor product. The existence of pyralline in vivo 
has been cast in doubt by Smith et al (1993) and FFI has been reported to be an 
artefact of its own purification [46,47 and 48]. 
1.3.2. Cross-linking 
Pentosidine is not only a AGE-fluorophore, it is also a cross-link between lysine 
and arginine residues bridged by a ribose moiety, but note that pentosidine forms 
less than 1% of all AGE-cross-links formed by in vitro glycation [46 and 175]. AGE- 
cross-links can be subdivided into two distinct groups, those that are fluorescent 
and those that are not. Cross-linking can be measured as a function of increased 
resistance to degradation by chemicals and enzymes, which is the generally 
preferred method used to investigate proteins of high molecular weight such as 
collagen [187 and 178]. A second approach is to study the formation of oligomers 
of small proteins upon glycation, such as RNase, IgG, lysozyme, etc. [176,185,183 
and 197]. The approach I have used in this thesis is the cross-linking of small 
proteins to form oligomers identified on denaturing discontinuous SDS-PAGE. 
1.3.3. Protein fragmentation 
Protein fragmentation caused by glycation and metal catalysed oxidation (MCO) is 
another example of AGE formation, MCO is discussed in greater detail in section 
1.5.; but in relation to protein fragmentation: - Cheng et al (1991) reported that 
degradation of glycated protein in the presence of Cu(II) was not inhibited by 
scavengers of hydroxyl and super-oxide radicals; implying that, if free radicals 
were involved, their action was local to their site of formation [491. Similarly 
Kawakishi, Okawa and Uchida (1990) reported degradation of BSA exposed to 
Cu(II) and fructose-ß-alanine or fructose-p-toluidine (which are Amadori 
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compounds found in food and can chelate copper); the enzyme catalase (CAT) 
inhibited the degradation but scavengers of free radicals, other than hydroxyl, did 
not [501. 
1.3.4. Carboxymethyllysine 
Carboxymethyllysine and carboxymethylhydroxylysine (CML and CMhL) are 
degradation products of Amadori product. Cleavage between carbons 2 and 3 of 
the glucose residue of Amadori product results in CML and erythronic acid, see 
figure 1.3.4.1. [51]. 
Dunn et al (1989) reported that CML accumulated in lens protein as a function of 
age and the same group in (1991) reported the accelerated accumulation of CML in 
lens protein and skin collagen in diabetics compared to normal individuals [52 
and 53]. CML and CMhL are carboxylic acids that have a pKa of around 3 (that is 
as long as the pKa is not modified by other local residues), which is very different 
to that of lysine (pKa = 10). If in vivo the lysine residue that had become glycated 
was involved in molecular recognition of the protein, such a change in charge 
could in theory inhibit this recognition and alter the properties of the protein. 
Amadori product 
R---i-TH-NH-R' 
O (CH2)4 
NH 
CH2 + 
C=O 
HOCH 
(ý HOH)2 
CH2OH 
02 -1110 
R--"i-ýH-NH"R' 
0 (CH2)4 
CML 
erythronic 
I 
NH 
I 
iH2 
COOH 
+ 
COOH 
yuironic I 
acid (CHOH)2 
CH2OH 
Fig. 1.3.4.1. Formation of CML from Amadori product, reproduced from Fig. 3 of 
Ahmed, Thorpe and Baynes (1986) [51]. 
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1.3.5. AGE-chromophores 
The browning reaction is what food scientists sometimes use to refer to the 
Maillard reaction that occurs during the cooking of foods, to produce brown 
pigmentation. The reaction of reducing sugars and the primary amino groups of 
free amino acids in foods is an important source of the 'brown' chromophores; 
proteins will also absorb in the visible region of the spectrum when exposed to 
reducing sugar (13). In vivo chromophores that absorb in the visible region are 
thought to occur on proteins although the melaniodins frequently quoted may also 
be products of lipid peroxidation. The absorbance of AGE-fluorophores can also 
be measured in the UV region [10]. 
1.3.6. Free radicals 
Mullarkey et al (1990) reported that free radicals were produced from glycated 
protein at a rate some fifty times that of non-glycated protein [741. In contrast 
advanced glycation end-products have been reported to exhibit free radical 
scavenging properties [75]. Free radicals generated in vivo can result in oxidative 
stress, such stress probably exacerbates existing disease processes (e. g. diabetic 
secondary complications), this is particularly important in people of older age 
because the levels of super-oxide dismutase (SOD) and CAT in the blood decrease 
with age [70]. 
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1.4. Assays for glycation and AGEs 
This section of the thesis is a description of the various assays used to measure 
glycation and the subsequent AGE formation that occurs both in vivo and in vitro. 
The measurement of in vivo glycation is important to monitor the degree of 
glycaemic control a diabetic has had over the life-span of the protein assayed; this 
is important for calculating the dosage of insulin to be administered. In vitro, the 
assays are used as research tools for the study of the Maillard reaction. Although 
not all the assays described below have been used in this thesis, this is a useful 
point at which to include them for the reader's interest. 
Glycated haemoglobin is used to monitor the glycaemic control a diabetic has had 
over the past few months. Proteins that have been glycated have a lower pKa than 
their native counterparts (due to the modification of the lysine residue), thus 
separation of glycated Hb is achieved using its altered isoelectric point. N-terminal 
glycation produces a species of Hb called HbAl that encompasses four subspecies 
designated HbAlai, HbAla2, HbAlb and HbAlc. Glucose produces HbAlc and 
this fraction contributes about 4% to the total haemoglobin in normal patients but 
in uncontrolled diabetes up to 20% has been observed (148]. Different methods 
used to assess glycaemic control use different Hb subfractions; the methods range 
from measurement of total glycated haemoglobin (GHb, all subfractions), through 
to HbAic on its own. More thorough reviews of the measurement of glycated 
haemoglobin can be found in Mortensen (1982), Standing (1992) and Kilpatrick 
(1994) [54,148 and 55]. 
The serum fructosamine assay measures ketones under alkali conditions and is 
aimed at measuring Amadori product of HSA; figure 1.4.1. illustrates the 
mechanism of the fructosamine assay as proposed by Baker et al, (1994) [581. The 
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assay relies on the production of an eneaminol from Amadori product under alkali 
conditions, this in turn reduces the nitroblue tetrazolium to form a blue black 
colour that can be quantified spectrophotometrically. The method is difficult to 
standardise because the colour varies with the protein, dye concentration, pH, 
temperature, interfering compounds (aldoses; e. g. glucose and Schiffs base) and 
assay time. Koskinen et al (1992) and Das et al (1992) have reported problems with 
the assay in clinical laboratories that are due to the non-specificity of the proteins 
used (all serum proteins) and have reported that only about half of a positive 
result is due to glycated protein [56 and 57]. 
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Fig. 1.4.1. The postulated reaction mechanism for formation of reduced NBT 
from Amadori product. Reproduced from Fig. 6 of Baker et al (1994) [58]. 
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The periodate assay relies on the release of formaldehyde upon cleavage of 
adjacent carbons or C-N bonds carrying hydroxyl or carbonyl groups upon 
reaction with sodium periodate. In practice this means that the structures known 
to give a positive result include free sugars, Schiffs base, Amadori product and 
chain terminal reducing sugars of glycoproteins; thus to measure Amadori 
product the other compounds must be removed. There are two possible isomers of 
Heyns product of which only the minor form will yield formaldehyde upon 
periodate oxidation. AGEs or their precursors may also yield formaldehyde upon 
periodate oxidation, this is however difficult to quantify without knowledge of the 
structures of these compounds. A description of the assay protocol can be found in 
section 2.7. 
The thiobarbituric acid (TBA) assay measures hydroxymethylfurfural (HMF) 
released by acid hydrolysis of sugars with 6 or more carbon atoms. It measures 
free sugar, Schiffs base, Amadori product, and the carbohydrate residues of 
glycoproteins if they are acid labile. Thus to measure glycation, free sugars and 
glycoproteins have to be removed prior to the assay. A similar assay is used to 
measure lipid peroxidation and the reactive substances are termed thiobarbituric 
acid reactive substances (TBARS). 
Phenylboronate chromatography relies on the complexation of the column matrix 
with coplanar cis-hydroxyl groups such as those on Amadori product. A solution 
of glycated protein is applied to the column, non-glycated protein is eluted off and 
glycated protein remains on the column. Comparison of the protein concentration 
in the solution applied to the column with that of the eluted solution allows 
calculation of the amount of protein that has become glycated. Problems with the 
method include; the non-detection of products of glycation that do not have 
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coplanar cis-hydroxyl groups, interference by glycoproteins and non- 
quantification of glycation at more than one site on a protein. 
Shima et al (1988) coupled phenylboronate chromatography with HPLC to assay 
for glycated human serum albumin [61]. Increased glycation of apolipoprotein B in 
diabetics (types 1 and 2) was reported by Panteghini et al (1994) using 
phenylboronate chromatography coupled to immunonephelometry [62]. 
Sodium borohydride reduces Schiffs base and Amadori product to deoxyhexitols 
that are acid stable; the glycated amino acids are then identified by acid hydrolysis 
of the protein followed by amino acid analysis. This method can be complimented 
with mass spectrometry or enhanced by the use of tritiated borohydride. 
The furosine assay was developed by Schleicher and Weiland (1981) to 
specifically detect Amadori product [63]. The method relies on strong acid 
hydrolysis of Amadori product (6M HCI, 95°C for 18 hours) to form furosine 
which can be quantified on reverse phase HPLC. 
The development of AGE-chromophores and fluorescence are characteristics of 
AGEs that are almost universally used throughout the literature. A problem with 
fluorescence is the lack of characterisation of fluorescent AGEs and the 
enhancement or quenching of their fluorescence by other AGEs, thus forming very 
broad fluorescence spectra. 
Reduced activity of enzymes upon glycation is potentially a very sensitive 
technique; Dolhoffer (1982) and Ganea (1988) reported the loss of activity in a 
variety of enzymes as a result of glycation using physiological concentrations of 
sugars [64 and 65]. 
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AGE-cross-links can be detected either by the increase in molecular weight using 
methods such as SDS-PAGE with denaturation of disulphide bridges (discussed in 
more detail in chapter 5. ), or by resistance to degradation by chemicals and 
enzymes, which is a useful way of measuring glycation in large proteins such as 
collagen [1791. 
Molecular recognition of AGEs by antibodies is another potentially powerful 
technique but suffers from the lack of characterisation of AGES and is only as 
specific as the method used to select the antigen or antibody. Cohen et al (1989) 
reported the use of monoclonal antibodies raised against in vivo glycated human 
serum albumin, isolated by phenylboronate affinity chromatography [661. In 
(1993) the same group reported glycated apolipoprotein B concentrations in non- 
diabetics and diabetics using the same method [671. 
Excellent reviews of the methods described above include Furth (1988) and 
Schleicher and Wieland (1989) [59 and 60]. 
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1.5. Glycoxidation 
The term glycoxidation was coined to emphasise the link between AGE formation 
and oxidation, specifically metal catalysed oxidation. In vitro AGE-cross-linking of 
collagen, formation of CML, fluorescence and protein aggregation requires 
oxidative conditions. Glycation under nitrogen (exclusion of oxygen); inclusion of 
the metal chelators diethylenetriaminepentaacetic acid (DTPA) or desferrioxamine; 
the reducing agents dithiothreitol (DTT) or penicillamine; the free radical 
scavengers' thiourea, mannitol (hydrogen peroxide, hydroxyl and super-oxide 
radicals) and the enzyme catalase (CAT) all inhibit AGE formation with a 
corresponding build up of Amadori product [134,179,177 and 72]. Glycoxidation 
requires free metal because oxygen-centred free radicals cannot directly react with 
biological molecules due to spin restriction, thus it requires the intervention of free 
metal (Cull or FeIII) to relieve the restriction [68]. Free copperll can, at high 
concentrations (200µM), induce BSA to polymerise; however in vivo, there is only 
about 1.5µM copperll that can take part in oxidative reactions in the serum and 
this is mostly bound to albumin; the majority of copper in circulation is stored 
bound in caeruloplasmin (about 14µM in normal individuals). Total serum copper 
increases as a function of age while concentrations of SOD, glutathione peroxidase 
and CAT are stable until old age whereupon they decrease. Thus, an increase in 
oxidative stress could be a major factor in the pathogenesis of diabetic secondary 
complications in non-insulin dependent diabetes mellitus (NIDDM). [69 and 70]. 
The phosphate buffer used in this thesis contains free copper and iron at a 
concentration that varies according to the stock used but both have a maximum 
concentration of between 2 and 5µM [207]. 
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Le Guen et al (1992) reported that the inclusion of SOD during in vitro glycation 
accelerated the development of AGE-fluorescence and concluded that hydrogen 
peroxide, free metal and hydroxyl radicals were all involved in AGE formation 
[72]. The generation of free radicals by Amadori product has also been reported to 
be a mechanism for the further oxidative damage of protein and protein with lipid 
[73 and 74]. Conversely mellanoidins, the term used for brown pigmented AGEs 
and products of lipid peroxidation, are reported to be scavengers of free radicals 
[173 and 75]. 
Metal catalysed oxidation and free radicals have been linked to the pathogenesis 
of many diseases associated with ageing; e. g. Alzheimers disease, cataractogenesis, 
pulmonary emphysema and exacerbation of tissue injury after stagnant hypoxia 
(caused by return of blood flow after, for example, stroke or heart attack) [76,77 
and 78]. Inflammatory diseases such as rheumatoid arthritis have been attributed 
to oxidative stress caused by the presence of oxidatively modified IgG. 
Neutrophils react to the modified IgG by releasing super-oxide to destroy it, but 
the super-oxide also oxidises previously unaltered IgG perpetuating the disease 
[79]. A similar mechanism has been suggested by the same group to be involved in 
the pathogenesis of atherosclerosis [78]. The accelerated ageing seen in diabetes 
could be linked to the co-ordination of free metal to the sugar moiety of glycated 
protein; the complex formation is likely since saccharides will strongly complex 
first row transition metals [80]. There are other free radicals produced in vivo that 
could exacerbate existing disease processes. Nitric oxide is now known to be the 
endothelial relaxing factor. Nitric oxide has been reported to cause release of iron 
from ferritin and in places of low super-oxide concentration, such as 
atherosclerotic plaques, acts as an oxidant [81 and 82]. Nitric oxide will also react 
with super-oxide (without the influence of free metal) to produce another free 
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radical called peroxynitrite that has been reported to be about 2000 times as 
reactive as hydroxyl radical in the initiation of lipid peroxidation and DNA 
scission [82]. Free radicals derived in vivo from sources other than free metal are 
receiving increased attention among researchers; iron-containing proteins have 
been reported to produce free radicals which could contribute to disease processes 
[71]. 
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1.6. Glycation by sugars other than glucose 
Glucose is present in circulation, in vivo, at a concentration much higher than any 
other sugar. Glucose also exhibits the lowest percentage open chain form (0.002% 
aldehyde at 20°C in aqueous solution) of any of the reducing sugars surveyed by 
Angyal (1984) [15]. Bunn and Higgins (1981) surveyed the reactivity of a range of 
monosaccharides with haemoglobin and found that glucose forms an adduct with 
the protein at a very low rate compared to other reducing sugars. The low 
percentage of open chain form was postulated to be the reason for the low 
reactivity of glucose with haemoglobin; hence glucose is the universal primary 
metabolic fuel rather than any of its stereoisomers [83]. The Maillard reaction with 
respect to glucose can be termed glucation to distinguish it from other sugars and 
is illustrated in figure 1.6.1. 
The food industry has long been concerned with sugars other than glucose because 
of their abundance in food and the fact that they form AGEs more rapidly than 
glucose. Burton and McWeeny 1963 reported that mannose, galactose and, in 
general, all ketoses formed chromophores with glycine at a faster rate than glucose 
[84]. 
This thesis is concerned with in vivo glycation where, with the exception of 
glucose, free reducing sugars are scarce. The human gut will absorb three 
monosaccharides (glucose, galactose and fructose) all of which are detected in 
circulation. Galactose is absorbed in the small intestine by active transport and its 
concentration prior to removal by the liver is dependent on the concentration in 
the ingested food or drink; in general circulation its concentration rarely rises 
above 1mM and has a basal concentration of around 0.1mM [85 and 2071. A major 
dietary source of galactose is in the form of lactose in milk. Deficiency of the 
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enzymes of galactose metabolism (three recessive disorders) causes galactosaemia, 
the symptoms of which are mental retardation, sugar cataracts and even death if 
untreated. The formation of cataracts due to galactosaemia is assumed to be 
analogous to that of diabetic cataract [85]. Fructose is available in vivo from two 
sources, dietary intake and the polyol pathway. 
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1.6.1. Dietary fructose and its metabolism 
Fructose is naturally abundant in the western diet in the form of a monashacharide 
(honey, apples, pears) and as a disacharide (sucrose) [89]. Fructose as a 
monosacharide is sweeter than sucrose, thus the use of high fructose corn syrups 
(HFCS) as sweeteners, has become more prevalent in the food industry; up to 90% 
of the carbohydrate in HFCS is fructose. HFCS are used primarily in the 
manufacture of soft drinks and convenience foods; their use has increased 
dramatically over the past 25 years both as a function of their substitution of 
sucrose and with the increased consumption of these goods [89 and 901. 
The average daily consumption of fructose varies in the literature, the majority of 
information originates from figures of food consumption issued by the US 
department of agriculture. Swanson et al (1992) reported 46g per day as an average 
for the population of America, this represents 10% of total daily calorific intake 
[911. Park and Yetley (1993) (using the same data) reported 15g per day in infants, 
54g per day in 15 to 18 year old males with an average for the whole US 
population of 37g per day which represents 7-9% of total calorific intake [901. 
Previous reports using the same source of information have also put the estimate 
of daily intake at 70g or between 50 and 100g mostly in the form of sucrose [92,93 
and 96]. Rumessen (1992) reported that when sucrose consumption is fully taken 
into account the highest consumers (15 to 18 year old males) consume an average 
of 150g daily which the article claims to be 4% of the total daily calorific intake 
[89]. 
If 50g (as a 10% solution) of fructose is ingested without the presence of another 
monosaccharide, 37.5% of the population will malabsorb fructose, producing 
bloating, flatulence and diarrhoea; this figure rises to 71% of the population if the 
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50g is ingested as a 20% solution. Fructose absorption is stimulated by 
simultaneous ingestion of glucose in a dose dependent manner, malabsorption 
only occurs if fructose is in excess of glucose [89]. Fructose is actively transported 
by a sodium-dependent stereospecific carrier called GLUT5 at a rate 60-90% that of 
glucose; the rate is partly dependent on the carrier concentration which in turn is 
dependent on the historical fructose content of the diet [94,89 and 95]. The 
concentration of fructose in the hepatic portal vein is largely dependent on the oral 
load and up to 2.5mM has been reported, while intravenous infusion of 1.5g per 
kg per hour produced 7mM [96]. 
Figure 1.6.1.1. shows a diagram of the metabolism of fructose as adapted from 
Shafrir (1985) and Gitzelman et al (1989) [standard texts of glycolysis, 93 and 96]. 
Fructose enters the liver by insulin independent active transport, here the enzyme 
fructokinase adds a phosphate group to carbon-1. Fructose-1 -phosphate is a 
substrate of aldolase which converts it to glyceraldehyde and 
dihydroxyacetonephosphate which then enter the glycolytic pathway. 
34 
Glycogen 
079 
A Pi 
G-1-P 
(15) 
GLUCOSE ATP (9) _6_P14) 50-75% (10) 
(18) 
Pi 
ATP (13) 
SORBITOL -(6L- FRUCTO (9) F-6-P 
ATP Pi ATP 
(1) (12) 
(11) 
F-i-P F-1,6-Di-P 
Acyl-DHA-P ý-ý 19ý DH, A-P 
(21) 
ý4ý 
AcetylCoA 1 
i 
NADPH + H+ Glycerol-3-P 
(8) IIATV 
I 
ATP 
ý-- 
ýZC 
LPPA Glycerol ý---ý- GAH ºGAH-3-P , ý, , _. Ii.. ._. lai a 1"41 . ACCLYLLAAV ArptvlCnA 1-1 AL %-i 
6 
AcetylCoA `"' A %°j t /-w\ 1.. " 
tzz1 
1 (3) _ 
(16) ATP I 
PPA ----- ºPhospholipids D-Glycerate ,, 2-P 
- 
-GA 
.w : (23) : 
ýpj 
;' ý24) 
Diacylglycerol Monoacylglycerol ý/ýý-- 
(25) cetylCoA 
AcetylCoA 
Triacylglycerol 
1-3% 
Lactate 
20-60% 
Fig. 1.6.1.1. Metabolism of fructose, the proportion of the products is represented 
by the percentage figures. Adapted from standard texts of glycolysis and refs. 93 
and 96. 
(17) 
T Alanine -w Pyruvate --- -TCA Cycle 
35 
Key to figure 1.6.1.1. 
Abbreviations; DHA = dihydroxyacetone; GAH = glyceraldehyde; F= fructose; 
G= glucose; GA = glycerate; LPPA = lysophosphatic acid; PPA = phosphatic acid: 
Enzymes; 1) fructokinase; 2) aldolase B; 3) triokinase; 4) glycerol-3-P 
dehydrogenase; 5) alcohol dehydrogenase and aldose reductase; 6) sorbitol 
dehydrogenase; 7) triose phosphate isomerase; 8) glycerol kinase; 9) hexokinase 
and glucokinase; 10) glucose-6-phosphatase; 11) fructose-1,6-bisphosphatase; 12) 
phosphofructokinase; 13) phosphohexose isomerase; 14) phosphoglucomutase; 15) 
glycogen phosphorlyase; 16) aldehyde dehydrogenase; 17) glycerate kinase; 18) 
aldose reductase; 19) dihydroxyacetone phosphate acyltransferase; 20) glycerol-3-P 
acyltransferase; 21) acyl-dihydroxyacetone phosphate reductase; 
22) 1-acylglycerol-3-P acyltransferase; 23) phosphatidic acid phosphatase; 
24) 2-monoacylglycerol acyltransferase; 25) diacylglycerol transferase; 26) aldolase 
A&C. 
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The high reactivity of fructokinase has been implicated in the production of 
hyperuricaemia and lactic acidosis that is observed with high doses (>lg per kg 
per hour) of intravenously administered fructose [96]. The lactic acidosis occurs 
because fructose metabolism bypasses phosphofructokinase which is the first 
regulatory enzyme of glycolysis and thus leads to a build up of lactate, see figure 
1.6.1.1. Hyperuricaemia occurs because the phosphorylation of fructose, by 
fructokinase, causes a build up of ADP and depletion of inorganic phosphate. This 
change triggers adenylate kinase to convert 2ADP to ATP and AMP; a build up of 
AMP is prevented by its catabolism, by AMP deaminase, to IMP which in turn is 
dephosphorylated to inosine (cytoplasmic-5-nucleotidase). Inosine is catabolised in 
2 steps, by nucleoside phosphorylase and xanthine oxidase, to produce uric acid 
and 2NADH [93 and 96]. 
Figure 1.6.1.1. shows the end products of fructose catabolism as ranges of 
percentages, the proportions of the final products formed are dependent on the 
concentration of fructose ingested [96]. High oral fructose loads have been 
reported to lead to increase the intracellular concentration of hexose phosphates 
which then inhibits glucose uptake in the liver [93]. This could have profound 
implications on the degree of hyperglycemia experienced by diabetics. The 
increased concentration of serum triacyglycerol caused by diets with normal 
western intake of fructose has been linked to hyperlipidaemia, atherosclerosis and 
coronary artery disease but is also affected by age, sex (hormone status), average 
serum glucose concentration, insulin concentration and resistance to it [93,97 and 
98]. Hyperinsulinaemic men are more susceptible to hyperlipidaemia when 
consuming average amounts of dietary fructose than the same men on low 
fructose diets or normal controls [92]. 
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1.6.2. Concentration of fructose in general circulation 
The high rate of uptake of fructose by the liver ensures that its concentration in the 
blood of general circulation is very low with a basal range of 0.03 to 0.1mM; the 
range represents differences in the methods used to detect fructose [99]. Marks and 
Flatt (1989) reported that serum fructose never exceeds 1mM upon an oral load 
while Gitzelmann reported 0.35mM [85 and 96]. Haber et a! (1977) studied serum 
fructose after eating apples, apple puree or drinking apple juice; after an overnight 
fast a maximum of 0.44mM was observed 1 hour after the meal. The apple meals 
contained 60g of available carbohydrate of which 10% was fructose (as a 
monosaccharide or as sucrose); the largest rise was observed with consumption of 
444m1 of juice [100]. MacDonald et a! (1978) reported a maximum fructose 
concentration, in the blood, of 0.53mM (SE ± 0.03mM) 1 hour after ingestion of 1g 
per kg (25% solution), after an overnight fast; a rise in serum fructose was 
approximately half when fructose was substituted with sucrose [101]. A maximum 
serum fructose concentration of 0.41mM was reported after ingestion of 75g of 
fructose (as 25% solution) by fasted normal healthy individuals [102]. 
Some pathologies adversely affect serum fructose concentrations upon an oral 
load. MacDonald and Turner (1971) studied atherosclerotic men and obtained 
maximum serum fructose concentration of -0.8mM when, after an overnight fast, 
they ingested 2g per kg of sucrose (as a 100% solution), while age matched normal 
controls exhibited a similar response as normal young men, i. e. a maximum of 
-0.3mM. Notably in this study the serum glucose concentrations in the 
atherosclerotic men were no different to their age matched controls yet in the 
former group the fructose concentration rose higher and remained elevated for 
longer [1031. Higher serum fructose concentrations were also observed, after 
administration of 100g of sucrose, in elderly type 2 diabetics compared with 
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normal healthy young controls [104). Bantle et al (1986) studied serum fructose 
concentrations of type 1 and 2 diabetics after starch (control), sucrose and fructose 
diets; the percentage of total calorific intake of these diets contributed by fructose 
were <5%, 11.5% and 21% respectively. The starch diet gave a maximum serum 
fructose concentration of 0.1mM in both types of diabetics; the sucrose diet gave 
0.2mM in type 1 and 0.3mM in type 2 diabetics; the fructose diet produced a 
maximum of 0.3mM in both types of diabetic although one individual had a 
concentration of 0.9mM [105]. The one individual that exhibited a fructose 
concentration of 0.9mM, in their blood after a fructose meal, could have had 
undiagnosed liver cirrhosis; liver disease would result in such a loss of its 
function. I have made this suggestion on the basis that glucose intolerance and 
liver cirrhosis are diseases that often occur together [106]. Avgerinos et al (1992) 
reported maximum serum fructose concentrations of 0.3mM in people with normal 
liver function upon ingestion of a meal high in sucrose, while cirrhotics with good 
liver function had a maximum of 0.8mM and those with poor liver function 2mM 
upon ingestion of the same meal [107]. 
The studies described above indicate that the concentration of fructose in the blood 
of general circulation is, with a normal balanced diet, never very high. The 
concentration does however increase after ingestion of foods that contain fructose. 
This concentration may be high enough to cause a rate of fructation beyond that 
which the body is able to destroy by turnover of proteins. Fructation from dietary 
fructose is particularly relevant to diabetics because of its use in foods 
recommended for their consumption. Diabetics produce AGEs from glucation that 
contribute to the formation and progression of diabetic long term complications, 
fructation can only add to this load and exacerbate the complications. 
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1.6.3. The Polyol Pathway 
The polyol pathway seems to occur in tissues that do not need insulin for the 
uptake of glucose. It is of great interest that such tissues also exhibit the long term 
complications of diabetes, i. e. lens, retina, cornea, nervous system and kidney. The 
pathway consists of the two enzymes aldose reductase and sorbitol dehydrogenase 
and it converts glucose to fructose via sorbitol, see figure 1.6.3.1. 
glucose 
OH 
sorbitol 
NADPH 
YH2OH 
+ H+ NADP H-y-OH NAD NADH 
fructose 
OH 
OH 
ý HO-ý-H ý Z, -; --ý--OHCH20H 
I 
EC 1.1.1.21 H-ý-OH dehydrogenase OH 
CH2OH EC 1.1.1.14 
aldose reductase H- y -Uri sorbitol 
Fig. 1.6.3.1. The polyol pathway. 
Aldose reductase is the most extensively studied enzyme of this pathway because 
it can be inhibited by a wide variety of compounds (termed 'aldose reductase 
inhibitors') of which sorbinil is the most widely known. Prevention of 
accumulation of sorbitol by such inhibitors has been hailed as a possible 
therapeutic measure for the prevention of diabetic secondary complications. This 
conclusion relies on the osmotic effect of sorbitol which, as a sugar alcohol, poorly 
penetrates cell membranes and thus accumulates and exerts intracellular osmotic 
pressure. The resultant over-hydration could disrupt a collagen matrix within a 
tissue such as the cornea and produce the effects seen in the secondary 
complications of diabetes. Aldose reductase has a low affinity for glucose, thus 
only binds glucose during hyperglycaemia. The accumulation of sorbitol during 
hyperglycaemia is an alternative theory to glycation and AGE formation for the 
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development of diabetic secondary complications and is extensively reviewed by 
Cohen (1987) [108]. 
Cohen (1987) in her review reported that sorbinil prevented progression of 
diabetic retinopathy in NIDDM patients, improved corneal re-epithialization of an 
IDDM woman with keratopathy and improved neural and glomerular Na/K- 
ATI'ase activity in diabetics [108]. Aldose reductase inhibitors do not however 
prevent glucation or glycation by catabolites of glucose; Lorenzi et al (1987) 
reported a three fold accumulation of glucose-6-phosphate (from glucose via 
hexokinse) in cultures of human endothelial cells, from human umbilical veins, 
when exposed to 20mM glucose and 0.1mM sorbinil [109]. 
Suarez et al (1988) reported inhibition of skin collagen AGE-fluorescence in 
diabetic rats treated with sorbinil; i. e. some of the in vivo fluorescence was derived 
from fructose. Additionally the AGE-fluorescence spectrum of the collagenase 
solubilised skin was indistinguishable from that of fructated BSA [110]. The same 
group in (1989) reviewed the fructose concentrations within various tissues with 
active polyol metabolism. In the 15 papers cited, the fructose concentration within 
the tissues of normal individuals was not less than 0.05mM and was much higher 
in diabetics, not less than 1.24mM. In the lens of a human diabetic, fructose 
concentrations up to 12mM have been cited [111]. The activities and concentrations 
of the enzymes of the polyol pathway differ between tissues and species, thus the 
ratio of sorbitol to fructose also varies, for example in the human lens, fructose is 
the major metabolite [108]. 
41 
1.6.4. In vitro fructation 
Ketoses in general have a lower reactivity than aldoses (approximately fifty fold 
lower), but the rate of glycation is also dependent on the relative concentration of 
the acyclic, reactive form of the sugar. Therefore fructose, which is 0.7% acyclic at 
20°C in aqueous solution, has a potential reactivity with primary amines some 7.5 
times faster than glucose [15 and 133]. This figure corresponds well to the 
observed rate of reaction of fructose with haemoglobin reported by Bunn and 
Higgins (1981) (an in vitro study that used reduction by [H3]-sodium 
cyanoborohydride to trap Schiffs base) [83]. The figure for the percentage of 
acyclic fructose has been reported by Yaylayan et al (1994) to have been 
underestimated by Angyal (1984) (0.7%), the proportion of the high energy open 
chain form of monosaccharides depends on the temperature and pH of the 
solution that contains it [86 and 15]. I have termed the Maillard reaction with 
respect to fructose, fructation, to distinguish it from glucation; a diagram of the 
known chemistry of fructation is illustrated in figure 1.6.4.1. 
The table in figure 1.6.4.2. is a summary of the results of a number of publications 
investigating fructation. It would be presumptuous to compare the actual figures 
presented in these articles with each other because of the different experimental 
conditions used. The literature also tends to confuse the picture of fructation with 
the use of assays for glycation that underestimate fructation [209]. An example of 
this is the furosine assay adopted by Sakai et al (1990), the assay only detects 
Amadori product, thus any positive result produced from fructation is probably 
due to rearrangement of Heyns to Amadori products [198]. The conclusions that 
can be drawn by comparison of the literature include: 
42 
The higher rate of Schiffs base formation from fructation of haemoglobin 
compared to that of glucation reported by Bunn and Higgins (1981) supports the 
evidence for fructose having a higher percentage of reactive acyclic form than 
glucose [83]. Lapolla et al (1994) measure glycation as a function of increases in the 
molecular weight of a protein, i. e. a sugar-protein adduct has a higher molecular 
weight than native protein. The results of this article indicate that incorporation of 
fructose into RNase is at least three times faster than glucose [115]. A higher rate of 
reactivity for fructation compared to glucation is also supported by the higher rate 
of AGE formation from fructose cited in the literature. 
The above paragraph logically concludes that because the concentration of the 
reactive form of fructose is higher than that of glucose, the rate of AGE formation 
would be higher upon glycation with the former. There are, however, two articles 
that confuse this neat scenario. Suarez et al (1989) reported that glucose and 
fructose blocked the primary amino groups of BSA at the same rates, yet fructation 
yielded ten times more fluorescence [14]. A later paper by the same group 
suggested that a possible explanation for this phenomenon could be; free fructose 
covalently reacts with the amino group of Heyns product such that two fructose 
residues are bound to a single lysine residue; the two fructose residues may in this 
way form a pyrrole by aldol condensation [87]. The second paper was by 
McPherson et al (1988) who reported that [U-14C]-glucose was incorporated at the 
same rate as [U-14C]-fructose into RNase, yet AGE formation on RNase was faster 
upon fructation than glucation. These results are not logically consistent, similarly 
the same paper reported that glucose was incorporated into HSA some 8 times 
faster than fructose, which is inconsistent with rates of AGE formation, for the two 
sugars, presented throughout the literature. A duplicate experiment carried out by 
myself is presented later in this thesis [88]. 
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Fig. 1.6.4.2. In vitro studies of fructation; 
sugar protein results Ref. 
concentration studied 
0.002 to 0.05M Hb rates of reduction with borohydride [83] 
glucose 0.0006 per mM per hour 
fructose 0.0045 per mM per hour 
0.2M polymerisation after 28 days glycation 
glucose fructose [112] 
BSA >1% -14% 
RNase >7% -18% 
lysozyme >7% -40% 
0.5M RNase fluorescence polymerisation [88] 
at 15 days per mg (% oligomer) 
glucose 53 
fructose 15 17 
0.5M BSA after 50 days glycation comparison [14] 
of glucation with fructation showed; 
the same number of blocked amino groups; 
fructation exhibits more absorbance and 10 
times more fluorescence than glucation. 
0 to 0.1M BSA fluorescence (units/mg) [113] 
sample 7 days 14 days glycation 
control 0.128 0.358 
glucose 0.377 1.1 
fructose 0.82 2.4 
sorbitol 0.13 0.37 
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Fie. 1.6.4.2. continued. 
0.2M collagen fluorescence (units per mg) [199] 
days of incubation 
sample 0 7 14 
control 0.84 1.14 1.29 
glucose 1.01 1.63 4.01 
fructose 1.22 11.3 18.21 
digest with collagenase (% before glycation) 
days of incubation 
sample 0 7 14 
control 100 - 95 
glucose 100 - 87 
fructose 100 - 44 
0.2M collagen Furosine (%) 
days of incubation 
[198] 
sample 0 7 14 
control 7 6 8 
glucose 7 187 304 
fructose 8 19 42 
0.5M a and g 
crystallins 
after 2 months fructation there is; 
an increase in periodate positive material, 
cross-linking, unfolding, aggregation and 
resistance to denaturation. 
decreased tryptophan absorbance and 
fluorescence 
[114] 
0.025 & 0.25M RNase increases in molecular mass as detected by 
matrix assisted laser desorption, 
occurs earlier upon fructation compared 
with glucation. 
[115] 
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1.6.5. In vivo fructation 
Direct evidence of in vivo fructation caused by dietary fructose can be seen in 
hereditary fructose intolerance (HFI). There are 3 types of this inborn error of 
metabolism; 1. fructokinase deficiency; 2. aldolase B deficiency; 3. fructose-1,6- 
biphosphatase deficiency. The first is seen medically as benign since it only leads 
to high serum fructose concentrations and fructosuria, however, the fructation 
occurring in these patients remains to be revealed. Aldolase B reversibly splits 
fructose-1 -phosphate to D-glyceraldehyde and dihydroxyacetone phosphate. 
People with a deficiency in aldolase B suffer gastrointestinal discomfort upon 
ingestion of foods containing fructose, continued eating causes hypoglycaemia and 
can be lethal, patients are treated with a fructose free diet. The third prevents 
gluconeogenesis which can be a problem with continued fructose ingestion but the 
main problem is lactic acidosis and uricaemia [961. Bohles et al (1987) reported 
increased HbAlab in HFI patients of the second variety of inborn error. The 
concentration of fructated haemoglobin was similar to that of glucated Hb found 
in diabetics, the authors attributed this finding to the small amount of fructose that 
is always present in a diet that is supposed to be free of it [150 and 1161. 
Burden (1984) reported a case of a juvenile IDDM with good glycaemic control yet 
high glycated haemoglobin. When reducing substances were tested for in her 
urine, fructose was found. The patient regularly ate diabetic foods that use 
fructose as a sweetener, substitution of these foods with other carbohydrates (other 
than glucose) brought the glycated haemoglobin within the normal range within 2 
months without affecting her glycaemic control [151]. 
Direct evidence of in vivo fructation, where it is probable that the fructose was 
derived from the polyol pathway was reported by Walton, McPherson and Shilton 
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(1988) and (1989). Ten to twenty percent of glycated human ocular lens protein 
was fructated. The group first showed the production of N-(2-deoxyhexitol-2- 
yl)lysine (2HL) from fructation and N-(1-deoxyhexitol-1-yl)lysine (1HL) from 
glucation. These deoxyhexitols, which are derived from borohydride reduction of 
Heyns and Amadori products were identified using HPLC and spiking with 
synthetic 1HL and 2HL [88 and 200]. The lens contains no cells only an outer 
epithelial layer, therefore the source of the fructose for production of Heyns 
product, remains to be elucidated. 
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1.7.3-Deoxyglucosone 
An alternative hypothesis for the formation of AGEs from fructose was proposed 
by Shin et al (1988). This involved the production of the dicarbonyl compound 3- 
deoxyglucosone (3-DOG). The basis of this hypothesis was the discovery that 
fructose at pH5.5 and 100°C produces 3-DOG. Although these optimal conditions 
are non-physiological, Shin et al (1988) argued that there will be some 3-DOG 
production from fructose at physiological pH and temperature (112]. 
Igaki et al (1990) reported that proteins incubated with 3-DOG produce the same 
types of AGE as monosaccharides [186]. Thus 3-DOG is a possible agent for 
development of AGEs, that is free in solution and highly reactive. Shin et al (1988) 
reported that fructose cross-linked succinylated lysozyme, whereas glucose did 
not, using arginine residues rather than the blocked lysine residues. The reaction 
of fructose with the side chain of arginine residues is negligible, thus 3-DOG was 
proposed by Shin et al (1988) to be the cross-linking agent involved, especially 
because it had been detected after incubation of monosaccharides with native 
protein. Ames (1993) reported that 1,2-enolisation of Amadori product produces 3- 
DOG, which reacts with primary amines and Amadori product to produce 
pyrrolaldehydes which rearrange to form bispyrroles [212]. Figure 1.7.1. is a 
summary of the reactions of 3-DOG, reproduced from Ames (1993) [212]. 
3-DOG is likely to be an important post-Amadori intermediate to AGE formation 
because of its occurrence in vivo. Niwa et al (1993) reported that the concentration 
of serum 3-DOG in diabetics was twice that of normal individuals and 4 times in 
diabetics with nephropathy [119]. In vivo metabolism of 3-DOG produces the less 
reactive compound 3-deoxyfructose (3-DOF) [118]. Knecht et al 1992 reported that 
the concentration of 3-DOF in fasting human plasma was some six times higher 
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than 3-DOG [118]. The same group in 1994 reported that diabetics had roughly 
double the concentration of 3-DOF in their urine than normal controls [120]. 
The rearrangement reactions of Amadori product and fructose, to form 3-DOG, are 
not redox reactions; yet protein glycated (using glucose, fructose or other 
monosaccharides) in the presence of a metal chelator, produces virtually no cross- 
linking. Note that metal chelation did not inhibit cross-linking mediated by 3- 
DOG under the same conditions [206]. The results of the article by Prabhakaram 
and Ortwerth (1994) indicate that if 3-DOG is produced in any quantity from 
Amadori product and fructose, then it requires free metal to form [206]. 
3-DOG is no doubt an important compound in the production of AGES. The 
amount of its contribution to AGE formation from fructose is, however, open to 
question. Shin et al (1988) reported that 3-DOG was produced some 1.3 to 2 times 
faster in a fructose protein solution than a glucose protein solution. AGE-cross- 
linking of the proteins in the same solutions was, however, 6 to 7 times higher for 
fructation of lysozyme than glucation; similarly 15 times for BSA, 2 to 3 times in 
RNase and 2 fold in ovalbumin [112]. The relative contribution of 3-DOG to AGE 
formation will vary with the sugar and protein in question and in certain systems 
this route may only be minor. 
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1.8. A brief review of the proteins used in this study 
The model proteins used in this study include serum albumin (human and 
bovine), lysozyme, ß-lactoglobulin and RNase. A thorough review of previous 
studies of the Maillard reaction using these proteins was published by Cox (1991) 
and only a brief review is included here [1211. 
Amadori rearrangement is an acid catalysed reaction so the sites of glycation on 
the various proteins are principally or initially on lysine residues with a low pKa, 
or in sequences near side chains that act as proton donors. In serum albumin Iberg 
and Fluckiger (1986) noted that the most reactive sites were in Lys-Lys, Lys-His, 
Lys-Lys-Lys and Lys-His-Lys sequences [122] 
Serum albumin is the major blood protein in humans; it is found in vivo at a 
concentration that decreases with age but with a mean of about 45mg ml-1 [127]. 
Serum albumin is rich in lysine, arginine, cysteine and aspartic acid and has a low 
number of tryptophan and methionine residues. The high content of cysteine 
residues is reflected by 17 disulphide bridges that maintain the high stability of 
the 3 repeat domains that make up the molecule. Serum albumin is an important 
transport protein of inorganic cations, organic anions, drugs, amino acids, 
bilirubin haemin and fatty acids which are, in the majority, hydrophobic ligands. 
The three repeat domains of serum albumin form an ellipsoid structure with 53% 
of its secondary structure in the form of a-helix. The secondary structure of 
albumin is very sensitive to glycation; one mole of 2-amino-2-deoxyglucose adduct 
per mole of human serum albumin reduces its a-helix content to 32% [1231. There 
are 59 lysine residues in the sequence of serum albumin of which 10 have been 
shown to become glycated. In vivo the principle site of glycation is Lys-525 (33% of 
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total reaction) while in vitro it is Lys-199; the difference is likely to be due to the 
fatty acids hydrophobically bound around Lys-199 in vivo. The fatty acids 
sterically hinder glycation in vivo but it is very likely that they are inadvertently 
removed during purification [124]. Lys-199 and 525 are thought to be the favoured 
sites of glycation because of the low pKa that surrounds these sites, this catalyses 
Amadori rearrangement shifting the equilibrium of glycation away from 
dissociation of Schiffs base. 
Lysozyme is an anti-bacterial enzyme found widely in nature; it cleaves the ß(1-4) 
linkage between N-acetylmuramic acid and N-acetylglucosamine, the monomeric 
constituents of bacterial cell walls [128]. Within the 129 residues of lysozyme are 6 
lysines, all of which occur on the external surface with two in sequence (Lys-96 
and 97). 
Lysozyme has been used as a model for the study of the Maillard reaction mainly 
by the Kato group in Japan. Cox (1991) reviews their work more thoroughly than 
in the remit of this thesis [121]. The Kato group have concentrated on cross-linking 
of lysozyme and other proteins using various sugars; they report that such cross- 
linking is mediated by free carbonyl compounds (other than the monosaccharides) 
generated during the course of the Maillard reaction. 3-Deoxyglucosone was 
identified as a major carbonyl compound generated in a protein sugar mixture and 
the group have proposed that this is the main cross-linking agent [112]. 
ß-lactoglobulin is an abundant milk protein that exists in vivo in various 
hydrophobically bound oligomeric states depending on pH, temperature and 
concentration. It is a 0-barrel protein with a strongly hydrophobic interior, this is 
utilised to transport retinol and fatty acids, although its exact function is unknown 
[129 and 1301. The protein contains 162 residues with 15 lysine residues; there are 
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two Lys-Lys sequences at 69,70 and 100,101 that could catalyse Amadori 
rearrangement [125]. 
The study of (3-lactoglobulin in relation to the Maillard reaction has been mostly 
analysis of the ß-lactoglobulin-lactose adduct found in milk, especially stored or 
processed milk. Lactose is bound to ß-lactoglobulin via the glucose residue leaving 
the galactose moiety free; this forms a powerful antigen that is proposed to be one 
of the most common food allergens. Five such antigenic sites on the f3- 
lactoglobulin-lactose adduct have been identified and all occur on surface lysine 
residues [121]. 
Hitz and Dain (1988) reported that ß-lactoglobulin incorporated an unusually high 
number of sugar residues per mole of lysine as other proteins. This occurred even 
though the protein did not incorporate as many moles of sugar residues than other 
proteins [126]. There was no explanation by Hitz and Dain 1988 for the results for 
ß-lactoglobulin, but they could be due to the involvement of amino acids other 
than lysine in the Maillard reaction as proposed by Shin et al (1988) [112]. 
Alternatively, addition of more sugar residues to the lysine-sugar adduct, possibly 
by aldol condensation, is occurring; such a mechanism was proposed by Suarez 
(1991) for the production of pyrroles [87]. 
Ribonuclease (RNase) cleaves RNA and is a single polypeptide of 124 amino acids 
containing 10 lysine residues. The three most reactive lysine residues (1,7 and 41) 
have a low pKa and lie near the phosphate binding region of the active site; the 
bound phosphate has been reported to catalyse Amadori rearrangement [138 and 
1391. McPherson et at (1988) reported that RNase incorporated glucose and fructose 
at the same rate over the first few days of exposure, yet fructose clearly produced 
more AGEs [88]. 
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1.9. Aims and objectives of this thesis 
The overall aim of the work presented in this thesis is to investigate fructation. 
There are, however, a number of particular points that need to be addressed. 
1. To clarify the connection between rates of incorporation and subsequent AGE 
formation. 
2. To compare AGE formation from glucation and fructation. 
3. To develop an assay for fructation that will quantify it on a molar basis. 
4. To use the fructation assay to elucidate the Mallard reaction as it pertains to 
fructose. 
5. To develop a model to illustrate the cross-linking between a fructated and non- 
glycated protein in the absence of free sugar. Thus to mimic fructation in vivo. 
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2. Methods 
All chemicals were purchased either from BDH laboratory supplies Ltd, Poole, 
U. K. or Sigma Chemical Co. Ltd., Dorset, U. K. Radiolabels were purchased from 
Amersham International plc, Amersham, Bucks, U. K. 
2.1. Buffers 
The water used in all experiments presented in this thesis was equivalent to 
double distilled, purified using a Elgastat option 3 ultra high quality (UHQ) water 
purifier. Elgastat quote that no ion or free metal in its UHQ water has a 
concentration greater than 0.2µg/l; free copper iron have concentrations of <0.01 
and <0.02. tg/l respectively. All buffers contained 3mM azide as a bactericide and 
were made up to pH7.4 (adjustment of the pH was either with the salts themselves 
or with HCl and NaOH). Unless otherwise stated the buffer used was O. 1M 
sodium phosphate, other buffers used were 10mM HEPES, 10mM TES and 0.5% 
(w/v) ammonium bicarbonate. 
2.2. Proteins 
The proteins used in this thesis include; serum albumin (fraction V), hen egg 
lysozyme, bovine milk ß-lactoglobulin and bovine pancreas ribonuclease A. The 
proteins were purchased from Sigma at various levels of purity; 95% pure 
lysozyme also contains ovalbumin (45kD) and an unknown protein of a molecular 
weight of -73kD. 98% pure ß-lactoglobulin contained two variants, A and B, 
which differ only by two amino acids; ß-lactoglobulin also contained a covalently 
linked dimer, probably produced as a result of Maillard type cross-linking by 
lactose. RNase A (type X11-A, >99% pure), essentially protease and salt free was 
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used in the radiolabelling experiments. Serum albumin (human and bovine) was' 
purchased as either 96 to 99 % pure or essentially globulin free (>99% pure); the 
less pure form contained many serum globulins, mostly of a molecular weight 
lower than the 66kD of serum albumin, removal of these contaminants was by 
agarose electrophoresis to produce the 99% pure form. Delipidated serum albumin 
was also purchased from Sigma. The method used to delipidate the protein used 
charcoal to avoid denaturation, the same method was also used in some 
experiments to remove lipid from glycated albumin [171]. 
2.3. In Vitro glycation 
Preparation of AGES was carried out by glycating the various proteins described 
in section 2.2. Protein and sugar were separately made up to double concentration 
in the appropriate buffer and mixed together in equal volumes. The protein-sugar 
mixture was then incubated in the dark (to prevent photo-production of free 
radicals) in a Memmert universal oven (model UM 100/1) at 37°C. Aliquots were 
removed periodically and frozen at less than -20°C. The pH of the incubation 
buffer was checked at intervals to ensure it did not change. 
2.4. Removal of unbound sugar 
All manipulations of non-frozen, non-diluted sample were carried out on ice. 
Removal of unbound sugar was carried out at 4°C in a cold room or refrigerator. 
Micro-dialysis was carried out using a Bethesda research laboratory (Life 
Technologies Inc. Gaithersburg MD 20877 USA) micro-dialysis kit with either 6- 
8kD or 12-14kD cut-off membranes. Exhaustive dialysis was performed against 
either phosphate or bicarbonate buffers over 4 days with 8 changes of dialysis 
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buffer and each change of buffer represented a dilution of at least one hundred 
fold. 
Size exclusion chromatography combined with ultrafiltration was used in one 
experiment for very rapid removal of free sugar. Sephadex G25 was hydrated, for 
2 hours, with phosphate buffer and then packed into a column (1cm by 10cm). The 
total, elution and void volumes were calculated from calibration using 10mg/ml 
haemoglobin in phosphate buffer. 200µl of fructated lysozyme was applied to the 
column and the 500µ1 fraction that corresponded to the protein peak was collected. 
Amicon Microcon concentrators (1OkD cut off) were used to reduce the 500µ1 
eluted fraction to 5Oµ1(1 hour, 14000g at 4°C). The microconcentrators also had the 
effect of further removing free sugar, 90% removal of small molecules is claimed 
by the manufacturers [131]. The concentrated samples were then diluted with a 
solution of ß-lactoglobulin, in phosphate buffer, to give a final protein 
concentration of 10mg/mi for both proteins. 
2.5. Sugar-free re-incubation 
After removal of free-sugar from glycated protein a second native protein was 
added, either as lyophilised powder, such that the final concentration of the two 
proteins was equal. Alternatively if the glycated protein had been concentrated 
during removal of free sugar, it was diluted into buffer containing the native 
protein, again the final concentrations of the proteins were equal. The two protein 
(glycated and native) were then re-incubated at 37°C in the Memmert universal 
oven. A second native protein was introduced in buffer diluted to an appropriate 
concentration such that both proteins were of known concentration. Aliquots were 
removed at appropriate intervals, or the whole sample was removed after a set 
time, and stored at -20°C until needed for assay. 
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2.6. Measurement of protein concentration 
Protein concentrations were measured in duplicate using the micro method kit 
from Pierce. The assay is based on the co-ordination of copper with protein using 
the method of Smith et al (1985) [132]. Briefly, glycated protein was separated from 
free sugar, which interferes with the assay, and diluted to approximately 
1mg ml-1. To 20gl of standard (0 to 2mg ml-1) or sample on a microplate, was 
added 200µ1 of detection reagents A and B (see below for recipe) which were 
mixed in a ratio of 50: 1. The microplate was covered and samples vortexed on a 
Wellmix 1 microplate stirrer before 30 minutes incubation at 37°C. The protein 
concentration of the samples were calculated from absorbance at 570nm (a typical 
calibration graph is illustrated in figure 2.6.1. ). 
Contents of detection reagents as reproduced from Smith et al (1985) [1321: Reagent 
A, 1% disodium salt of bicinchoninic acid, 2% Na2CO3. H20,2% disodium 
tartrate, 0.4% NaOH, 0.95% NaHCO3 with further addition of the last two to 
adjust the pH to 11.25: Reagent B, 4% CuSO4.5H20. 
When appropriate, the protein concentration of serum albumin was measured 
using its absorbance at 280nm on a Cecil 4000 spectrophotometer. The assumption 
was made that 1mg ml-1 of non-glycated serum albumin had an absorbance of 
0.67 at 280nm when read against distilled water (the assumption was also checked 
using the Pierce protein assay). The production of AGE chromophores on diluted 
glycated protein was measured in a similar manner using a range of UV 
wavelengths. 
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2.7. Periodate assay 
Periodate positive material, including Amadori product was measured by 
periodate oxidation, according to the micro-assay method of Ahmed (1992); the 
protocol of which is as follows [133]; 
1. Prepare fructose calibration standards from 0 to 60nM in the same buffer as 
the sample (usually bicarbonate buffer). 
2. In duplicate pipette 60gl of sample (10mg ml-1 of protein) or fructose 
standard to 1.5ml eppendorfs; 
3. Add 30µ1 of O. 1M HCl, followed by 30gl of 0.05M NaIO4, vortex and allow 
to react at room temperature for 30 minutes. 
4. The reaction is stopped by placing on ice and adding 30gl of pre-cooled 
0.7M NaOH, followed by 30µl of pre-cooled 15% ZnSO4 (w/v) 
5. Vortex and centrifuge at 14000g for 10 minutes to form a pellet of the 
precipitate. 
6. Remove 100µl of supernatant to a microplate and add 200µl formaldehyde 
detection reagent (1Oml 3.3M ammonium acetate with 46µl acetyl acetate). 
7. Cover the microplate and incubate for 1 hour at 37°C. 
8. Measure the absorbance at 405nm. I used a Bio-Tech microplate autoreader 
(model EL311, Luminar Technology, Hampshire). 
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2.8. Fluorescence 
Fluorescence was measured on an Aminco Bowman fluorimeter, model J4-8960, or 
a Perkin Elmer fluorimeter, model LS50B, (spectral band width: 10nm for both 
excitation and emission). Calibration of both machines was carried out using ing 
ml-1 of quinine sulphate made up in O. 1M H2SO4. All measurements were made 
in at least duplicate, the results were corrected for any daily changes in the 
fluorescence readings of the quinine sulphate standard and expressed as relative 
fluorescence per mg of protein. 
Fluorescence was measured at the wavelengths that correspond to the maximum 
for the AGE biomarker pentosidine (excitation 325nm and emission 375nm) or that 
attributed to the maximum for glycated BSA (excitation 350nm and emission 
420nm) [14]. The concentration of protein used for the fluorescence measurements 
was never more than 1mg ml-1, such that the UV absorbance did not exceed more 
than 1 and quenching of the fluorescence was reduced to minimum. 
Fluorescence spectra were measured by either exciting at a single wavelength and 
measuring the emission spectra or vice versa. 
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2.9. SDS-PAGE 
Discontinuous sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed according to the method described by Laemmli 1970 [135] 
on Bio Rad minigels (8 x 10cm, 1mm thick). The constituents of the gel, unless 
otherwise stated, were; 
Resolving gel: 15% (w/v) acrylamide, 0.4% (w/v) PDA, 0.75M Tris-HC1 pH8.8, 
0.1% (w/v) SDS, 0.5% (w/v) ammonium persulphate and 0.5% (v/v) TEMED all 
made up in ultra pure water. The gel was topped with water to exclude 
atmospheric oxygen (polymerisation is inhibited by oxygen) and poured off after 
the gel had set. Any remaining water was removed with a corner of tissue before 
layering of the stacking gel. 
Stacking gel: 4% (w/v) acrylamide, 0.1% (w/v) PDA, 0.124M Tris-HC1 pH6.8, 
0.1% (w/v) SDS, 0.05% (w/v) ammonium persulphate and 0.1% (v/v) TEMED all 
made up in ultra pure water. A comb was inserted to obtain sample wells. 
Sample preparation 50 W of protein sample, diluted to 1mg ml-1 with 
appropriate buffer, was boiled for 5 minutes with 25µl of freshly made sample 
buffer; 200mM Tris-HCJ pH6.8,10% (v/v) glycerol, 5% (w/v) SDS, 0.01% (w/v) 
bromophenol blue and 5% (v/v) 2-mercaptoethanol. 
Molecular weight markers: Markers ranging from 14 to 66 kD were re-constituted 
in phosphate buffer and underwent the same preparation as the samples before 
loading on to the gels. The markers were obtained as a pre-mixed lyophilised vial 
(code; SDS 6) from Sigma, Pool, Dorset, UK. 
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Electrophoresis: Once the stacking gel had set, the minigel apparatus was 
assembled and running buffer (25mM Tris base, 192mM glycine and 0.1% (w/v) 
SDS at pH8.3) poured over the top and bottom of the gel to complete the circuit. 
l0µ1 of freshly boiled sample or marker were applied to the wells of the stacking 
gel. Once all the samples or markers had been loaded, the apparatus was 
connected to a Bio Rad power supply, 170V was applied until the bromophenol 
blue was near the bottom of the resolving gel (about 1 hour). 
2.9.1. Gel staining 
Gels were either stained with colloidal Coomassie brilliant blue (CCBB) or Bio Rad 
silver stain plus. 
CCBB staining: After electrophoresis the gels were removed to a single dish and 
stained overnight according to the optimal one step method of Neuhoff (1988), 
with additional destaining in the storage solution (20% ammonium sulphate) 
overnight [136]. This method has the advantage over conventional Coomassie 
staining in that it utilises the colloidal properties of the stain; the fixing, staining 
and destaining steps are all combined in a single step. A second advantage of this 
method is its sensitivity, the method has been reported to detect as little as 0.5-1ng 
of protein compared to other conventional Coomassie brilliant blue methods that 
have a detection limit of around 0.2-0.5µg of protein [136]. The only drawback of 
the method is that the stain has to be made fresh each time otherwise the 
Coomassie brilliant blue precipitates out and the colloidal properties are lost. 
The protocol; 
1. Overnight staining, on a rocking table, in 0.1% (w/v) Coomassie brilliant 
blue, 2% (v/v) phosphoric acid, 10% (w/v) ammonium sulphate and 20% 
(v/v) methanol. The stain was most easily prepared if the Coomassie 
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brilliant blue was dissolved in the methanol and the ammonium sulphate in 
water before mixing the two together with phosphoric acid. 
2. Brief wash of the gels and staining vessel with 25% (v/v) methanol to 
remove adsorbed CCBB stain. 
3. Overnight destaining in storage solution (20% ammonium sulphate, w/v). 
Bio Rad silver stain plus: After electrophoresis, gels were removed to separate 
vessels that had been cleaned with 50% (v/v) nitric acid and rinsed with water. 
The gels were then stained according to the manufacturer's instructions [137]. 
Figure 2.9.1.1. compares the CCBB stain with that of Bio Rad silver stain plus, both 
of these stains have similar sensitivities (0.5-1. Ong of protein per band) but give 
slightly different staining patterns [1371. Samples of a solution of lysozyme and ß- 
lactoglobulin in phosphate buffer were incubated at 37°C for 7 days with and 
without O. 1M fructose. The two samples were then prepared in sample buffer and 
loaded (using 13.4µg of protein in 10µl of sample buffer per lane) onto two 15% 
SDS polyacrylamide gels; after simultaneous electrophoresis one of the gels was 
stained with the CCBB stain and the other with silver. If the sugar-free controls 
(lanes A and C in Fig. 2.9.1.1. ) are regarded as the standard stain for these 
proteins, lanes B and D illustrate the effect of 7 days fructation on the stain. Some 
loss of monomer with fructation would be expected due to cross-linking, however 
silver staining indicates almost complete loss of ß-monomer (lane B), while CCBB 
staining of the same sample (lane D) does not indicate any such loss. In contrast, 
fructated lysozyme is less well defined in the CCBB stain than the silver. The silver 
stain also fails to stain the high molecular weight aggregates that are very clear on 
the CCBB stain. The 28kD lysozyme homodimer and 32kD heterodimer are clear 
with both stains although the contrast becomes better on the CCBB when it has 
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been further destained by overnight storage in 20% ammonium sulphate (w/v, 
results not shown). 
The addition of sugar residues to what was a positively charged lysine residue by 
glycation possibly inhibits binding of SDS and thus complete denaturation of the 
protein. Incomplete denaturation causes proteins to run as diffuse rather than 
discrete bands upon SDS-PAGE, thus the greater the extent of glycation the 
broader the protein band in the gel. Figure 2.9.1.1. illustrates that the Bio-Rad 
silver stain is also inhibited by glycation. The manufacturers informed us that 
glycosylated proteins are poorly stained, thus glycation is probably preventing the 
stain by a similar mechanism. 
The mechanism of initiation of silver staining is obscure and various amino acids 
have been implicated; polyhistidine gives the most intense reaction out of all the 
water soluble amino acids but lysine, cysteine, methionine, aspartic acid and 
glutamic acid also play a role [202]. It is probable that fructation of ß-lactoglobulin 
sterically hinders the site of silver ion complexation; either by the hexose itself 
blocking the site, or by inducing a conformational change in the protein that buries 
the site of complexation. This suggests that the glycation of ß-lactoglobulin could 
be followed by loss of silver staining after SDS-PAGE. Conversely, Hodny et al 
have used silver stain to show glycation of collagen and BSA, they attribute the 
more intense staining that they have found, as a function of the period of 
glycation, to silver ion complexation with Maillard reaction products [203 and 
204]. 
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Fig 2.9.1.1. A comparison of the staining by colloidal Coomassie brilliant blue 
and Bio Rad silver stain plus. The control lanes A and C represent 7 days 
incubation of lysozyme and ß-lactoglobulin without free sugar. Lanes B and D 
included O. IM fructose during the 7 days of incubation. 
67 
Silver stain 
ý-lactoglobulin homodimer 
ý 
luft--" 
heterodimer 
lysozyme homodimer 
ß-lactoglobulin 
lysozyme 
S 
tiý 
ýý 
.ýýý -"-ý. 
ý 
ýW 
;; Qw 
--ý. 
CCBB stain 
qw ab .. 
f Qýý - 
ý 
; 11 
iy. 
ý. ý""- , 4! 
201 
ý ýýýýý 
AB CD 
Fig 2.9.1.1. A comparison of the staining by colloidal Coomassie brilliant blue 
and Bio Rad silver stain plus. The control lanes A and C represent 7 days 
incubation of lysozyme and ß-lactoglobulin without free sugar. Lanes B and D 
included O. 1M fructose during the 7 days of incubation. 
67 
2.9.2. Photography and Densitometry 
Photography: Gels were photographed using a Polaroid Land Camera and type 53 
film with various apertures and exposure times used to obtain the best contrast of 
bands against the background. 
Densitometry: Gels were scanned using a LKB Ultroscan XL laser densitometer 
with smoothing and band width detection for integration set to 0.1mm, i. e. a 
detection resolution of 0.1mm. The amount of oligomer produced by glycation is 
expressed as a percentage of the total amount of stain in that lane. A problem with 
this method in quantification is that in order to observe cross-links that are only a 
minor product, the gels have to be overloaded. Therefore the absorption by 
stained monomer might exceed the bounds of the Beer-Lambert law, thus 
underestimating monomer concentration. Because the other bands are expressed 
as a percentage of total stain for the whole lane these would thus be over- 
estimated. 
The LKB densitometer uses a laser that emits light at the red end of the visible 
spectrum and thus is at the optimum for absorption by Coomassie brilliant blue. 
The silver stain, however, absorbs in the blue green area of the visible spectrum 
(actual wavelengths depend on the protein stained), thus poorly stained minor 
products are also poorly quantified using this densitometer. Since the CCBB stain 
is as sensitive as the silver and is more readily quantified, the CCBB stain has been 
used as the standard stain in this thesis unless otherwise stated. 
The gels were finally dried using a LKB 2003 slab gel dryer and stored in a low 
humidity environment. 
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3. Conditions necessary for AGE formation from fructose 
3.1. Introduction 
Fructation is an area that has not previously been extensively studied, partly 
because it is not detected by the assays normally used to detect glycation [209]. It 
was therefore necessary, before a more in depth study of fructation was 
undertaken, to investigate the conditions required for AGE formation from 
fructose, using methods that can relate it to glycation by other sugars, particularly 
glucose. This chapter of the thesis investigates the effect of different experimental 
conditions on a readily available measure of fructation, i. e. fluorescence. The rate 
of development of fluorescence due to glycation by glucose and fructose is also 
compared to the rates of incorporation of the two sugars. 
I have already reviewed the literature concerning studies of fructation in section 
1.6. but a brief recapitulation is necessary here. Throughout the literature fructose 
produces AGEs at a faster rate than glucose, the actual rates vary according to the 
experimental conditions and AGE studied. However, the picture of what happens 
in the Maillard reaction between free fructose and production of AGEs is very 
confused by the contradictory results published by a number of authors. Suarez et 
al (1989 and 1991) reported that the rate of blockage of primary amino groups of 
BSA by glucose and fructose was the same; the higher rate of AGE formation from 
fructose was attributed to the addition of more than one molecule of fructose per 
lysine residue, with the resultant structure forming a pyrrole [14 and 87]. This 
hypothesis could be modified considering the work by Shin et al (1988) [112]. The 
similarity in loss of primary amino groups, upon glucation or fructation, may be 
illustrating similar rates of production of Amadori and Heyns products; the 
additional AGEs observed upon fructation, compared to glucation, may be due to 
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enolisation of fructose to 3-DOG which will produce AGEs via arginine. Studies 
using radiolabelled monosaccharides indicate that fructose forms Schiffs base with 
haemoglobin some 7.5 times faster than glucose, which tends to indicate that 
Heyns product would form some 7.5 times faster than Amadori product [83]. 
Conversely McPherson et al (1988) report that HSA incorporated glucose eight 
times faster than fructose and RNase incorporated both monosaccharides at the 
same rate [88]. I have repeated the experiment reported by McPherson et al (1988) 
to try and shed some light on the confused picture of fructation painted by the 
literature [88]. 
In vitro experiments investigating disease processes are usually set up so that the 
conditions mimic those in vivo. Phosphate buffer is used almost exclusively 
throughout the literature for the study of AGE formation, although the exact 
conditions vary from paper to paper. Watkins et al (1987) reported that the 
inorganic phosphate complexes with RNase near the site of glycation and catalyses 
Amadori rearrangement [138]. The same group, in 1992, reported that a 
component of phosphate buffer was taking part in post-Amadori reactions because 
increasing the concentration of the buffer increased the rate of AGE formation 
[133]. The group have since reported that it is the free metal of phosphate and 
other inorganic buffer that takes part in post-Amadori reactions; if the free metal is 
chelated or if organic buffers (which have a low concentration of free metal 
contamination) are used, then AGE formation is inhibited [51,134,139,140,138 
and 140]. 
In order to produce detectable amounts of AGEs, many in vitro studies glycate for 
long periods of time with high concentrations of sugar. Although such an 
approach does produce AGES, there may be reactions occurring that are non- 
physiological. In vitro experiments set up to mimic conditions in vivo will produce 
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results that are more relevant to the pathology of diabetes. This chapter is a good 
place to show how AGE formation relates to monosaccharide concentration. 
Several authors have shown that the glucose incorporation into protein and the 
subsequent AGE formation is directly proportional to the glucose concentration up 
to 40mM [141,148 and 1851. Meriesh et al (1982) reported similar results up to 
0.14M glucose, however interpolation of the points on figure 2, of the article, 
would have produced an exponential growth curve rather than the least squares fit 
presented [142]. The results of these articles indicate that above a glucose 
concentration of 40mM the Maillard reaction is not proceeding at the same rate as 
below 40mM. Thus experiments using glucose concentrations that exceed 40mM 
may be investigations of non-physiological reactions. If this hypothesis is true then 
much of the literature concerning the Maillard reaction in vivo could be criticised 
and said to have been studies of artefacts. The problem of the low yield of AGEs 
upon glycation with physiological concentrations of sugar has been overcome by a 
more sensitive assay, namely the study of inactivation of enzymes due to 
glycation. Ganea (1988) reported decreased activity of several enzymes upon 
glycation with as little as 5mM glucose over 6 days incubation [65]. 
The study of production of chromophores upon glycation was largely outside the 
remit of this thesis because the classic browning products, (melanoidins) of food 
science are both Maillard and lipid peroxidation products. Note that melanin, the 
dark pigmentation of skin, hair, etc. is an oxidation product of tyrosine and 
dihydroxyphenol compounds, and should not be confused with the Maillard 
reaction. This chapter is however a convenient place to illustrate the changes in 
absorbance spectra of protein due to glycation. Two types of chromophore are 
reported in the literature; those that occur in the UV region, which are probably 
the absorbance of fluorophores and those that occur after production of 
fluorophores in the visible region [51 and 14]. 
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3.2. Aims 
1. To compare the rate of incorporation of glucose and fructose into various 
proteins. 
2. To compare the rate of radiolabelled hexose incorporation with the subsequent 
rate of development of AGE-fluorescence. 
3. To illustrate the effect of various buffers on the development of AGE- 
fluorescence. 
4. To investigate the effect of sugar concentration on development of AGE- 
fluorescence. 
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3.3. Methods 
The incorporation of hexose into protein was investigated by glycating native 
HSA, BSA (40mg ml-1) and RNase (type X11-A, 20mg ml-1) with glucose or 
fructose (0.1M) that had been spiked with 46tCi of the appropriate [U-14C]- 
monosaccharide. The duplicate samples were incubated at 37°C for 8 days in 0.1M 
phosphate buffer. At appropriate time points during the 8 days, 25µl of each 
sample was removed in duplicate. To the 25µl aliquot was added 0.5m1 of 10M 
fructose; this was to compete with the labelled monosaccharide for sites of non- 
specific adsorption to the protein. The protein was precipitated by addition of 
0.5ml of cold 20% trichloroacetic acid (TCA) and centrifugation at 14000g for 5 
minutes to form a pellet. The supernatant was pipetted away for appropriate 
disposal and the pellet resuspended in 0.5m1 0.5M sodium hydroxide. It was 
necessary to wash the protein by repeated precipitation and resuspension, with 
TCA and NaOH, 6 times before all excess (non-covalently bound) labelled hexose 
was removed (results not shown). The final resuspension was in lml of 0.5M 
sodium hydroxide which was transferred to scintillant and the counts per minute 
measured. The activity of the protein and thus the total moles of sugar (labelled 
and linear extrapolation to non-labelled) incorporated into that protein were 
calculated by daily calibration of the scintillation counter with lml of radiolabel 
diluted with NaOH. All radioactivity was accounted for and disposed of 
according to local rules. The recovery of the protein from the vigorous washing 
procedure was determined, using non-labelled protein, by measuring the protein 
concentration, by its absorbance at 280nm and by the Pierce protein assay (page 
58), before and after the washing procedure. The percentage recovery of the 
proteins were approximately 80% for the serum albumins and 10% for RNase. All 
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results are expressed per mole of protein to take into account any loss of protein, 
but the low recovery of RNase makes interpretation of the results very difficult. 
The incorporation of hexose into protein was compared to the fluorescence (page 
62) of samples glycated in an identical manner but without the radiolabel spiking. 
The effect of different buffers (all pH 7.4) on AGE fluorescence was studied by 
substitution of phosphate buffer with non-buffered double distilled water, 10mM 
TES or 0.5% bicarbonate buffers. The results shown are the change in fluorescence 
that occurred during 7 days Eructation. 
The effect of sugar concentration on development of AGE-fluorescence was 
investigated using 10mg ml-1 BSA (fraction V) incubated for 0,5 and 10 days with 
various concentrations of glucose and fructose. 
Formation of AGE-chromophores was investigated by either glycating BSA 
(fraction V) with 0.2M glucose for up to 18 days or fructating (0.1M fructose) 
essentially globulin free HSA (fraction V, ~99% pure) for up to 8 days. The spectra 
were measured from 200 to 400nm. 
Changes in protein secondary structure due to fructation were investigated by 
the changes in the proteins UV absorbance. Fructated lysozyme (10mg ml-1) was 
prepared by; 'minimal fructation, ' lysozyme in phosphate buffer was dialysed for 
12 hours at 4°C introducing up to 5mM fructose in bicarbonate buffer; or by 24 
hours glycation (0.5M fructose, 37°C in phosphate buffer) in addition to the 
minimal fructation. To the fructated lysozyme was added 10mg m1-1 
ß-lactoglobulin and the absorbance spectra of the samples measured before and 
after 7 days incubation at 37°C. The purpose of this experiment was to illustrate 
post-Amadori or post-Heyns reactions and emphasise that only a short period of 
glycation is necessary to produce AGEs. 
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3.4. Results 
3.4.1. Comparison of fructation with glucation 
Figure 3.4.1.1. illustrates the incorporation of glucose and fructose into HSA, BSA 
and RNase. In HSA and RNase the results indicate a similar rate of incorporation 
for glucose and fructose up to 3 days of incubation; after 3 days, and at all time 
points for BSA, fructose is incorporated to a higher degree than glucose. A higher 
rate of incorporation of fructose is matched by a higher rate of development of 
AGE-fluorescence in all the proteins upon fructation compared to glucation (Figs. 
3.4.1.2. and 3.4.1.3. ). 
Figures 3.4.1.4. and 3.4.1.5. compare AGE-fluorescence with incorporation of 
hexose. For up to 15 moles of fructose or 9 moles of glucose incorporation per mole 
of protein, HSA and BSA both exhibit the same relative fluorescence as a function 
of incorporation of the sugars. This suggests that because BSA incorporates hexose 
at a faster rate than HSA, it develops more AGE-fluorescence over the same period 
of time. Fructated BSA fluorescence forms a plateau with respect to incorporation 
of fructose after 15 moles per mole (Figs. 3.4.1.4. and 3.4.1.5. ). This indicates that 
incorporation of hexose continues unabated even after development of 
fluorescence ceases (compare Figs. 3.4.1.1. and 3.4.1.2. ). It is probable that the 
AGE-fluorophores themselves, or their precursors, are taking part in other post- 
Amadori or post-Heyns reactions to produce other types of AGE. 
Figures 3.4.1.6. and 3.4.1.7. show the fluorescence excitation and emission spectra 
at the two sets of wavelengths quoted in the methods chapter (see page 62). The 
fluorescence readings have been adjusted for any daily differences in the absolute 
fluorescence of quinine sulphate (the calibrant) and divided by the protein 
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concentration. The spectra show that AGE-fluorescence is a very broad single peak 
rather than several sharp distinct peaks; this implies that there are many 
fluorophores with overlapping excitation and emission wavelengths. Indeed at the 
wavelengths used for the biomarker pentosidine, excitation at 325nm produces a 
peak around 4lOnm and thus it is the shoulder, at 375nm, that is used to assess 
pentosidine fluorescence. 
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Fig. 3.4.1.1. Incorporation of monosaccharide into HSA, BSA and RNase upon 
fructation or glucation for up to 7 days. Incubation with 0.1M monosaccharide is 
indicated by the triangle symbol for fructose and star for glucose. 
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Fig. 3.4.1.2. Pentosidine-linked fluorescence of HSA, BSA and RNase on up to 7 
days fructation or glucation. Incubation with 0.1M monosaccharide is indicated by 
the triangle symbol for fructose and star for glucose. 
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Fig. 3.4.1.3. Fluorescence, at an excitation wavelength of 350nm and emission of 
420nm, on up to 7 days fructation or glucation. Incubation with 0.1M 
monosaccharide is indicated by the triangle symbol for fructose and star for 
glucose. 
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Fig. 3.4.1.4. Comparison of development of pentosidine fluorescence, due to 
glycation, with the total incorporation of hexose into HSA, BSA and RNase. 
Proteins were glycated with either fructose or glucose (0.1 M) for up to 7 days. 
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Fig. 3.4.1.5. Comparison of development of fluorescence, (excitation at 350nm 
and emission at 420nm) due to glycation, with the total incorporation of hexose 
into HSA, BSA and RNase. Proteins were glycated with either fructose or glucose 
(0.1M) for 7 days. 
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Fig. 3.4.1.6. Fluorescence spectra at pentosidine wavelengths of glycated BSA. 
The upper part of the figure illustrates the fluorescence spectra of BSA fructated 
for a range of time, up to 8 days. The lower part of the figure illustrates the same 
fluorescence spectra when the glycating sugar is glucose. 
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Fig. 3.4.1.7. Fluorescence of glycated BSA, at ex. 350nm and em. 420nm. The 
upper part of the figure illustrates the fluorescence spectra of BSA fructated for a 
range of time, up to 8 days. The lower part of the figure illustrates the same 
fluorescence spectra when the glycating sugar is glucose. 
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3.4.2. Effect of buffers other than phosphate 
Figure 3.4.2.1. illustrates the effect of buffer on AGE-fluorescence development in 
HSA and BSA after fructation in two inorganic buffers (phosphate and 
bicarbonate), the organic buffer TES or in water. The figure is also a tentative 
investigation of how the lipid portion of the two proteins affects the development 
of AGE-fluorescence. This was an initial experiment for a line of investigation for 
which there was, unfortunately, no more time left to pursue. I make this point here 
because it makes comparison of the two proteins difficult; the HSA and BSA have 
been prepared to different levels of purification. The BSA is 96-99% pure whereas 
the HSA is essentially globulin free (>99% pure) and the delipidated forms have 
been prepared from their respective purified proteins. See figures 3.4.1.2. and 
3.4.1.3. for comparison of the development of fluorescence of HSA and BSA, of the 
same level of purification, upon fructation. 
Figure 3.4.2.1. shows that the increase in fluorescence due to fructation is greater in 
the inorganic buffers phosphate and bicarbonate, than in the organic buffer TES or 
in water. HSA fructated in bicarbonate buffer produces more fluorescence than 
when fructated in phosphate buffer. Conversely, BSA is much more fluorescent 
after fructation in phosphate buffer than in bicarbonate. Comparison of the two 
proteins (HSA and BSA) shows that BSA is much more fluorescent than the HSA 
upon fructation; this is probably an artefact of their different levels of purification; 
compare this result with those presented in figures 3.4.1.2. and 3.4.1.3. 
Figure 3.4.2.1. illustrates that fructation of delipidated HSA and BSA produces 
different fluorescence than the native forms of the protein. Delipidated BSA 
develops less fluorescence than its native form, which is consistent with the results 
of Cochrane (1995) [1241. Delipidated HSA, however, develops more fluorescence 
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than its native form. If time had been available I would like to have checked this 
result using a lower level of purification of the HSA, this is because the number of 
steps involved in the purification of the delipidated HSA (used for Fig. 3.4.2.1. ) 
may have denatured the protein. Denaturation of HSA would allow glycation of 
lysine residues otherwise unavailable in the non-denatured molecule; thus the 
extra Amadori or Heyns products formed would produce more AGEs (including 
fluorescence). 
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Fig. 3.4.2.1. The effect of using different buffers on development of pentosidine- 
linked fluorescence of HSA and BSA. The N and D labels indicate the native and 
delipidated form of that protein. The buffers are indicated in pairs of columns on 
the histograms. The results are expressed as the net increase in fluorescence after 7 
days glycation with 0.1M fructose. 
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3.4.3. Relationship between sugar concentration and AGE formation 
Figure 3.4.3.1. illustrates the relationship between the glycating sugar 
concentration and development of pentosidine-linked fluorescence. The 
fluorescence prior to glucation or fructation has been subtracted from the results 
such that the net change due to glycation is apparent. The figure reveals that, for 
this concentration of BSA (10mg m1-1), increasing the concentration of fructose 
above 0.1M, does not produce any additional AGE-fluorescence. At O. 1M fructose 
and 10mg ml-1 BSA the sugar to protein molar ratio is 667: 1. 
The development of fluorescence of BSA as a result of glucation does not plateau 
off to a similar degree as fructation during the time investigated by this 
experiment. There is a rate change in the development of fluorescence between 0.2 
and 0.4M glucose, which could be the change in rate analogous to that of OA M 
fructose. It would have been useful to glucate for longer times to confirm this 
hypothesis. 
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Fig. 3.4.3.1. Relationship between pentosidine-linked fluorescence, produced 
after 5 and 10 days fructation or glucation, and sugar concentration. The figures 
are adjusted to take into account the fluorescence prior to glycation. 
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3.4.4. Formation of AGE-chromophores 
Maillard browning is very important to the food industry, it occurs only after all 
other types of AGE have begun to form and is responsible for colour, aroma, 
flavour and, with other AGEs, texture of cooked foods [173 and 212]. A spin off 
from the food industry are the preparations used to artificially tan people; 
dihydroxyacetone in the tanning preparations reacts with Heyns product 
(aldehyde rather than the ketone of Amadori product) to form pyrroles that absorb 
in the blue end of the visible spectrum [174]. 
Development of AGE chromophores, as in Maillard browning, can cause problems 
for the study of glycation. Figure 3.4.4.1. illustrates an increase in absorbance of 
native BSA, at 280nm, due to glycation with 0.2M glucose for up to 20 days. Taken 
at face value it would indicate that the protein concentration increases as a result 
of glycation. The same samples, however, when assayed for protein concentration 
using the Pierce protein assay (see page 61 for a description of the assay), showed 
that there was no significant increase in protein concentration as a result of 
glycation (results not shown). Therefore these results indicate that there is 
production of chromophores that absorb at 280nm as a result of glucation. 
Figure 3.4.4.2. shows the absorbance spectra of native HSA at several time points 
during fructation (O-1M fructose); the lowest line represents the absorbance before 
glycation and the upper-most line after 8 days fructation. The increasing 
absorbance, between 250 and 350nm, that develops during fructation represents 
the production of AGE chromophores that absorb in the UV range. 
The left hand side of figure 3.4.4.3. shows the absorbance spectra of four samples 
containing ß-lactoglobulin and fructated lysozyme in bicarbonate buffer; the free 
fructose used to glycate the lysozyme has been dialysed away. Sample (a) contains 
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lysozyme, that was 'minimally fructated' (12 hours at 4°C in bicarbonate buffer 
using 0.005M fructose), to which has been added native ß-lactoglobulin. Sample 
(b) is similar except that the lysozyme has additionally been fructated for 24 hours 
at 37°C in phosphate buffer using 0.5M fructose. Samples (c) and (d) are samples 
(a) and (b) respectively after 7 days sugar-free re-incubation. 
The right hand side of figure 3.4.4.3. shows the net fluorescence of the two types of 
samples after the 7 days of sugar-free re-incubation, i. e. fluorescence of sample (c) 
minus that of (a) and similar for (d) and (b). The range of samples containing 
lysozyme that had been fructated for periods of time intervening the samples 
shown, exhibited spectra in between those illustrated in figure 3.4.4.3. and have 
been omitted for clarity. 
The absorbance in figure 3.4.4.3. is expressed per mg of protein to enable 
comparison of proteins that were diluted to different extents. The samples were 
diluted to different extents to bring the absolute absorbance below 1.5 and thus 
within the bounds of the Beer-Lambert law. The absorbance of non-glycated 
lysozyme with ß-lactoglobulin was unchanged by sugar-free re-incubation. 
The right hand side of figure 3.4.4.3. shows that the net absorbance of both types of 
sample increased at 220nm as a result of sugar-free re-incubation. It is the peptide 
bond of proteins that absorbs in this region, and shifts in the position of the 'maxi 
up or down the spectra, usually indicate a change in the type of secondary 
structure. An increase in absorbance usually represents a loss of secondary 
structure [201]. Thus the right hand side of figure 3.4.4.3. indicates that sugar-free 
re-incubation of fructated lysozyme with native ß-lactoglobulin, results in a loss of 
secondary structure that is proportional to the time for which the lysozyme was 
fructated. 
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The tyrosine and tryptophan residues of a protein absorb at 275-300nm. The 
absorbance of these residues decreases slightly if they become more exposed to an 
aqueous solvent, they are therefore sensitive indicators of denaturation. The 
absorbance of the sample containing 'minimally fructated' lysozyme decreases 
slightly in this region upon 7 days sugar-free re-incubation which suggests some 
degree of denaturation. Any change in the absorbance, due to sugar-free re- 
incubation, of tyrosine and tryptophan residues of the sample containing the more 
extensively fructated lysozyme, is masked by the development of AGE- 
chromophores. 
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Fig. 3.4.4.1. Increase in absorbance at 280nm of BSA glycated (0.2M glucose) for 
up to 20 days. 
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Fig. 3.4.4.2. Absorbance spectra of native HSA (lowest line) and after 2,4 and 8 
(upper line) days fructation (O. 1M fructose) respectively. 
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Fig. 3.4.4.3. Left: Absorbance spectra of fructated lysozyme before and after 
sugar-free re-incubation. The notations represent; a and c= minimal fructation 
before and after re-incubation; b and d are similar samples but the lysozyme had 
additionally been fructated for 24 hours. See the text for a fuller explanation of the 
conditions for fructation. Right: a difference absorption spectra of the left graph, 
i. e. the change in absorbance due to sugar-free re-incubation; the lower spectra 
contained minimally fructated lysozyme while the upper had additionally been 
fructated for 24 hours. 
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3.5. Discussion 
3.5.1. Incorporation of hexose 
The incorporation of glucose and fructose into BSA, HSA and RNase is illustrated 
in the graphs of figure 3.4.1.1. Direct comparison with other published work is 
difficult because of the different glycating conditions used, however the results of 
some articles are summarised in the table below; 
days of 
glucation 
glucose 
conc. 
protein protein concentration moles of glucose 
per mole of protein 
ref. 
10 0.5M BSA 6mg ml-1 (0.09mM) 10 [14] 
7 0.02M RSA 7mg ml-1 (0.105mM) 1 [141] 
1 0.005M HSA 40m ml-1(0.6mM) 0.5 [143] 
7 0.5M HSA 20mg ml-1(0.3mM) 12 [88] 
The results for incorporation of glucose into HSA or BSA presented in this thesis 
are similar to those reported by McPherson et al (1988) and Suarez et al (1989) [88 
and 14]. The differences in the exact figures are likely to be due to differences in 
glucose and protein concentrations. Figure 3.4.1.1. clearly shows, for all three 
proteins, that fructose incorporates at a faster rate than glucose of equal 
concentration. It is unwise to make any conclusions from the results of hexose 
incorporation into RNase because of the poor protein recovery (10%) from the 
wash procedure used to remove unbound radiolabelled monosaccharide. 
McPherson et al (1988) reported that glucose was incorporated 8 times faster into 
HSA than the same concentration of fructose and at similar rates into RNase [88]. 
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The results presented here are in complete contrast to the results of McPherson et 
al (1988) in the case of HSA, but similar to those presented for RNase. 
Cox (1991) stated that out of the 59 lysine residues present in serum albumin, ten 
were known to be readily glycated [1211. Figure 3.4.1.1. and the literature quoted 
in the table above, indicate that while HSA and BSA will incorporate 
approximately this amount of glucose under these conditions, fructose is 
incorporated to a much greater extent. Up to 37 moles of fructose per mole of BSA 
were recorded in the experiment used in this thesis, there are several possible 
reasons for this result. 
The first reason could be experimental error; if time had been available I would 
have liked to repeat the experiment on a number of occasions and compare the 
results statistically. It is possible that the washing procedure used to remove non- 
covalently bound hexose was not vigorous enough, thus producing an 
overestimation of the hexose incorporated. Alternatively the calculation of the 
number of incorporated hexose residues, from the counts of the stock sugar, was 
inaccurate; if I was to repeat the experiment I would use a range of standards 
containing a fixed concentration of protein and monosaccharide but with varying 
proportions of the labelled hexose. 
Another reason for the high number of moles of fructose incorporated into BSA 
could be the involvement of amino acid residues other than the 10 lysines known 
to become glycated, or more of the 59 lysine residues are involved than the 10 that 
are initially glycated [1211. This could include the other lysine residues, which 
may become more readily fructated as the conformation of the BSA is altered 
during glycation. Alternatively other amino acid residues react with fructose 
directly or with a post-Heyns compound and thus incorporate radiolabel; arginine 
residues have been reported to take part in fructation [117]. The involvement of 
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amino acids, other than lysine, in fructation could be confirmed by radiolabelling 
coupled to amino acid analysis (if the fructose-protein adduct is acid stable), this 
could be used to distinguish between incorporation on to lysine or arginine 
residues. 
A third possible reason for a high level of incorporation of fructose in relation to 
lysine residues of serum albumin, involves the reaction of fructose with the 
secondary amino group of Heyns product as proposed by Suarez et al (1991) [87]. 
Such a reaction would produce bispyrroles involving two residues of fructose and 
one lysine residue. Alternatively, free fructose could combine with the fructose 
residue of Heyns product to form a cyclic acetal; interestingly the formation of 
cyclic acetals and rearrangement of Heyns product are both acid catalysed. Either 
of these two explanations would allow incorporation of more than 10 moles of 
fructose per mole of serum albumin; but only the latter can explain the 
incorporation of more than 20 moles of fructose onto 10 lysine residues (by 
perpetuation of acetal formation). 
A faster rate of incorporation of fructose than glucose would explain the higher 
rate of development of AGE-fluorescence (see figures 3.4.1.2. and 3.4.1.3. ). A 
higher rate of development of fluorescence upon fructation, compared to 
glucation, confirms similar reports for BSA, RNase, Hb and collagen [14,113,88, 
83,198 and 1991. 
Direct comparison of AGE production with incorporation are shown in Figs. 
3.4.1.4. and 3.4.1.5. The figures illustrate the relationship between glycation and 
development of fluorescence. When the in vivo produced fluorescence of the 
proteins has been taken into account there is little difference between HSA and 
BSA; both proteins upon glycation exhibit the same amount of fluorescence per 
mole of incorporated monosaccharide. It is only because BSA incorporates glucose 
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and fructose more quickly than HSA that it develops a higher fluorescence than 
HSA in the same time period. Thus the results indicate that for up to 15 moles of 
fructose or 9 moles of glucose per mole of protein, BSA and HSA are developing 
very similar, if not identical, AGEs. The figures 3.4.1.4. and 3.4.1.5. also show that 
after incorporation of 15 moles of fructose per mole of BSA, the rate of AGE- 
fluorophore formation is not at the same rate as incorporation of fructose, even 
though figure 3.4.1.1. shows unchanged incorporation. Such halting of 
development of fluorescence could mean that the fluorophores or their precursors 
are substrates for an AGE formed at a later stage in the Maillard reaction. 
The upturned curves of glucated albumin in figures 3.4.1.4. and 3.4.1.5. suggest a 
lag between incorporation of glucose and development of fluorescence; i. e. post- 
Amadori reactions are slower than glucation and the rate of incorporation of 
glucose, as Amadori product, is only slowed when equilibrium between Schiffs 
base and Amadori product is reached. An alternative hypothesis that could also 
explain the results is that a certain amount of glucose needs to be incorporated 
before AGE-fluorescence will develop; i. e. a fluorophore is made by the reaction of 
two or more precursors both of which need to be present for it to form. The two 
hypotheses could be tested by glucating for a short time (i. e. less than 2 days using 
0.1M glucose), removing the excess free sugar and re-incubating. If the first 
hypothesis is true then fluorescence will develop during sugar-free re-incubation; 
if no fluorescence develops then it could mean that the latter hypothesis is true 
because there is insufficient precursor present, on the protein, for a fluorophore to 
form. 
Figures 3.4.1.2., 3.4.1.3., 3.4.1.6. and 3.4.1.7. all indicate that fluorescence develops 
faster upon fructation than glucation. The latter two figures are fluorescence 
spectra that I have used to observe development of AGE formation. Comparison of 
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the shape of the spectra produced either by glucation or fructation, does not, 
unfortunately, reveal any difference in the fluorophores produced by the two 
monosaccharides; except fructation produces fluorescence of a higher intensity 
than glucation. Figures 3.4.1.6. and 3.4.1.7. illustrate the fluorescence spectra used 
to measure AGE formation throughout this thesis, i. e. the pentosidine wavelengths 
and those specific for the 'max of glycated albumin. These wavelengths were 
selected to enable comparison of the results of different experiments used to 
prepare this thesis and to other literature. 
3.5.2. Effect of buffers other than phosphate 
The effect of buffers on AGE formation is quite profound. Baynes (1989) reported 
that incorporation of glucose did not occur to the same extent in the organic buffer 
TAPSO, than in the anionic inorganic buffers such as phosphate, arsenate and 
bicarbonate [140]. The same group have reported similar results for the organic 
buffer MOPS and in chapter 5. similar results are presented for HEPES buffer 
[138]. The results presented in figure 3.4.2.1. confirm the observations of the 
Baynes group; i. e. fluorescence development from glycation only occurs in 
inorganic buffers. 
It is the free metal contamination of the inorganic buffers that is thought to take 
part in AGE formation. This is because chelation of the free metal, in the inorganic 
buffers or inclusion of free radical scavengers during glycation, inhibits AGE 
formation (see chapter 4. for discussion) [179,2051. The results of figure 3.4.2.1., 
however, show that it is not just the free metal of the inorganic buffers that affects 
AGE formation. At the concentrations and pH used, bicarbonate buffer potentially 
contains more free metal (maximum concentrations of 16µM copper and 9µM iron) 
than phosphate buffer (maximum concentrations of 5µM copper and 6µM iron); 
yet BSA when fructated for 7 days in phosphate buffer, exhibits three times more 
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fluorescence than if the buffer were bicarbonate. If I assume that the minimum 
concentration of free metal quoted by the manufacturers is similar to the actual 
concentration of those ions, then some other component of the buffers must also be 
taking part in the reaction to explain the observed results. A definitive assay is 
needed for the free metal content of the buffers, to confirm or disprove this 
hypothesis. Anions of the buffers are candidate compounds that could take part in 
AGE formation. Watkins et al (1985) proposed that inorganic phosphate bound in 
the active site of RNase was catalysing Amadori rearrangement on lysine residues 
nearby. It is possible that phosphate forms a ligand with BSA near lysine residues 
that take part in glycation and catalyses rearrangement, in this case to Heyns 
product. Conversely native HSA develops more fluorescence in bicarbonate buffer 
than phosphate, which is consistent with the free metal content of the buffers, but 
the difference is not large. The differences in the results for HSA and BSA shown 
in figure 3.4.2.1. are likely to be due to their different levels of purification; 
although, generally, BSA does develop slightly more intense fluorescence than 
HSA (see figures 3.4.1.2. and 3.4.1.3. ). 
Delipidation of BSA inhibits development of fluorescence upon glycation (Fig. 
3.4.2.1. ); indicating that the lipid component of BSA takes part in AGE formation. 
Delipidated HSA, however, develops a more intense fluorescence than its native 
counterpart, this is probably an artefact of the number of steps used to purify this 
protein. Denaturation of the HSA would lead to a higher rate of glycation and thus 
AGE-formation due to exposure of more lysine residues. If, however, the result is 
not due to denaturation of delipidated HSA, it would indicate that the lipid 
component of HSA has a protective role against development of AGES. The lipid 
component of serum albumin is very important in AGE formation because it will 
also undergo peroxidation. Sugar derived AGES and products of lipid 
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peroxidation have very similar properties; additionally the presence of one type 
has been reported to enhance the production of the other [163 and 164]. 
3.5.3. Relationship between sugar concentration and AGE formation 
To obtain large amounts of AGEs, some studies have used large non-physiological 
sugar concentrations with very long incubation times, e. g. 90 days incubation of 
various proteins with 0.5M glucose, to produce AGE-proteins against which 
antibodies were raised [145 and 146]. I am critical of the physiological relevance of 
AGEs produced after such harsh glycation and thus the antibodies raised against 
them. Figure 3.4.3.1. shows the development of AGE-fluorescence of BSA due to 5 
and 10 days glycation at various concentrations of glucose and fructose. The figure 
illustrates that increasing the concentration of fructose between O. 1M and 0.5M 
does not result in a corresponding increase in AGE-fluorescence; whereas at less 
than O. 1M fructose the increase in fluorescence is directly proportional to the 
concentration. The relationship between glucose concentration and development 
of fluorescence is not so straightforward as for fructose, which is probably a 
reflection of the lower reaction rate of glucation compared to fructation. If the 
experiment were carried on for a longer time of glucation, I would have expected 
to see similar results to those produced with fructose because there is a change in 
the slope of the graphs between 0.2 and 0.4M, which could be the beginnings of a 
plateau. 
3.5.4. Formation of AGE-chromophores 
HSA and BSA have been reported to have an increased absorbance, around 
290nm, which is proportional to the period of glycation [147 and 141. Figures 
3.4.4.1. and 3.4.4.2. show the increase in absorbance at 280nm caused by glucation 
of BSA and the absorbance spectra of HSA fructated for various time periods up to 
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8 days. The apparent increase in absorbance at 280nm would suggest an increase 
in protein concentration as a function of the time of glucation; however, the same 
samples assayed for protein using the Pierce protein method (page 58) indicated 
no such change in protein concentration. The increase in absorbance at 220 and 
290nm seen in figure 3.4.4.2. could be due to changes in protein conformation since 
these wavelengths correspond to absorbance by the peptide bond and the amino 
acids tryptophan and tyrosine respectively. A change in conformation would alter 
the absorbance at 220 and 280nm but it would produce peaks with narrow ranges 
of wavelengths. Figure 3.4.4.2. however, shows increasing absorbance from 250 to 
350nm, as a function of the time of fructation, which can only be due to formation 
of AGE-UV-chromophores. The UV-chromophores that absorb in the 250 to 350nm 
region are probably the excitation wavelengths of AGE-fluorophores. Observation 
of the increase in absorbance at these wavelengths could be used as a simple 
method for observing glycation, without having to resort to fluorescence. 
The last figure of this chapter (Fig. 3.4.4.3. ) illustrates the absorbance of 
(3-lactoglobulin together with one of two extremes of fructated lysozyme, before 
and after 7 days sugar-free re-incubation. Sugar-free re-incubation of 'minimally 
fructated' lysozyme (12 hours, 4°C, 0.005M fructose in bicarbonate buffer) with 
native 3-lactoglobulin, produces a large increase in absorbance at 220nm, 
suggesting a change in the protein secondary structure. This conclusion is 
supported by the negative absorbance between 270 and 300nm indicating an 
increased exposure of tryptophan and tyrosine residues to polar solvent [210]. The 
sample containing the more highly fructated lysozyme (37°C, 0.5M fructose in 
phosphate buffer) has increased in absorbance at both 220nm and 250 to 300nm. 
The increase in absorbance at 220nm, again, indicates loss of secondary structure, 
whereas the broadening of this peak suggests formation of conjugated dienes 
(which absorb at 230-240nm) on the lipid component of 0-lactoglobulin [211]. The 
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broad increase in absorbance between 250 and 300nm, of the more highly fructated 
sample, is probably due to production of AGE chromophores rather than changes 
in protein secondary structure. 
Ames (1993) reviewed the work of Kato's group into modification of ovalbumin 
secondary structure by glucation, and reported that although there was an increase 
in secondary structure disorder, as measured by circular dichroism. The glycated 
monomer was more resistant to denaturation than native protein, this was 
proposed to be due to increased intramolecular cross-links within the glycated 
monomer [2121. Thus the results of this thesis support the hypothesis that 
glycation alters protein conformation as well as quarternary structure. 
The results of this chapter tell us several things about fructation and AGE 
production from"it. Fructose is incorporated into serum albumin to a greater extent 
than an equal concentration of glucose over the same time period and this is 
reflected by the production of AGEs from the respective monosaccharides. Post- 
Heyns reactions cause changes in the conformation of lysozyme and ß- 
lactoglobulin and also produce AGE-chromophores. Incorporation of fructose into 
BSA continues after the development of fluorescence halts, indicating the 
production of non-fluorescent AGES that are undetected in this experiment. The 
large number of moles of incorporated fructose per mole of BSA suggests that 
residues other than lysines are taking part in the Maillard reaction. Lastly AGE 
formation, from fructose, is influenced by several components of the buffer, such 
as the free metal content (discussed in chapter 4. ) and possibly the buffer anions. 
The action of the anions is probably by interaction with the protein, catalysing 
Amadori or Heyns rearrangement. 
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3.6. Summary 
1. Fructose is incorporated into protein to a greater extent than glucose and this is 
reflected in the development of fluorescence. 
2. BSA incorporates more moles of hexose and develops a greater fluorescence 
than HSA; although, for less than 15 moles of incorporated hexose per mole of 
serum albumin they develop the same fluorescence per mole of incorporated 
fructose or glucose. 
3. Incorporation of fructose into BSA continues after development of fluorescence 
has ceased. 
4. Several components of inorganic buffers take part in AGE formation. One of 
the components is the free metal that contaminates these buffers (see later 
chapters); another component is probably the interaction between the protein 
and the anions. 
5. Delipidation inhibits the development of AGE-fluorescence of BSA. 
6. If in vitro fructation is performed in phosphate buffer at 37°C, for 5 or more 
days with 0.15mM BSA, maximum fluorescence is developed using 0.1M 
fructose. Under these conditions higher fructose concentrations do not increase 
the yield of fluorescence. 
7. AGE-chromophores that absorb in the UV-regions (220-370nm) could be used 
as a simple assay for glycation. 
8. Sugar-free incubation of native ß-lactoglobulin with 'minimally fructated' 
lysozyme produces a change in the UV-absorbance of the two proteins that 
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corresponds to an increase in secondary structure disorder, including the 
movement of the side groups of tryptophan and tyrosine residues towards a 
polar environment. 
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4. Protein-bound carbonyl intermediates in the Maillard 
reaction: colorimetric detection of fructation 
4.1. Introduction 
4.1.1. The need for an assay for fructation 
Ahmed and Furth (1992) reported that serum fructosamine, thiobarbituric acid 
(TBA), periodate and phenylboronate assays all underestimate fructation when 
compared to fluorescent AGE formation [209]. The fundamental difference in the 
chemistry of Heyns and Amadori products (Fig. 4.1.1.1. ) means that fructation is 
undetected or underestimated 
glycation by glucose. 
Amadori product 
(fructoslysine, ketoamine) 
H 
I 
R-N-ýH2 
C=O 
I 
HO-C-H 
I 
H-ý-OH 
H-C-OH 
I 
CH2OH 
by the chemical assays developed to detect 
Heyns product 
(aldamine) 
HOý 
I 
C-N-R 
I 
HOJ-H 
H-Y-OH 
H-Y-OH 
CH2OH 
Fig. 4.1.1.1. Amadori and Heyns products. 
(ketoamine) 
? H2OH 
ý-NH"R 
H-ý-OH 
H-T-OH 
CH2OH 
The implications of fructation in vivo were only realised when it was shown to 
occur using methods that can detect it. One of these methods is measurement of 
glycated haemoglobin (HbA1, see page 21 for more information). The particular 
fraction of HbA1 used to assess glycaemic control depends on the assay used, but 
in poorly controlled diabetics, up to 20% of total Hb has been found in the form of 
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the HbAic subfraction [148 and 1491. The fractions of HbAl other than HbAic are 
formed by N-terminal glycation of haemoglobin by other sugars such as fructose 
and galactose. High HbAl values have been observed in people who are not 
diabetic but suffer from hereditary fructose intolerance or galactosaemia [150]. 
Dietary fructose has also been blamed for the high 'glycosylated haemoglobin' 
observed in a type 1 diabetic who had good glycaemic control but ate liberal 
amounts of 'diabetic food' that used fructose as a sweetener. Substitution of the 
fructose by other forms of carbohydrate brought the glycosylated Hb down to 
within normal limits with no appreciable change in glycaernic control [151]. 
Clearly measurement of total glycated haemoglobin can show glycation by other 
sugars, which could confuse diagnosis of glycaemic control in diabetics, but 
measurement of HbAic alone misses the contribution of other sugars to glycation 
of circulating proteins [150]. 
Evidence of in vivo fructation includes fructose derived from the polyol pathway 
(page 40). Fructose from this source has been implicated in the formation and 
progression of diabetic secondary complications; e. g. Ten to twenty per cent of the 
hexose bound to human ocular lens was reported by Walton et al (1989) to derive 
from fructose [111 and 200). 
A principle aim of this PhD was to develop a method that would quantify, on a 
molar basis, protein fructation in a similar manner to the glucation assays. 
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4.1.2. Reactions of 2,4-dinitrophenylhydrazine 
An important method for the detection and identification of saccharides is by 
reaction with 2,4-dinitrophenylhydrazine (DNPH) to form hydrazones and 
osazones, see figure 4.1.2.1. Osazones have characteristic absorbance spectra which 
can allow identification of the parent monosaccharide, although in the case of 
glucose and fructose they form the same osazone [152 and 153]. 
DNPH has previously been used to detect glycation. Acharya and Manning (1980 
and 1983) used an adaptation of the method described by Fields and Dixon (1971) 
to detect glycation by glyceraldehyde. These studies were model experiments to 
show that glyceraldehyde and a-hydroxyaldehydes could glycate haemoglobin, 
which in turn prevented aggregation of sickle cell deoxyhaemoglobin. Unreacted 
DNPH was removed by size exclusion chromatography. The articles showed that 
protein-bound carbonyl increases with the concentration of aldehyde allowed to 
glycate a protein over a set period of time [154,155 and 156]. Fischer and 
Winterhalter (1981) followed up the work of Acharya et al and looked for protein- 
bound carbonyl groups on glycated haemoglobin isolated from diabetic sera. They 
reported very little reaction and concluded that the concentration of open chain 
Amadori product (assumed to be the reactive compound) in haemoglobin was 
below the resolution of the assay [157]. Ghiggeri et al (1986) detected protein- 
bound carbonyl groups, using DNPH, on glycated albumin purified from diabetic 
sera. These were attributed to reaction of the DNPH with Amadori product; 
however, the total amount of carbonyl groups detected were very low in 
comparison with the total bound carbohydrate [158]. Kobayashi et al (1992) have 
developed a quick method for detection of Amadori product using DNPH; 
Amadori product is released as 2-keto-glucose under the influence of hydrazine 
and pressure, this in turn reacts with DNPH to form an osazone which is detected 
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by its absorbance at 390nm [159]. Ahmed (1992) in his PhD thesis used the DNPH 
method of Fields and Dixon to detect fructation and it was from here that my 
investigation started [133 and 156]. 
The DNPH methods reported by Kobayashi et al (1992) and Fields & Dixon (1971) 
are both limited by insensitivity, this is because there is no separation of excess 
DNPH from the 2,4-dinitrophenylhydrazone product. The two compounds have 
overlapping absorbance spectra and thus the excess reagent has a significant 
absorbance in the same region as that used to detect the product (390nm) [159 and 
1561. The sensitivity of assays that do not remove excess reagent can be improved 
by measuring the ratio of absorbance at 375 and 405nm, and observing the change 
due to glycation. Absorbance at 375nm corresponds mostly to the DNPH and, as it 
is in large excess, only decreases slightly due to a small loss of hydrazone. While 
the absorbance of the 2,4-dinitrophenylhydrazone is shifted higher up the 
spectrum to 405nm. The DNPH does absorb at 405nm but the increase due to 
formation of 2,4-dinitrophenylhydrazone is relatively large in comparison to the 
decrease at 375nm. Thus a measurement of the ratio of 375 and 405nm emphasises 
2,4-dinitrophenylhydrazone formation and small changes can be observed. This 
method, however, when put into practice, by myself, revealed that the increase in 
sensitivity was not enough to reduce the inter-assay coefficient of variation to an 
acceptable value (results not shown), so an alternative method that removed excess 
reagent was sought. 
A sensitive method for determining protein oxidation using DNPH was reported 
by Levine et at (1990). It involved the removal of excess DNPH and osazones 
formed from reaction with free sugar [170]. I have used this method to quantify 
fructation as a function of carbonyl groups formed on TCA insoluble protein. A 
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description of the assay protocol and the adaptations I have made to it is covered 
later in the chapter. 
2,4-Dinitrophenylhydrazine Glucose 2,4-Dinitrophenylhydrazine Fructose 
U2 HV U2 H2OH 
HOH =o 
02N N-NH2 + HOH)3 
02N 
O 
N-NH2 + HOH)3 
H H2OH H H, )OH 
2,4-Dinitrophenylhydrazone 
02N 
&2OH 
DNPH 
H2N-NHC6H3(NjO2)2 
2,4-Dinitrophenylhydrazone 
N-N==C + H20 
I 
g C, HOH 
c6ox)ý, 
02N 
0, H 
4, n2vn 
DNPH 
H2N-NHC6H3(NO2)2 
=N-NHC6H3(NO2)2 
NH3 
++ 
H2N-NHC6H3(NO2)2 
=N-NHC6H3(NO2)2 
=N-NHC6H3(NO2)2 
( HOH)3 
H2OH 
Oswzone 
H2OH 
NI -N + H2O 
H( HOH)3 
H2N-NHC6H3(N02)2 
Fig. 4.1.2.1. Reaction of DNPH with glucose and fructose [152]. 
HOH)3 
ý, 1Nn3 
H2OH ++ 
H2OH 
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4.1.3. Role of lipid in the Maillard reaction 
This chapter also deals briefly with the effect of lipid on various measures of 
glycation, this is because lipid oxidation products may also have free carbonyl 
groups that would react with DNPH. Modification of protein by lipid oxidation 
products has been reported to produce fluorescence spectra similar to those of 
AGEs [160,161 and 162]. The lipid oxidation product malondialdehyde has been 
reported to accelerate the formation of AGE-chromophores by reaction with 
Amadori product [163]. Also Bucala et al (1993) have reported enhanced 
production of lipid peroxidation products after formation of AGEs; the group also 
showed that glycation of low density lipoprotein (LDL) produces AGES on both 
the lipid and protein components [164]. Thus the production of lipid peroxides 
and AGEs is intimately connected, with the formation of one enhancing the 
production of the other. 
4.1.4. Mechanisms of aminoguanidine action 
Aminoguanidine and DNPH are both nucleophilic hydrazines and probably have 
very similar reactive properties [165]. This means that the carbonyl groups 
detected, upon glycation, by the DNPH assay will also react with aminoguanidine. 
If in the absence of aminoguanidine these same protein-bound carbonyl groups 
take part in AGE formation, then their sequestration by aminoguanidine could 
explain the anti-AGE activity of the hydrazine. Thus investigation of the point in 
the Maillard reaction detected by DNPH is also an investigation of the inhibitory 
mechanism of aminoguanidine. 
The site of the inhibitory action of aminoguanidine has been investigated by a 
number of workers and several hypotheses have been proposed. Brownlee et al 
(1986) suggested that aminoguanidine reacts with the carbonyl group of Amadori 
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product and, by blocking that group, prevents its further reaction, see figure 
4.1.4.1. 
Amadori Product Aminoguanidine Substituted Amadori Product 
R-NH 
H 
R-NH 
H2 ýH2 H 
+ H2N-N-C-NH2 -ý =N-N-C-NH2 Cý 11 
(i HOH)3 
NH2+ (ýHOH)3 
NH2+ 
H 
CHOH CH2OH 2 
Fig. 4.1.4.1. Putative reaction of aminoguanidine with Amadori product [165]. 
Blackledge (1993) reported that the yellow chromophore ('max 313nm) produced 
when aminoguanidine is used as an inhibitor of glycation, is from its reaction with 
the glycating sugar [166]. With glucose the chromophore was reported to be 
probably mostly hydrazone with some osazone, see figure 4.1.2.1.; Blackledge 
went on to state that labelled aminoguanidine did not react with fructoslysine 
(Amadori product) and proposed that it reacts with free dicarbonyl intermediates 
derived from Amadori product, such as 3-deoxyglucosone; this hypothesis is 
supported by the findings of Edelstein and Brownlee, (1992) [166 and 167]. 
Requena et al (1993) reported that although aminoguanidine would react with 
Amadori product and block its reactive carbonyl group, this was not a major site 
of its action. The article also stated that scavenging of glucose by aminoguanidine 
had little impact on furosine yields, thus the site of action must be elsewhere, 
again 3-DOG was suggested [168]. Figure 4.1.4.2. illustrates the reaction of 
aminoguanidine with a range of dicarbonyl compounds proposed by Hirsch and 
Feather (1994) to be possible intermediates in the Maillard reaction [169]. Since 3- 
DOG is a free dicarbonyl, its contribution to post-Amadori or post-Heyns reactions 
could be tested by re-incubating the sugar-free protein solution at 37°C while 
dialysing continually against new buffer. 
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R=a= 3-deoxyglucosone b= 3-deoxyxylosone c= glucosone d= xylosone 
i H2 
ýyH2 
H -H HO -H 
HI- 
H -OH 
H 
CH2OH H --OH 
HýHgOH 
H2OH H2OH 
HO 
',! 
ý=O 
R 
aminýgnaniduýe 
H 
I 
+ H2N-N-j-NH2 
NH 
H` N% 
NH 
ý 
=Co 7 =NH 
R NH2 
NH2 0 ý=NH 
=N-NH 
R 
-- 
--º 
N 
RN NH2 
XÖTNH2 
R" 'N 
Fig. 4.1.4.2. Reaction of aminoguanidine with some dicarbonyl compounds 
[reproduced from Fig. 1 of 169]. 
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4.2. Aims 
1. To develop a quantifiable colorimetric method that would detect glycation by 
fructose (fructation). 
2. To use this method to elucidate the biochemical mechanism of AGE formation 
from fructose. 
3. To investigate the role of lipid in the production of protein-bound carbonyl 
groups and AGEs. 
4. To investigate the site of action of aminoguanidine. 
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4.3. Methods 
4.3.1. The DNPH assay 
The protocol for detection of glycation using reaction with DNPH is as follows: 
1. Place three 100µ1 aliquots of each sample (containing 1mg of protein) into 
separate 1.5m1 eppendorfs. 
2. To two of the 10Oµ1 samples, add 400µ1 of 7mM DNPH made up in 2M HC1. 
3. To the third sample just add 40Oµl of 2M HCl to form a sample blank. 
4. Leave at room temperature for 1 hour for complete reaction of DNPH with 
free carbonyl groups. 
5. Add 500µl trichioroacetic acid (4% w/v) to precipitate the protein. 
6. Centrifuge at 14000g for 5 minutes. 
7. Wash the pellet 4 times in 1: 1 ethanol/ethyl acetate (v/v); at each wash 
vortex to break up the pellet, allow to stand for 10 minutes and then reform 
the pellet by centrifugation (14000g for 3 minutes). 
8. Keep the supernatant of each wash to check the removal of free DNPH by its 
absorbance at 379nm. 
9. After washing the pellet, add 0.6m1 6M guanidine hydrochloride in 20mM 
phosphate buffer, adjusted to pH 2.3 with trifluoroacetic acid and vortex. 
115 
10. Freeze at -20°C overnight and thaw, this allows the pellet to fully break up 
and dissolve in the guanidine hydrochloride. 
11. Pipette duplicate 2O0µ1 aliquots of the solution of protein in guanidine 
hydrochloride to a microplate, and measure the absorbance at 379nm. The 
microplate colorimeter used was a Bio-tek microplate autoreader EL311, 
(Laminar technology, Hampshire). 
The moles of protein-bound DNPH and thus the moles of carbonyl groups can be 
calculated directly from the absorbance using the molar extinction coefficient of 
2,4-dinitrophenylhydrazone (22000 M-1 cm-1 [1701). The calculation is as follows; 
[DNPH or Carbonyl] = 
(nee )A3n 
according to Beer- Lambert law 
c= 22000M-'cm-' 
1=0.7cm 
(nett)A379 = (sample) A379 - (sample blank) A379 
sample blank = sample that has undergone all steps of the 
assay except reaction with DNPH. 
Carbonyl concentration in mmol ml' -- 
(nett)A379 x 103 
22000 x 0.7 
but there is a1 in 6 dilution due to the 
addition of guanidine hydrochloride thus 
Carbonyl conc. in mmol ml'' = 
(nett)A379 X6 
15.4 
Carbonyl conc. in mmol ml-' = (nett)A379 x 0.39 
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4.3.2. In vitro glycation of nBSA and dBSA 
Delipidated BSA (dBSA) purchased from Sigma (Sigma, Pool, Dorset, UK. ) was 
produced by reaction of native BSA (nBSA) with charcoal by the method of Chen 
(1967); this is said not to cause denaturation [1711. Comparison of dBSA was made 
with nBSA of the same level of purification (fraction V). nBSA and dBSA were 
glycated for up to 21 days in phosphate buffer, assayed according to the methods 
described in chapter 2. and in addition assayed with DNPH as described above. 
4.3.3. Sugar-free re-incubation 
BSA fructated to a range of extents (0.05M for up to 21 days) was separated from 
free fructose by exhaustive dialysis versus phosphate buffer (see page 57). Upon 
completion of dialysis the samples of fructated BSA were re-incubated at 37°C in 
sugar-free phosphate buffer for up to 15 days, assayed according to the methods 
described in chapter 2. and in addition assayed with DNPH as described above. 
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4.4. Results 
4.4.1. DNPH assay development 
Calculation of the path-length (1) of the microplate was necessary because the 
absorbance is measured through the meniscus and thus the length of the light path 
is dependent on the viscosity and volume of the liquid in the well. The curvature 
of the meniscus was taken into account by reading the average absorbance of three 
measurements taken at set distances from the centre of the well. The path-length 
was calculated for set volumes of liquid in the microplate as follows. The 
concentration of a BSA solution (in phosphate buffer) was calculated from its A280 
(see page 58). This BSA was then stained using the bicinchoninic protein kit assay 
and the molar extinction coefficient (e) of the complex was calculated (using A=ecl) 
from its absorbance at 570nm. Varying volumes, of this stained BSA, were loaded 
onto a microplate and their absorbance at 570nm measured. The path length was 
calculated (again using A=ecl) using the known concentration of BSA and its 
molar extinction coefficient when stained using the bicinchoninic protein kit assay. 
Figure 4.4.1.1. shows the linear relationship between path-length and the volume 
of liquid in the well; 200µl in this case gave an average path-length of 0.7cm across 
the meniscus. 
Absorbance spectra of fructated protein after undergoing the DNPH assay are 
shown in figure 4.4.1.2. The left hand spectrum shows a fructated sample that has 
undergone the DNPH assay, the lower line is the sample blank and the upper line 
is after reaction with DNPH; both samples are in guanidine hydrochloride 
solution. The right hand difference spectrum (calculated from the left spectrum) 
represents the absorbance of protein-bound DNPH, illustrating a Xmax at 375nm. 
Note that the slight blip in the spectrum of DNPH at 376 to 378nm is due to 
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experimental error, this is the region in which the Cecil 4000 spectrophotometer 
switches lamps to measure absorbance either in the UV or visible ranges. 
Removal of excess DNPH from the protein is essential to increase the sensitivity 
of the assay. Figure 4.4.1.3. shows the effectiveness of the ethanol-ethyl acetate 
wash by its absorbance at 379nm. After 3 washes little more DNPH was removed 
and hence, in the case of BSA, 4 washes were adequate to remove unreacted 
DNPH. 
Loss of protein during the assay was a concern; Levine et al (1990) reported that 
albumin was partially soluble in ethanol/ethyl acetate [172]. The concentration of 
total BSA (glycated and non-glycated) was measured before and after DNPH 
assay and showed a recovery of 99.7%. For the study of BSA in this thesis the loss 
of protein was therefore assumed to be negligible, but it should be checked for 
each protein studied. The results are summarised in the table below; 
Before DNPH assay After DNPH assn 
Mean protein concentration 
(m ml-1) 
39.9 39.8 
number of samples 8 96 
standard error from mean 
(± mg ml-1) 
1.8 1.3 
The lower limit of linearity of the absorbance at 379nm is shown in figure 4.4.1.4. 
BSA was fructated (0.05M fructose) for 8 days and diluted to various 
concentrations into phosphate buffer containing non-glycated BSA, such that the 
overall protein concentration in each sample was 40mg ml-1; hence the protein 
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concentration remained the same, but the proportions of fructated BSA varied. The 
DNPH assay was then used to test for carbonyl groups in the range of samples. 
The inter-assay coefficient of variation is shown for a range of samples in figure 
4.4.1.5. The figure describes the formation of protein-bound carbonyl groups on 
BSA incubated either with 50mM fructose or on its own over 8 days. There is a 
clear increase in protein-bound carbonyl groups due to fructation which forms a 
plateau after 5 days. The error bars on the figure are the standard error of the 
mean of 8 separate assays, while the figures represent the inter-assay coefficient of 
variation. A benchmark of acceptable coefficient of variation is <5%, which is 
easily met by all the samples that have been fructated; but the results for day 0 and 
all the results for the sugar-free control can only be used as an indicator of trend, 
not as an accurate indicator of absolute quantity. 
Freezing and thawing the protein pellet in 6M guanidine hydrochloride breaks it 
up into smaller particles allowing a greater surface area to volume ratio for the 
solvent to act on. Without the freezing step, a great deal of protein remains as 
precipitate even after 15 minutes boiling in 6M guanidine hydrochloride. Figure 
4.4.1.6. shows the results of the same samples of BSA incubated with 200mM 
glucose for up to 18 days with and without the freezing step, the figure clearly 
shows a greater yield with the step than without. 
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Fig. 4.4.1.1. The path-length is proportional to volume of liquid in a microplate 
well. 
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Fig. 4.4.1.2. Left; absorbance spectra of BSA fructated for 21 days with 0.005M 
fructose, upper line is reacted with DNPH, lower line is its sample blank. The 
right hand graph is the difference spectra of the spectrum on the left; i. e. net 
absorbance due to the 2,4-dinitrophenylhydrazone-protein adduct. 
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Fig. 4.4.1.3. Typical graph of the DNPH content of ethanol/ethyl acetate (1: 1) 
washes. 
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Fig. 4.4.1.4. The concentration range in which protein-bound DNPH is directly 
proportional to its absorbance at 379nm. Fructated BSA was prepared by 8 days 
incubation with 0.05M fructose followed by dilution into non-glycated BSA. 
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Fig. 4.4.1.5. Comparison of the protein-bound carbonyl content of fructated BSA 
(upper line, 0.05M fructose included) with its sugar-free control (lower line). The 
DNPH assay was carried out 8 times; the error bars represent the standard error 
from the mean of those assays, while the figures are the inter-assay coefficient of 
variation of the samples. 
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Fig. 4.4.1.6. The freezing step increases the yield of protein-bound DNPH by 
breaking up the protein pellet, allowing greater solvation. The upper line is with 
the final freezing step of the assay while the lower line is without. Glycated BSA 
was prepared by up to 18 days incubation with 0.2M glucose. 
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4.4.2. The effect of lipid 
The previous section showed that the production of protein-bound carbonyl 
groups was dependent on glycation (Fig. 4.4.1.5. ); i. e. there was very little change 
in the sugar-free control. This section investigates the effect of lipid on protein- 
bound carbonyl production and relates it to AGE-fluorescence. Peroxidation of 
lipids and AGE formation occurs in vivo under similar conditions; both 
mechanisms are essentially oxidative in nature and lead to development of similar 
fluorescence spectra [160 and 162]. Products of lipid oxidation have been reported 
to react with Amadori product, enhancing the production of AGE-chromophores; 
also, lipid oxidation has been reported to be enhanced in the presence of AGES 
[163 and 164]. Thus the production of lipid peroxides and AGEs is interactive, 
with the production of one influencing the production of the other. The DNPH 
assay detects carbonyl compounds that are TCA and ethanol/ethyl acetate 
insoluble. By comparing glycated native and delipidated protein the influence of 
lipid on the Maillard reaction can be investigated. 
Figures 4.4.2.1. through to 4.4.2.3. compare glucation and fructation using various 
measures of glycation and AGE formation, and illustrate the effect of lipid on 
these measures. Please note that graphs of the sugar-free controls have been 
omitted from these figures for clarity. There was no increase in any of the 
measures of glycation, unless monosaccharide was also present during incubation 
(e. g. Figs. 4.4.3.1., 4.4.1.5. and 4.4.3.3. ). The assay results of the sugar-free controls 
have been subtracted from the results of the glycated protein, to enable 
comparison of glycation on the different proteins. 
The periodate assay measures formaldehyde released from hexose upon periodate 
oxidation. Amadori product is assumed to be the major product of glucation that 
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produces a positive result. The minor ketonic Heyns product will also produce 
periodate positive material (PPM) according to Malprades' rules [14]. The higher 
initial level of PPM in the dBSA compared with the nBSA is probably due to 
differences in the starting material from which the proteins were purified from. 
Figure 4.4.2.1. illustrates the formation of Amadori product upon glucation of 
nBSA and dBSA. The figure shows that while dBSA exhibits more Amadori 
product per mole of protein than nBSA, the rate of glucation is similar in both 
proteins. Fructation of BSA produces much less PPM than glucation, and 
fructation of delipidated BSA produces less PPM than the native form. 
In contrast to the production of PPM, fructation of nBSA produces more protein- 
bound carbonyl groups and pentosidine-linked fluorescence than glucation (Figs. 
4.4.2.2. and 4.4.2.3. ). This occurred even though the concentration of fructose used 
for preparation of the samples used in the DNPH assay was ten fold lower than 
that of the periodate assay. 
Figure 4.4.2.2. also indicates that in contrast to the production of PPM, the 
production of protein-bound carbonyl groups is not as great on the delipidated 
BSA than on the nBSA. In fact there is very little production of protein-bound 
carbonyl groups on dBSA when glycated by either monosaccharide. The slightly 
lower rate of production of PPM upon fructation (Fig. 4.4.2.1. ) suggests that, if this 
is a true effect, then PPM production, from fructation of BSA, is at least in part 
dependent upon the presence of lipid. The production of PPM from fructose is an 
area of the work presented in this thesis that deserves more attention, if more time 
had been available I would have liked to have investigated the effect seen in figure 
4.4.2.1. more thoroughly. 
The development of pentosidine-linked fluorescence (Fig. 4.4.2.3. ) upon glycation 
is very similar to the production of protein-bound carbonyl groups on the same 
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samples (Fig. 4.4.2.2. ). Fructation of nBSA produced more fluorescence than 
glucation even though the concentration of glucose was 40 times that of fructose. 
Delipidated BSA developed very little fluorescence upon glycation when 
compared to its native counterpart, this indicates that the lipid component of BSA 
is involved in the production of AGES. 
A preliminary experiment in which nBSA was delipidated after fructation, 
showed that the DNPH assay detects carbonyl groups produced both on the 
protein and the lipid components of BSA (results not shown). The experiment used 
the method of Chen (1967) to delipidate the protein, so that the results would be 
comparable to commercially produced dBSA [171]. The results indicated that, after 
10 days glycation of BSA with 0.5M fructose, 60% of the carbonyl groups detected 
by the DNPH assay were present on the lipid fraction of the protein. After 21 days 
the total carbonyl detected had increased, but the proportion on the lipid 
component had decreased to 30%, indicating that the majority were present on the 
protein component of the BSA. 
The results of this section indicate that while fluorescent AGES are dependent on 
the presence of lipid, Amadori product is unaffected. The production of protein- 
bound carbonyl is also dependent on lipid, thus the DNPH assay must be 
detecting post-Amadori (and by analogy also post-Heyns) compounds. 
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Fig. 4.4.2.1. Production of periodate positive material on nBSA and dBSA as a 
result of glycation by glucose (0.2M) or fructose (0.05M). 
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Fig. 4.4.2.2. Formation of protein-bound carbonyl groups on nBSA and dBSA 
upon glycation with glucose (0.2M) or fructose (0.005M). 
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Fig. 4.4.2.3. Development of pentosidine-linked fluorescence of nBSA and dBSA 
upon glycation with glucose (0.2M) or fructose (0.005M). 
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4.4.3. Inhibitors of AGE formation 
Glycoxidation is a term that has been coined to highlight the link between metal 
catalysed oxidation (MCO) and AGE formation [134]. Amadori product formation 
is unaffected by factors that affect oxidation of proteins whereas AGE formation is 
dependent on MCO [179,134 and 1771. This section of the chapter investigates the 
effect of DTPA and aminoguanidine on protein-bound carbonyl formation. DTPA 
is a metal chelator and its inclusion during glycation inhibits metal catalysed 
oxidation and thus AGE formation. Aminoguanidine is a nucleophilic hydrazine, 
that inhibits the production of AGEs, probably by reacting with the same 
compounds detected by DNPH [165]. 
The effect of aminoguanidine and DTPA on the various measures of glycation is 
illustrated in figures 4.4.3.1. through to 4.4.3.5. The first figure (4.4.3.1. ) shows that 
the formation of Amadori product is promoted by the presence of aminoguanidine 
or DTPA. In contrast to this, formation of protein-bound carbonyl is partially 
inhibited and fluorescence completely inhibited by 50mM aminoguanidine (Figs. 
4.4.3.2. and 4.4.3.3. ). Similarly 1mM DTPA inhibits formation of protein-bound 
carbonyl groups and fluorescence (Figs. 4.4.3.4. and 4.4.3.5. ). 
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Fig. 4.4.3.1. Promotion of Amadori product formation in the presence of 50mM 
aminoguanidine or 1mM DTPA, upon glycation of BSA with 0.2M glucose. 
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Fig. 4.4.3.2. Protein-bound carbonyl group formation of BSA incubated alone 
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Fig. 4.4.3.3. Development of fluorescence is inhibited by 50mM aminoguanidine. 
Glycation of BSA was with 0.2M glucose. 
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Fig. 4.4.3.4. Inhibition of protein-bound carbonyl formation on fructated BSA 
(0.5M fructose) by the metal chelator DTPA. Note that the moles of carbonyl per 
mole of protein is an underestimate because the absorbance was measured at 
405nm and the freezing step was omitted. 
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Fig. 4.4.3.5. Inhibition of fluorophore formation on fructated BSA (0.5M fructose) 
by 1mM DTPA. 
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4.4.4. Order of the intermediates in the Maillard reaction 
In the introduction of this thesis, figure 1.1. illustrated the Maillard reaction as we 
know it now, with two known intermediates to AGE formation (Schiffs base and 
Amadori or Heyns product). Part of this chapter is an investigation of the points at 
which the compounds that react with DNPH occur in the Maillard reaction. So far, 
I have shown that protein-bound carbonyl groups and fluorophore formation are 
dependent on free metal and lipid for their formation. Amadori product, on the 
other hand, is unaffected by free metal or lipid. These findings suggest that along 
with fluorescence the protein-bound carbonyl groups detected by DNPH are post- 
Amadori or post-Heyns products. This section of the thesis presents results of 
experiments designed to determine whether the protein-bound carbonyl groups 
detected are themselves end-products of the Maillard reaction or intermediates in 
the production of AGEs. 
The figures of this section of the thesis illustrate the changes in the measures of 
glycation as a function of the time of sugar-free re-incubation of fructated BSA. 
The time of incubation with fructose is marked on the graphs, while the extent of 
fructation can be read off the y-axis. The points on the x-axis marked 'before re- 
incubation' represents the measurements assayed before dialysis; thus for figures 
4.4.4.2. and 4.4.4.3. the change between 'before re-incubation' and 0 days of re- 
incubation, occurred during the 4 days of exhaustive dialysis. 
The upper part of figure 4.4.4.1. shows the production of periodate positive 
material (PPM) during sugar-free re-incubation of fructated BSA. The lower part 
shows the same samples, but the PPM produced during the initial glycation has 
been subtracted, thus illustrates the changes during re-incubation only. The graphs 
in the lower part of figure 4.4.4.1. indicate that there is an increase in PPM that is 
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not due to fructation. Both non-glycated (day 0 sample) and fructated BSA show 
an increase in PPM that is proportional to the time of re-incubation, but is the same 
no matter for how long the BSA was initially fructated. This indicates that the 
increase of PPM seen with re-incubation is due to oxidation rather than post- 
Heyns reactions. The higher yield of PPM from fructated BSA than from the sugar- 
free control is probably a reflection of the oxidative damage to the protein caused 
by glycation. 
The decrease in protein-bound carbonyl groups during re-incubation is illustrated 
in figure 4.4.4.2. With the exception of the samples that were initially fructated for 
0 days, all the samples show a decrease in protein-bound carbonyl proportional to 
the period of re-incubation. The net decrease in protein-bound carbonyl groups 
during sugar-free re-incubation is illustrated by the lower part of figure 4.4.4.2. 
The figure shows that there is a decrease in protein-bound carbonyl groups that is 
proportional to the degree of initial fructation of the BSA (i. e. days of fructation). 
Conversely fluorescence of fructated BSA increases, with the time of sugar-free 
re-incubation, in proportion to the time period of initial fructation (Fig. 4.4.4.3. ). 
The lower part of figure 4.4.4.3. illustrates the net increase in fluorescence that 
occurred during sugar-free re-incubation, while the upper part of the figure also 
shows the fluorescence produced during fructation. 
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Fig. 4.4.4.1. Periodate positive material produced as a result of re-incubation of 
fructated BSA in sugar-free phosphate buffer. The days of initial glycation (0.05M 
fructose) of the BSA are indicated by the figures on each curve. Upper; the total 
increase in PPM during fructation and sugar-free re-incubation. Lower; net 
increase in PPM during sugar-free re-incubation only. 
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Fig. 4.4.4.2. Loss of protein-bound carbonyl due to sugar-free re-incubation. The 
days of initial glycation (0.05M fructose) of the BSA are indicated by the figures on 
each curve. Upper; the increase in protein-bound carbonyl groups during 
fructation is illustrated by the points marked 'before re-incubation, ' followed by 
their subsequent decrease as a function of the time of sugar-free re-incubation. 
Lower: net decrease in protein-bound carbonyl groups during sugar-free re- 
incubation. 
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Fig. 4.4.4.3. Increase in pentosidine-linked fluorescence with time of re- 
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Lower: net increase in fluorescence during sugar-free re-incubation. 
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4.5. Discussion 
Ahmed and Furth (1992) reported that the common assays for glucation failed to 
detect fructation and that the higher AGE-fluorescence of fructation indicated that 
its role in vivo was being underestimated [209]. Detection of fluorescence is not a 
quantitative technique; some fluorophores may fluoresce more than others, 
different proteins and sugars may form different proportions of different AGEs 
and some proteins will quench more than others. A principle aim of this thesis was 
to develop a quantifiable assay for protein fructation and glycation by other 
sugars. 
4.5.1. The DNPH assay 
The reaction of hydrazines, specifically 2,4-dinitrophenylhydrazine, with 
aldehydes and ketones is an important method used for their detection and has 
also been used with varying success for the detection of glycation; see the 
introduction of this chapter for a brief review. A method reported by Levine et al 
(1990), using DNPH for detection of oxidation of protein, has here been adapted to 
detect fructation [1701. To decrease the assay time, the absorbance was measured 
using a microplate reader (colorimeter), which measures absorbance through the 
meniscus and will therefore vary with the height of the liquid in the wells of the 
microplate. Calculation of the moles of protein-bound DNPH utilises a known 
molar absorption coefficient and the Beer-Lambert law (A=ecl); the path-length (1) 
is a variable in this formula, thus it was necessary to calculate it for various 
volumes in the microplate. Figure 4.4.1.1. shows the relationship between the 
volume in the well and path-length for the microplates used throughout this 
thesis. The moles of carbonyl per mole of protein is assumed to be equivalent to 
the moles of DNPH per mole of protein, since one carbonyl group reacts with one 
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molecule of DNPH. The calculation of the moles of carbonyl per mole of protein 
would have been easier to determine using a calibration curve. I was, however, 
unable to think of an appropriate compound that would serve this assay as a 
calibrant. The calibrant would have to react with DNPH and be insoluble in TCA 
and ethanol/ethyl acetate; a protein is the obvious choice for the assay conditions, 
but native proteins do not exhibit enough moles of carbonyl to be accurately 
detected by this method. Glycated protein could have been used, but another 
assay would need to be used to determine its moles of carbonyl per mole of 
protein and again there is the question of calibration. If more time had been 
available for the development of the assay, I would have tried to tackle the 
problem of calibration more thoroughly. 
The absorption spectra of fructated BSA after reaction with DNPH, along with its 
appropriate sample blank, is shown in figure 4.4.1.2. The wavelength of the 
maximum absorbance of the DNPH-protein adduct is 375nm. The nearest 
standard filter for the microplate reader was 379nm. A 375nm filter could, at extra 
cost, have been especially manufactured for us, but since the filters do not absorb 
the 10nm either side of their quoted peak, it was felt that the extra expense was not 
necessary. 
Washing excess DNPH away from the protein-hydrazone was important because 
of its high absorbance at 379nm. Figure 4.4.1.3. shows that 4 washes with 1: 1 
ethanol: ethylacetate were sufficient to remove the vast majority of excess reagent. 
The solubility of BSA in ethanol: ethylacetate was a point of error reported by 
Levine et al (1990), thus the loss would need to be checked for each protein assayed 
[170]. I found, however, nearly 100% recovery and regarded any such loss with 
BSA as negligible. 
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Figure 4.4.1.4. shows the result of the DNPH assay on a sample of fructated BSA 
diluted into native BSA, such that the concentration of glycated protein is reduced, 
while the overall protein concentration is maintained. The undiluted sample 
(40mg ml-1) contained approximately 1 mole of carbonyl per mole of protein. The 
figure shows that if the fructated BSA is diluted into native BSA and assayed with 
DNPH, the absorbance of DNPH is directly proportional to the concentration of 
the protein down to 0.25mg ml-1. This means that, at a BSA concentration of 
10mg ml-1, the DNPH assay can detect as little as 0.025 moles of carbonyl per mole 
of BSA. Below 0.025 moles of carbonyl per mole of protein the absolute absorbance 
of the DNPH-protein adduct is probably too small for an accurate calculation. The 
loss of accuracy at low concentrations of carbonyl groups is illustrated by the poor 
interassay coefficient of variation (CV) of the sugar-free control samples of figure 
4.4.1.5. 
Figure 4.4.1.5. illustrates two important points. The first is that it shows that the 
production of protein-bound carbonyl groups only occurs upon glycation. The 
sugar-free controls exhibit a slight increase in DNPH positive material, as a 
function of time, that is likely to be due to oxidation. The second point is that it 
shows that the CV of the fructated samples are all less than 2%, which is an 
acceptable, although undesirable, error between assays. The results of the sugar- 
free controls, however, resulted in a CV of more than 5%, which is probably due to 
exceeding the lower limit of the assay; this means that the results of the non- 
glycated samples can only indicate trends rather than absolute values of moles per 
mole. 
Poor solubility of fructated BSA, after reaction with DNPH in 6M guanidine 
hydrochloride (pH 2.3), was an initial problem of the assay that was not resolved 
by heating. The solution to the problem was to freeze the sample at -20°C and 
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subsequent thawing. Figure 4.4.1.6. shows the results from the same set of samples 
assayed with and without the final freezing step; there is quite a dramatic increase 
in yield with the freezing step. A possible explanation for this is that the freeze- 
thaw action on the protein pellet may increase the surface area available for the 
solvent to act upon and thus dramatically improve the solubility. All the DNPH 
assays used in this thesis included the freezing step, unless otherwise specified. 
4.5.2. Identity of periodate positive material from fructation 
The production of periodate positive material (PPM) upon glucation or fructation 
of native or delipidated BSA is shown in figure 4.4.2.1. The amount of PPM 
produced from fructation is very much less than from glucation, because the 
aldehydic form of Heyns product does not yield formaldehyde on periodate 
oxidation. The minor ketone form of Heyns product will, however, yield 
formaldehyde upon periodate oxidation, thus the positive result seen on fructation 
could be from that moiety [209 and 111]. Examination of the production of PPM 
upon fructation (Fig. 4.4.2.1. ), reveals a difference between native and delipidated 
BSA. The results suggest that PPM production upon fructation of BSA is, to a 
degree, dependent on the presence of lipid. In contrast, glucation of BSA is not 
affected by lipid. The higher initial level of Amadori product in glucated dBSA is 
possibly a reflection of the difference between the batches of BSA used to prepare 
the native and delipidated BSA. Some of the PPM observed upon fructation could 
be from Amadori product formed directly from glucose; glucose and fructose 
share a common enediol, thus one can be converted to the other. If, however, the 
PPM observed upon fructation were from glucose, it would not be inhibited by 
delipidation, thus the majority of PPM produced during fructation cannot have 
been formed using this route. The ketone form of Heyns product will produce 
PPM but if its production is analogous to formation of Amadori product, then it 
147 
should also be unaffected by the lipid component [8]. Some Amadori product can, 
in theory, be formed by rearrangement of Heyns product, and this could also be 
responsible for some of the PPM observed. Although this is possible the 
arguments above strongly suggest that the majority of PPM produced upon 
fructation is from unknown post-Heyns compounds. 
4.5.3. Identity of protein-bound carbonyl groups 
Figure 4.4.2.2. shows that fructation produces protein-bound carbonyl groups at a 
faster rate than glucation, even though the glucose was at a concentration some 40 
times higher than fructose. The graph also illustrates the necessity for lipid in 
production of protein-bound carbonyl groups, for both glucation and fructation. 
Similarly fructation produces a much higher fluorescence than glucation of BSA 
and the production of AGE-fluorophores is less in dBSA than nBSA (Fig. 4.4.2.3. ). 
Figures 4.4.2.2. and 4.4.2.3. indicate that the majority of production of protein- 
bound carbonyl groups and fluorescence requires the presence of the lipid 
component of BSA. There is, however, a slight increase in these measures upon 
glycation of dBSA, thus there must also exist lipid independent pathways to the 
production of protein-bound carbonyl and fluorescence. Further investigation of 
the effect of lipid on protein-bound carbonyl formation showed that fructation of 
nBSA for 10 days, and subsequent removal of the lipid, resulted in a 60% loss of 
carbonyl groups; this figure drops to 30% after a further 11 days fructation. 
The data presented in this thesis indicate that protein-bound carbonyl groups only 
occur in the presence of lipid; and that the majority of the carbonyls detected by 
the DNPH assay occur initially on the lipid component and later, on the protein 
component of BSA. Comparing the build up, from glucation and fructation, of 
PPM, protein-bound carbonyl and fluorescence on dBSA, suggests; first, that the 
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effect of lipid on AGE formation is a post-Amadori or post-Heyns event; second, 
that the PPM observed is also from post-Heyns compounds; third, that the DNPH 
assay detects carbonyl groups formed on compounds produced from both 
Amadori and Heyns products. 
Inhibition of AGE formation and a simultaneous build up of Amadori product has 
been reported by Fu et al (1994), for a variety of compounds that can therefore be 
assumed to affect post-Amadori or post-Heyns reactions [179]. Figure 4.4.3.1. 
shows the promotion of Amadori product formation by the metal chelator DTPA 
and the hydrazine compound aminoguanidine. The promotion of Amadori 
product, but inhibition of AGE-fluorescence, by DTPA and aminoguanidine, 
indicates that the compounds block the Maillard reaction at a point between the 
two measures of glycation (Figs. 4.4.3.3. and 4.4.3.5. ). 
DNPH should in theory react with the same compounds as aminoguanidine 
because they are both hydrazine compounds. Thus elucidation of the point in the 
Maillard reaction detected by DNPH, should give insight into the inhibitory action 
of aminoguanidine. The effect of aminoguanidine on production of PPM, protein- 
bound carbonyl groups and AGE-fluorescence (Figs. 4.4.3.1., 4.4.3.2. and 4.4.3.3. ) 
gives support to the theory of DNPH and aminoguanidine competing for sites of 
action, i. e. promotion of Amadori product, complete inhibition of AGE- 
fluorescence and partial inhibition of protein-bound carbonyl formation. The 
partial inhibition could occur because the protein-aminoguanidine adduct is 
hydrolysed by the acid used to solvate DNPH reagent and thus regenerates the 
parent carbonyl compound [1521. Alternatively, aminoguanidine may have more 
than one site of action, before and after the point detected by DNPH (assuming 
that it detects a specific point in the Maillard reaction). A later point in the 
Maillard reaction, for which aminoguanidine has a higher affinity, would explain 
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partial inhibition of protein-bound carbonyl but complete inhibition of AGE- 
fluorescence. 
The metal chelator DTPA also promotes Amadori product formation, while 
inhibiting both protein-bound carbonyl and AGE-fluorescence formation (Figs. 
4.4.3.1., 4.4.3.4. and 4.4.3.5. ). This indicates that DNPH detects protein-bound 
carbonyls produced as a result of post-Amadori or post-Heyns reactions and that 
these reactions are metal dependent. 
The lipid and inhibitor experiments strongly indicated that DNPH is detecting a 
post-Amadori or post-Heyns intermediate of the Maillard reaction, thus an 
experiment was set up to confirm this by investigating post-Amadori or post- 
Heyns reactions without the influence of further glycation by free sugar. Figure 
4.4.4.1., however, shows only a slight increase in formation of periodate positive 
material upon sugar-free re-incubation of Eructated BSA. The increase was 
however very slight and when the Amadori product formed in the initial 
incubation (to produce fructated protein) was subtracted, the increase was the 
same in all of the fructated samples (lower part of figure 4.4.4.1. ). This, along with 
the increase in periodate positive material of the sugar-free control, suggests that 
the increase during sugar-free re-incubation is due to oxidation rather than post- 
Amadori or post-Heyns reactions. Fructated protein does show a greater increase 
in PPM than the non-glycated protein which could be due to a conformational 
change in the protein, as a result of fructation producing a greater susceptibility to 
oxidation. 
Figure 4.4.4.2. shows that post-Amadori or post-Heyns reactions lead to a decrease 
in protein-bound carbonyl groups that is proportional to the degree to which the 
BSA was initially fructated (as measured by days of fructation). This indicates that 
the protein-bound carbonyl detected by DNPH is an early or intermediate 
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compound in post-Amadori or post-Heyns reactions rather than an end-product. 
The protein-bound carbonyl groups, detected by DNPH and sequestered by 
aminoguanidine, may be precursors of the fluorescent AGEs. These conclusions 
are supported by the increase in fluorescence seen in the same samples during 
sugar-free re-incubation, where again the change is proportional to the degree of 
initial fructation (Fig. 4.4.4.3. ). 
Compounds that have been isolated from in vitro glycation mixtures and are 
possible candidates for reaction with DNPH and thus with aminoguanidine 
include: 1) the acyclic forms of Amadori product and Heyns product, although the 
results of this thesis would indicate that these are not major products detected by 
DNPH; 2) pyrrolaldehydes and their dimers, maltoxazine (produced by reaction 
of 3-DOG with the amino acid proline, see page 48 et sequa for reactions of 3-DOG); 
3) 3-DOG itself. Small free molcules (such as maltoxazine and 3-DOG), however, 
would be soluble in TCA and ethanol/ethyl acetate and are thus not necessarily 
detected by this assay [212]. 
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4.6. Summary 
1. This chapter describes an assay for glycation (including fructation) based on 
detection of protein-bound carbonyl groups by reaction with 2,4- 
dini trophenyihydrazine. 
2. The production of protein-bound carbonyl groups and AGE-fluorescence are 
both dependent on the presence of lipid and free metal. 
3. The production of PPM upon fructation is dependent on lipid and thus the 
periodate assay is detecting a post-Heyns compound. 
4. The protein-bound carbonyl groups detected by DNPH are post-Amadori or 
post-Heyes intermediates in the Maillard reaction that occur before 
fluorophore formation. 
5. The principle sites of action, within the Maillard reaction, of the AGE inhibitor 
aminoguanidine are probably the same post-Amadori or post-Heyns 
intermediates detected by DNPH. 
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5. Cross-Linking 
5.1. Introduction 
Advanced glycation end-products (AGEs) include intra- and intermolecular 
covalent cross-links, for example the fluorescent AGE biomarker pentosidine (Fig. 
1.3.1.1. ) is a cross-link between lysine and arginine residues [175]. As with other 
types of AGE produced in vitro, post-Amadori or post-Heyns reactions that lead to 
cross-linking are dependent on metal-catalysed oxidation (MCO) [176,177 and 
134]. 
Collagen is a major structural protein of the body that has a very long half life, 
which means that it can accumulate a large number of AGEs. This can, in turn, 
contribute to formation of secondary complications. In vitro glycation of collagen 
(from rat tail tendon) leads to loss of solubility, increased resistance to degradation 
(enzymatic and chemical) and accumulation of yellow and fluorescent pigments 
[178 and 179]. In vitro glycation of human tissues rich in collagen, such as the 
cornea or glomerular basement membrane (GBM), produces the same types of 
AGEs as those found in the rat tail collagen [177 and 1801. AGE cross-linking 
between collagen fibrils of the cornea disrupts their regular packing. In vitro 
glycated GBM traps more serum proteins, in the absence of free sugar, than native 
GBM. While it is implied that the serum proteins are covalently cross-linked to the 
GBM, this has not to my knowledge been conclusively proven [181]. A similar 
accumulation of LDL into glycated arterial wall collagen has been suggested as a 
contributory factor in vascular disease [182]. 
Similarly to in vitro glycation, in vivo glycation of collagen causes it to become less 
soluble, more cross-linked and results in accumulation of yellow and fluorescent 
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pigments; these changes occur as a function of age in normal individuals. The 
collagen-linked fluorescence of severe atherosclerotic lesions, is greater than that 
of the vessel wall of a person without macrovascular disease, indicating a greater 
concentration of AGEs in the former. Interestingly, collagen from superficial 
plaques (fatty streaks) exhibits a lower fluorescence than the non-diseased 
controls. Lee et al (1993) suggested that the lower fluorescence in superficial 
plaques was because this stage of the disease attracts the attention of macrophages. 
Macrophages induce intensive tissue remodelling, which probably masks AGE 
formation by replacement of the collagen [187 and 188]. Basement membranes 
thicken as a function of age and this is accelerated in diabetes, although whether 
this is due to cross-linking of the collagen in the membrane or some other process 
is not clear [189]. 
Although the changes in collagen-rich tissues, described in the paragraph above, 
increase as a function of age, people with diabetes mellitus show the same changes 
but at an earlier age, in this respect diabetes is an ageing disease [187]. People with 
diabetes mellitus also show increased incorporation of serum proteins into 
structural collagen elements such as basement membranes. There is in vivo 
evidence that diabetics have a greater amount of IgG and IgM incorporated in 
peripheral nerve myelin than age matched controls [190]. The concentration of 
trapped HSA and IgG in renal basement membranes is also higher in diabetic 
kidney as opposed to non-diabetic kidney with other renal diseases, and normal 
controls (free of any disease) [191]. Increased deposition of albumin has also been 
reported in extracellular dermal capillary basement membrane in patients with 
IDDM, compared to non-diabetics [192]. Such incorporation of serum proteins into 
structural elements of the body is thought to exacerbate vascular pathogenesis and 
renal disease; thus the increased levels in diabetes would explain the earlier onset 
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of these complications in diabetics than in people of the same age without the 
disease [182 and 191]. 
Deposition of amyloid fibrils on the synovial membrane of joints is a serious 
complication of patients on long term haemodialysis. Analysis of the fibrils 
indicates that glycated 02-microglobulin is a major component. In vivo glycated 
ß2-microglobulin, isolated from urine of diabetics, enhances in vitro chemotaxis 
and chemokinesis of human monocytes. The macrophages release enough tumor 
necrosis 
factor-a and interleukin-lß to stimulate collagenase release from cultured synovial 
cells. These same cytokines are known to induce tissue re-modelling in a variety of 
tissues. Miyata et al (1994) proposed that an immune response to glycated 02- 
microglobulin in amyloid fibrils could initiate inflammatory disease [193]. 
The breakdown products of enzymatic tissue remodelling of AGE-proteins may 
also cause problems in vivo. Makita et al (1994) found elevated concentrations of 2- 
6kD protein fragments in the serum of diabetics. Isolation of this molecular weight 
range revealed that the fragments had a high cross-linking potential with collagen. 
In people with normal kidney function the protein fragments have a very short 
half life in circulation, however their high reactivity suggests a possible role for 
exacerbation of vascular disease. The 2-6kD protein fragments are not, however, 
cleared in end-stage renal disease either by the kidney or the normal dialysis 
systems used to keep these patients alive. The resultant build up of the fragments 
in these patients probably contributes to the deterioration of their health [194]. 
AGE formation on collagen is an important area of research because of its 
ubiquity. Alteration of the properties of tissues containing collagen is probably 
responsible for many degenerative diseases. Collagen is not, however, the only 
protein to have AGEs form upon it. The in vivo cross-linking of blood proteins to 
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each other also probably contributes to diabetic secondary complications. Up to 
21% of intraplatelet calmodulin was found to be glycated in a survey of diabetics, 
and hyperaggregation of platelets has been attributed to perpetuation of diabetic 
arteriosclerosis, hypertension and retinopathy [195]. Lubec et al (1993) reported 
that Maillard cross-linking of IgG is greater in diabetics than non-diabetics, but 
that such cross-linking was inhibited by oral administration of L-arginine. The 
group proposed that the L-arginine reacted with Amadori product and prevented 
its further part in the Maillard reaction [196]. 
In vitro studies of Maillard cross-linking are usually carried out to either show that 
a particular protein cross-links, or to investigate the mechanism of cross-link 
formation. The molecular weight of collagen makes it a difficult protein to study 
cross-linking in. Studies of proteins, other than collagen, that have been shown to 
cross-link in vitro include; IgG, lens proteins, RNase and lysozyme [183,184,185 
and 186]. A principle aim of this thesis was to study AGE formation from fructose, 
including cross-linking and to relate the conclusions of this thesis to fructation in 
vivo. Fructose has been shown, in vitro, to cross-link collagen, BSA, lysozyme, and 
RNase at a faster rate than glucose [198,199 and 200]. I chose to use lysozyme and 
f3-lactoglobulin to study cross-linking because they have useful molecular weights 
for SDS-PAGE, also they are relatively inexpensive. There are a few problems with 
using these proteins that should be pointed out before the reader analyses the 
results. Lysozyme is contaminated with a number of proteins: several of lower 
molecular weight than lysozyme (i. e. <14kD), also ovalbumin (45kD) and an 
unknown protein of 73kD; each of which could confuse interpretation of the 
results. f 3-lactoglobulin has been purified from bovine milk which contains lactose 
at an average concentration of 0.13M [207]. This means that in any preparation of 
f 3-lactoglobulin there will be some glycated protein. The amount of glycated 
f 3-lactoglobulin, and similarly the AGEs, present in a preparation of the protein 
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depends on the duration of storage of the milk; such information is, unfortunately, 
not available from Sigma. The presence of some in vivo glycated ß-lactoglobulin in 
the protein preparation can be confirmed by the presence of a ß-lactoglobulin 
homodimer in the sugar-free controls, again this can confuse analysis of the results 
if it is not noted. 
Knowledge of the mechanism of the formation of Maillard-cross-links would make 
possible the rational design of drugs to block the reaction in vivo, thus preventing 
the progression of diabetic secondary complications. Inhibition of Maillard cross- 
linking can be achieved in vitro by non-oxidative conditions or by sequestration of 
reactive groups. A useful review of some of the compounds that inhibit AGE 
formation can be found in Fu et al (1994) [134,197 and 179]. Since the Maillard 
reaction produces compounds by metal catalysed oxidation, chelation of that metal 
can produce non-oxidative conditions. L-arginine (as mentioned above) and 
aminoguanidine are examples of compounds that will sequester reactive groups 
and block the Maillard reaction. The site of the inhibitory action of 
aminoguanidine is contentious, it is a hydrazine that will react with carbonyl 
groups presented at many stages in the Maillard reaction. For a more detailed 
discussion of aminoguanidine see pages 111 et seq. 
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5.2. Aims 
1. To illustrate Maillard-cross-linking upon fructation. 
2. To show that two different proteins can be covalently joined by Maillard-cross- 
linking. 
3. To study the effect of inhibitors of AGE formation on Maillard-cross-linking. 
4. To investigate the effect of incubating fructated and native proteins together in 
the absence of free sugar. 
5. To illustrate how low levels of fructation can still produce detectable AGES in 
the form of cross-links. 
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5.3. Methods 
In vitro glycation was carried out according to the methods described on page 56 
et sequa. 
Precipitation by formation of high molecular weight aggregates was a problem in 
some experiments. If, for example, lysozyme (10mg ml-1) was glycated for 9 or 
more days with 0.5M fructose, or fructation (0.1M fructose) of lysozyme together 
with 13-lactoglobulin (10mg ml-1) for 2 to 5 days, then precipitation occurred 
(results not shown). The samples containing precipitate were centrifuged (3 
minutes, 14000g) and the supernatant diluted to an appropriate concentration for 
assay. 
The cross-linking of fructated lysozyme (10mg ml-1), (i-lactoglobulin (10mg ml-1) 
and BSA (40mg/ml) was detected using SDS-PAGE, quantified by laser 
densitometry and compared to fluorescent AGES (see pages 62 et sequa). 
SDS-PAGE of denatured (boiled with SDS and 2-mercaptoethanol) fructated 
lysozyme, ß-lactoglobulin and BSA was used to illustrate AGEs in the form of 
covalent, non-thiol, cross-links. Densitometry was used to quantify cross-linking 
as a percentage of the total staining in that lane and assumed that the intensities 
are such that absorbance is linear with concentration, according to the Beer- 
Lambert law. To further quantify the amount of protein that has become cross- 
linked, it was also necessary to assume that the cross-linked protein stained to the 
same degree as the native protein. Both of these assumptions have faults; the 
actual concentration of cross-linked protein is low compared to that of the native 
monomer so a certain degree of overloading is necessary to detect the cross- 
linking. Glycation clearly inhibits silver staining (Fig. 2.9.1.1. ), thus such staining 
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cannot be relied upon for accurate quantification and so CCBB staining was 
preferred. CCBB staining was also preferred because the laser used in the 
densitometer emits light at the red end of the spectrum which is where the 
Coomassie brilliant blue Imax occurs, whereas silver stain absorbs in the blue 
green region. 
Inhibition of cross-linking was investigated by adding aminoguanidine (50mM) 
or the metal chelator diethylenetriaminepenta-acetic acid (DTPA, 1mM) to the 
phosphate buffer used during glycation. To further investigate the role of metal 
catalysed oxidation (MCO) and free radicals, the buffer HEPES (10mM), which is 
low in free metal and has free radical scavenging properties, was used as a 
substitute for phosphate buffer. 
Post-Heyns reactions were investigated without interference from free sugar, by 
removal of excess free sugar from fructated protein, either by exhaustive dialysis 
or size exclusion chromatography (section 2.4. ). A second non-glycated, native 
protein was added to the fructated protein and the two were re-incubated for 1 
week at 37°C in either phosphate or bicarbonate buffer. 
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5.4. Results 
5.4.1. Fructation-Induced Cross-linking 
The production of AGE cross-links and fluorescence upon fructation of lysozyme 
is proportional to the period of glycation; figure 5.4.1.1. shows the production of a 
28kD dimer and 42kD trimer. Densitometry of this gel (Fig. 5.4.1.2. ) illustrates that 
the rate of oligomerisation is not linear with respect to the period of fructation. 
Formation of dieter ceases after 4 days, probably because the dimer is a precursor 
for another AGE, only produced when a critical amount of its substrates are 
present. The trimer is produced in lower yields than the dimer but at an almost 
continuous rate throughout the experiment. The top curve in figure 5.4.1.2., 
however, indicates that the rate of formation of dimer and trimer, considered 
together, is slowing. It is possible that two dimers are cross-linking to form a 54kD 
protein made up of four monomers; the gel in figure 5.4.1.1. does show darkening 
in lanes E and F (6 and 8 days fructation) in the 45 to 66kD region of the gel; the 
bands are, however, too faint and broad to positively confirm the production of a 
54kD lysozyme oligomer. Precipitation was not a problem with this experiment, 
because the glycation of lysozyme at this concentration of fructose was for less 
than 9 days. 
Figure 5.4.1.3. illustrates the pentosidine-linked fluorescence of the same samples 
of fructated lysozyme used in the gel of figure 5.4.1.1. After 8 days incubation the 
sugar-free control shows very little change in its fluorescence, while the fructated 
lysozyme has produced fluorophores at a rate that was initially large but is 
starting to form a plateau. It is conceivable that the fluorophores themselves, or 
intermediates in their production, are at the later stages of the Maillard reaction 
used to produce other AGEs. 
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Similarly fructation induces cross-linking of (3-lactoglobulin. Figure 5.4.1.4. 
illustrates production of a 36kD dimer and a 54kD trimer of 3-lactoglobulin upon 
15 days fructation. The densitometry of this gel (Fig. 5.4.1.5. ) shows that 
dimerisation ceases around day 10 while formation of trimer is linear throughout 
the duration of the experiment. The gel also shows an increase in staining, as a 
function of fructation, throughout the molecular weight range from 36kD 
upwards, with only the trimer at 54kD forming a discernible band, suggesting 
production of multimers of various molecular weights. Interestingly 
ß-lactoglobulin fructated on its own did not precipitate even after 15 days 
incubation with O. 1M fructose. When 3-lactoglobulin is incubated with lysozyme, 
however, precipitation occurs very quickly (2 to 5 days in O. 1M fructose). Figure 
5.4.1.6. illustrates such high molecular weight aggregates produced after 7 days 
fructation (lane D). The figure also shows that fructation of (3-lactoglobulin and 
lysozyme together (lane D) produces a 32kD heterodimer as well as the 
homodimers of the two proteins (32kD and 28kD respectively). 
Oligomerisation can also be demonstrated in larger proteins. Figure 5.4.1.7. shows 
that when BSA is incubated for up to 7 days with 50mM fructose a new protein 
band is produced at 72kD. This shows a further increase in staining intensity, and 
thus in protein concentration, after 14 and 21 days of fructation. Faint protein 
bands also appear at 29kD and 33kD and there is an apparent loss of staining (thus 
a loss of protein) in the bands corresponding to BSA and other smaller 
contaminating globulins, as a function of the time of fructation. 
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Fig. 5.4.1.1. Glycation (0.5M fructose) induced cross-linking of lysozyme produces a 
28kD homodimer and a 42kD trimer. Lane A represents 8 days incubation in the 
absence of free sugar while lanes B, C, D, E and F represent 0,2,4,6 and 8 days 
incubation with 0.5M fructose respectively. Ovalbumin is a contaminant of the 
lysozyme preparation. 
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Fig. 5.4.1.1. Glycation (0.5M fructose) induced cross-linking of lysozyme produces a 
28kD homodimer and a 42kD trimer. Lane A represents 8 days incubation in the 
absence of free sugar while lanes B, C, D, E and F represent 0,2,4,6 and 8 days 
incubation with 0.5M fructose respectively. Ovalbumin is a contaminant of the 
lysozyme preparation. 
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Fig. 5.4.1.2. Quantitation of fructation (0.5M fructose) induced cross-linking of 
lysozyme; samples taken from the gel depicted in figure 5.4.1.1. 
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Fig. 5.4.1.3. Pentosidine-linked fluorescence of the fructated (0.5M fructose) 
lysozyme samples depicted in figure 5.4.1.1. 
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and 15 days incubation with 0.05M fructose respectively. 
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Fig 5.4.1.4. Glycation (0.05M fructose) induced cross-linking of ß-lactoglobulin 
produces a 36kD homodimer and a 54kD trimer. Lane A represents 15 days 
incubation in the absence of free sugar while lanes B, C, D and E represent 0,7,11 
and 15 days incubation with 0.05M fructose respectively. 
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Fig. 5.4.1.5. Quantitation of fructation (0.05M fructose) induced cross-linking of 
(3-lactoglobulin by densitometry of the gel depicted in Figure 5.4.1.4. The results 
presented are net, the dimer and trimer formed in vivo (lane B) has been subtracted 
from those formed in vitro (lanes C to E). 
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show the protein before glycation; A contains no free-sugar while B contains O. IM 
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5.4.2. Inhibition of cross-linking 
The inhibition of AGE-cross-linking was studied by including aminoguanidine or 
the metal chelator diethylenetriaminepenta-acetic acid (DTPA) in the phosphate 
buffer. HEPES buffer was also used as a substitute for phosphate, because it has 
free radical scavenging properties and low free metal contamination. The gel in 
figure 5.4.2.1. and its densitometric analysis (Fig. 5.4.2.2. ) illustrates the effective 
inhibition of cross-linking by these 3 compounds. Comparison of lanes A and B 
(before and after 7 days fructation respectively) reveals production of homodimers 
(28 and 36kD), a heterodimer (36kD) and high molecular weight aggregates 
(>4OkD) as a result of fructation. HEPES, aminoguanidine and DTPA (lanes C, D 
and E-respectively) all inhibit the formation of these oligomers (Fig. 5.4.2.2. depicts 
the heterodimer in particular). Figure 5.4.2.3. illustrates similar results for the 
pentosidine-linked fluorescence of the same samples (Fig. 5.4.2.1. ); HEPES, DTPA 
and especially aminoguanidine, inhibit development of fluorescence compared to 
the control (columns C, E, D and B respectively). 
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various inhibitors of AGE formation. Lane A is the two proteins before 7 days 
fructation, while lane B is after. Lanes C to E are also after 7 days fructation: in C the 
phosphate buffer has been substituted with HEPES; the samples in lanes D and E are 
in phosphate buffer but 50mM aminoguanidine (D) or 1mM DTPA (E) are also 
included. 
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Fig 5.4.2.1. Lysozyme and ß-lactoglobulin fructated (O-1M fructose) together with 
various inhibitors of AGE formation. Lane A is the two proteins before 7 days 
fructation, while lane B is after. Lanes C to E are also after 7 days fructation: in C the 
phosphate buffer has been substituted with HEPES; the samples in lanes D and E are 
in phosphate buffer but 50mM aminoguanidine (D) or 1mM DTPA (E) are also 
included. 
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Fig. 5.4.2.2. Densitometry of the gel depicted in Figure 5.4.2.1. Inhibition of cross- 
linking between lysozyme and ß-lactoglobulin after 7 days incubation with 0.1M 
fructose. Column A is the two proteins before 7 days fructation, while column B is 
after. Columns C to E are also after 7 days fructation: in C the phosphate buffer has 
been substituted with HEPES; the samples in columns D and E are in phosphate 
buffer but 50mM aminoguanidine (D) or 1mM DTPA (E) are also included. 
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Fig. 5.4.2.3. Inhibition of pentosidine-linked fluorescence. Column A is the two 
proteins before 7 days fructation, while column B is after. Columns C to E are also 
after 7 days fructation: in C the phosphate buffer has been substituted with 
HEPES; the samples in columns D and E are in phosphate buffer but 50mM 
aminoguanidine (D) or 1mM DTPA (E) are also included. 
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5.4.3. Investigation of cross-linking as a post-Amadori or post-Heyns reaction 
The previous experiments of this chapter have shown that when lysozyme and ß- 
lactoglobulin are fructated together, they form 2 homodimers and a heterodimer 
(28,36 and 32kD respectively). This section of the chapter concerns the formation 
of a glycated protein that can actively cross-link with another non-glycated protein 
after the removal of free sugar. In vivo hyperglycaemia, caused by an oral load, 
normally only occurs for a short time (<2 hours) before it is brought under control 
by the influence of insulin. Fructose is not controlled hormonally but is actively 
and rapidly removed from circulation by the liver. Thus the time for elevated rates 
of serum protein glycation is short, especially in the case of fructose. This 
experiment was designed to reflect such in vivo physiology. Proteins were 
incubated for short time intervals with elevated fructose concentrations and then 
re-incubated in the absence of free sugar with another native protein. Formation of 
AGEs are detected by cross-linking of fructated protein to non-glycated protein. 
Figure 5.4.3.1. shows the results of one such experiment. Lysozyme was Eructated 
for between 0 and 8 days whereupon free fructose was removed by exhaustive 
dialysis against bicarbonate buffer (see page 57). The lysozyme that had been 
fructated to varying degrees (measured by the time of initial fructation), was then 
re-incubated at 37°C for 7 days with native ß-lactoglobulin. Lane C in figure 
5.4.3.1. illustrates the cross-linking between lysozyme (fructated for 2 days) and 
native ß-lactoglobulin, producing a 32kD heterodimer. The heterodimer is not 
produced in the sugar-free control (lane A) in which lysozyme (incubated on its 
own for 8 days in phosphate buffer) and ß-lactoglobulin were incubated together 
in bicarbonate buffer for a further 7 days. Lanes D to F show that the heterodimer 
is produced with greater intensity if the lysozyme is fructated for longer (4 to 8 
days respectively). 
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Figure 5.4.3.2. shows the results of a similar experiment using native BSA. 
Lysozyme that had been glycated for 7 days with 0.5M fructose, was separated 
from the free fructose by exhaustive dialysis. The fructated lysozyme was then re- 
incubated in phosphate buffer with native BSA (fraction V) for between 0 and 8 
days. The gel in figure 5.4.3.2. shows the typical results of this experiment with 
non-enzymatic modification of the BSA preparation. The gel illustrates production 
of a 71kD protein band, the yield of which is dependent on the time of exposure of 
the BSA to fructated lysozyme. A 5kD contaminant of the lysozyme preparation 
would have been removed by dialysis, thus the 71kD protein could not be a cross- 
link between BSA and such a contaminant. The 71kD protein is, however, of 
remarkably similar molecular weight to a 72kD band produced when BSA is 
fructated, as shown in figure 5.4.1.7. It is conceivable that the 71 kD protein is a 
cross-link between lysozyme and a contaminant of the BSA preparation. 
Alternatively, a free cross-linking agent, such as 3-deoxyglucosone, derived from 
fructated lysozyme, could cross-link the contaminants to each other or BSA. 
Fructated lysozyme is not exclusive in its ability to cross-link with non-glycated 
protein. Figure 5.4.3.3. shows the results of sugar-free re-incubation of native 
lysozyme with fructated ß-lactoglobulin (O. 1M fructose for 7 days in phosphate 
buffer). Lane A is the sample of native lysozyme and fructated 13-lactoglobulin 
before re-incubation; lanes B and C are the samples after re-incubation for 4 and 8 
days at 37°C. The 32kD lysozyme-ß-lactoglobulin heterodimer is formed after 4 
days of re-incubation. Thus glycation of either the lysozyme or 13-lactoglobulin 
will, upon sugar-free re-incubation, form the heterodimer with non-glycated 
protein. 
All the figures presented so far, in this chapter, have been prepared from samples 
glycated for days at a time. I wanted to reduce the time of fructation, thus out of 
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the experiments presented in this section so far, I chose to incubate native 
$3-lactoglobulin with fructated lysozyme. This is because this experiment produced 
distinct heterodimer bands at 32kD (see Fig. 5.4.3.1. ). Figures 5.4.3.4. through to 
5.4.3.7. are the results of a series of such experiments designed to reduce the time 
of fructation and yet still be able to detect AGEs. Figure 5.4.3.4. shows the results 
of an experiment where lysozyme was incubated with 0.5M fructose for between 0 
and 90 minutes. The free fructose was removed by a rapid method (<2 hours) 
using size exclusion chromatography and ultrafiltration (see section 2.4. ). The 
separated, fructated lysozyme was then re-incubated at 37°C in phosphate buffer, 
with native f3-lactoglobulin, for 7 days. There is staining in the 32kD heterodimer 
regions of lanes B and C (Fig. 5.4.3.4. ), due to cross-linking of native 
ß-lactoglobulin to lysozyme fructated for 30 and 90 minutes, however no distinct 
bands were formed. 
The gel in figure 5.4.3.4. showed very low amounts of heterodimer in comparison 
to the monomer, thus another experiment to investigate the minimal conditions of 
fructation necessary for cross-linking was devised. Figure 5.4.3.5. shows the results 
of that experiment. Lysozyme was fructated in phosphate buffer for up to 24 hours 
and exhaustively dialysed against bicarbonate buffer. During the first 12 hours of 
dialysis the fructose concentration, in the dialysis buffer, gradually increased from 
zero to 5mM (the fructose originated frbm the samples). Therefore all of the 
samples, including what had been the sugar-free control, were exposed to 5mM 
fructose for up to 12 hours at 4°C in bicarbonate buffer and were thus minimally 
fructated. Some of the sugar-free control had not been dialysed and so could still 
be used as the true control (lanes A), but the control sample that had been dialysed 
now served as a useful marker of minimal fructation (lanes BY Lanes C to L are 
samples where the lysozyme was fructated (0.5M fructose in phosphate buffer). for 
between 30 minutes and 24 hours, before free fructose was removed by exhaustive 
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dialysis (including the minimal fructation). All of the samples were then re- 
incubated in sugar-free bicarbonate buffer with native ß-lactoglobulin. Note that 
the lanes are in pairs, the left lane of each pair is the sample before sugar-free re- 
incubation and the right is after. 
The results of the gel of figure 5.4.3.5. reveal a distinct protein band at 32kD that 
corresponds to the lysozyme-ß-lactoglobulin heterodimer in the sample that 
contains extensively fructated lysozyme, i. e. was fructated for 24 hours (right lane 
of Q. The heterodimer can, however, be clearly made out even in the sample that 
was minimally fructated (right lane of B). Figure 5.4.3.6. illustrates the increase in 
heterodimer band intensity through the range of samples, as a function of the time 
of the initial fructation of the lysozyme. The right lane of each pair of lanes on the 
gel (Fig. 5.4.3.5. ) was scanned with a densitometer and the amount of heterodimer 
in the completely sugar-free control was subtracted from that of each sample, this 
ensured that only in vitro glycation was measured. The cross-linking observed in 
the sugar-free control (right lane of A) is probably between in vivo glycated 
ß-lactoglobulin and the lysozyme. 
Observation of the heterodimer in the gel and its quantification by densitometry 
(Figs 5.4.3.5. and 5.4.3.6. ) shows that the minimally fructated sample (lane B on the 
gel or point bisecting the 'Y-axis' of the graph) contains around 1% of its total 
protein in the form of the lysozyme-ß-lactoglobulin heterodimer. The percentage 
of heterodimer steadily increases with the degree of fructation of the lysozyme 
(measured in hours of fructation). There is a change, in the slope of the graph, at 
around 5 hours of initial fructation, the more extensively fructated lysozyme 
appears to produce heterodimer more slowly than the less fructated lysozyme. 
Figure 5.4.3.7. shows the net pentosidine-linked fluorescence, due to in vitro 
fructation, of the same samples used in the gel of figure 5.4.3.5.; the lysozyme only 
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shows a very slight increase in fluorescence even after 24 hours of fructation. The 
same samples, after dialysis and addition of ß-lactoglobulin but before re- 
incubation, show very little difference in fluorescence. This illustrates the low rate 
of AGE formation during dialysis; the slight drop in fluorescence of the sample 
that contains lysozyme that was fructated for 24 hours, after dialysis, may be due 
to quenching by the added ß-lactoglobulin or it could be due to experimental 
error. The fluorescence after 7 days re-incubation at 37°C in bicarbonate buffer is 
vastly changed, all the re-incubated samples (including 'minimally fructated') 
exhibit greater fluorescence than before re-incubation. The fluorescence of the 
samples containing lysozyme fructated for four or more hours, is proportional to 
the time for which the lysozyme was fructated. Between thirty minutes and four 
hours of fructation of lysozyme, there is no change in fluorescence; this may 
indicate that a certain concentration of fructated lysozyme is necessary before 
fluorescent AGEs will form. 
178 
---..., 
M. .m 
do- " 
Wý 
do 
.. ý- 
ý 
ý 
kD 
high molecular weight 
aggregates 
P-lactoglobulin dimer 
heterodimer 
lysozyme homodimer 
ß-lactoglobulin 
lysozyme 
41up 41M am W-: #Moo low$% 
ý lý . ý.. WO rr. emo gý 
ABCD E 
66 
45 
36 
29 
24 
20 
14 
F+ 
Fig 5.4.3.1. Fructated lysozyme cross-links with native ß-lactoglobulin upon 7 days 
sugar-free re-incubation in bicarbonate buffer. Lane A is the sugar-free control (see 
text). Lanes B, C, D, E and F contain P-lactoglobulin after 7 days incubation with 
lysozyme that had been glycated for 0,2,4,6 and 8 days with 0.5M fructose in 
phosphate buffer. 
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Fig 5.4.3.5. Lysozyme glycated with 0.5M fructose for 0,0.5,1.5,2.5,3,4,5,7,8,12 
and 24 hours, upon 7 days sugar-free re-incubation in bicarbonate buffer cross-links 
with native (3-lactoglobulin (pairs of lanes B to L respectively). Lanes A are the 
completely sugar-free control. The left lane of each pair is the sample before sugar- 
free re-incubation and the right is after. The abbreviations represent; (3D = ß- 
lactoglobulin homodimer, H= heterodimer, LD = lysozyme homodimer, ßM = 13- 
lactoglobulin monomer and LM = lysozyme monomer. 
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5.5. Discussion 
The study of Maillard cross-linking is important to increase our understanding of 
the biochemical basis of the pathogenesis of diabetic secondary complications in 
vivo. If diabetic secondary complications are representative of accelerated ageing, 
greater knowledge of the Maillard reaction would also increase our 
comprehension of the normal ageing process. It is likely that conjugation of two 
different proteins in vivo would alter their activity, function, receptor-mediated 
uptake and turnover. Thus Maillard cross-linking in vivo has a great potential for 
alteration of the function of tissues and production of degenerative diseases. 
5.5.1. Fructation-induced cross-linking 
The faster rate of cross-linking of lysozyme, RNase and collagen upon fructation 
compared to glucation (at equal sugar concentrations) has been reported 
previously [198,199,200 and 133]. The results contained in this thesis agree with 
those results and add ß-lactoglobulin to the list of proteins studied. Fructation of 
lysozyme or ß-lactoglobulin produces intermolecular AGE-cross-links, resulting in 
oligomers (Figs. 5.4.1.1. and 5.4.1.4. ). Also, if a solution of lysozyme and ß- 
lactoglobulin is fructated, they will cross-link to form a 32kD heterodimer, figure 
5.4.1.6. The lysozyme preparation is contaminated by two proteins that are clearly 
stained in figure 5.4.1.1.; ovalbumin at 45kD and an unknown contaminant at 
about 73kD. The ß-lactoglobulin preparation is contaminated by its own dieter 
(36kD) which is likely to have been produced from in vivo glycation by lactose 
since the protein is purified from bovine milk. 
BSA is not an ideal protein to use when studying cross-linking by SUS-PAGE 
because of its high molecular weight, i. e. dimers and trimers of BSA have 
186 
molecular weights in the region of the gel that has a non-linear gradient. Figure 
5.4.1.7. is a gel of fructated BSA and shows the production of a 72kD protein band 
as a function of the time of fructation. The nature of the 72kD band cannot be 
determined using SDS-PAGE and I would have liked to have performed western 
blotting on it, but there was not enough time available. It is possible that the 72kD 
protein is formed by the cross-linking of two contaminants of the BSA preparation 
rather than BSA plus a 5kD oligomer. Glycation of the globulins that contaminate 
BSA is indicated by the spreading and fading of their stained bands as a function 
of the time of fructation, for example ß-lactoglobulin monomer also fades and 
spreads in figure 5.4.1.4. The spreading and fading is due to impaired binding of 
SDS to glycated protein, which causes it to migrate in the gel behind the native 
form. Alternatively, the 72kD band could be BSA monomer with a number of 
fructose residues attached. Lapolla et at (1994) reported that BSA increased in 
molecular weight with addition of glucose residues to form a stable molecule of 
7OkD [115]. If however the 72kD protein were BSA with a number of fructose 
residues attached, I would have expected to see bands between 67 and 72kD of 
other BSA-fructose adducts. 
5.5.2. Inhibition of cross-linking 
Figures 5.4.2.1. to 5.4.2.3. illustrate inhibition of AGE formation by the use of anti- 
oxidative conditions (HEPES and DTPA) and by sequestration of reactive groups 
(aminoguanidine). Substitution of phosphate buffer with HEPES was the most 
effective method to prevent heterodimer formation, while inclusion of DTPA or 
aminoguanidine in phosphate buffer does result in some cross-linking, albeit at a 
lower rate than without the inhibitors. It is possible that DTPA does not fully 
prevent the free metal of phosphate buffer from taking part in MCO [681. This may 
account for the higher percentage of lysozyme dimer and heterodimer produced 
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upon fructation with DTPA than in HEPES buffer. The low level of AGE formation 
in HEPES buffer indicates that there are routes to AGE formation that are 
independent of MCO. 
Prabhakaram and Ortwerth (1994) wrote an interesting article concerning cross- 
linking of glycated lysozyme to [14C]-lysine and other amino acids in the presence 
of 1mM DTPA [206]. Glycation using fructose, galactose and glucose gave rise to 
virtually no cross-linking; while 3-DOG, ascorbate, and its degradation products 
did produce cross-links. The fact that 3-DOG produced cross-links but fructose did 
not, indicates that the hypothesis of 3-DOG formation from fructose is not a 
reaction with a high rate under conditions similar to those in vivo. Alternatively, it 
indicates that such a conversion is free metal dependent, see section 1.7. for a 
review of 3-DOG production from fructose. 
The inhibition of AGE formation by aminoguanidine is interesting because the 
results of this chapter indicate that it completely inhibits fluorophore formation 
(Fig. 5.4.2.3. ) but not cross-linking (Fig. 5.4.2.2. ); thus cross-linking could be an 
earlier or more sensitive indicator of AGE formation than fluorescence. 
Alternatively the mechanism of production of some cross-links is different to that 
of fluorophore formation and aminoguanidine does not block them all. 
Aminoguanidine is a non-specific hydrazine and will react with any available 
carbonyl group that occurs in the Maillard reaction. The principle site of 
aminoguanidine action in the Maillard reaction is, however, contentious and 
several sites have been proposed. See chapter 4. for more information; briefly, 
aminoguanidine can potentially react with free sugar, Amadori or Heyns product 
and post-Amadori or post-Heyns intermediates to AGE formation. 
Aminoguanidine can react with the acyclic aldehyde or ketone forms of free 
sugars inhibiting glycation. Blackledge (1993) reported the production of 
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chromophores from such a reaction [166]. Lane D of figure 5.4.2.1., however, 
illustrates a spreading and fading of the ß-lactoglobulin monomer in the presence 
of aminoguanidine, as a function of the time of fructation,. while AGE formation 
in the same samples is blocked; this indicates that aminoguanidine has a low 
reactivity with free sugar in comparison to a product of glycation. This effect of 
inhibiting AGE formation, but not glycation, by aminoguanidine, supports the 
theory that it reacts with post-Amadori or post-Heyns compounds preventing 
their further reaction, which would otherwise produce AGES. This theory was 
proposed by Fu et al (1992) and supported by evidence presented in chapter 4. 
[134]. 
The conclusions drawn from the inhibitor experiments of this chapter are used to 
modify figure 1.1. and produce figure 5.5.2.1. 
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Fig. 5.5.2.1. Schematic diagram of the possible routes for post-Amadori or post- 
Heyns reactions and their inhibition by DTPA and aminoguanidine. 
5.5.3. Investigation of cross-linking as a post-Amadori reaction 
The third part of the results section of this chapter shows how glycated protein can 
form cross-linked and fluorescent AGEs with non-glycated proteins in the absence 
of free sugar. In vivo elevated monosaccharide concentrations, in circulation, are 
caused by ingestion of a carbohydrate rich meal. Glucose is removed from 
circulation under the influence of insulin throughout the body and normal 
concentrations of ingested fructose are removed by the liver before the blood in 
the hepatic portal vein enters general circulation. Thus proteins throughout the 
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body can be exposed to hyperglycaemia, but only those in the blood of the hepatic 
portal vein and surrounding tissues are exposed to short periods of elevated 
concentrations of dietary fructose. It is conceivable that the rate of fructation is 
swift enough such that dietary fructose could produce stable glycated protein that 
would contribute to diabetic secondary complications and ageing in the general 
population. 
Figure 5.4.3.1. shows that fructated lysozyme will cross-link with native 
ß-lactoglobulin upon 7 days sugar-free re-incubation and form a very sharp 
lysozyme-ß-lactoglobulin heterodimer band (32kD) that increases in intensity if 
the lysozyme is fructated for longer periods. Figure 5.4.3.3. illustrates that 
fructated (3-lactoglobulin will cross-link to native lysozyme and form the 32kD 
heterodimer after 4 days of sugar-free re-incubation in phosphate buffer. Thus 
glycation of either lysozyme or ß-lactoglobulin produces a form of protein that 
will actively cross-link with the other native protein upon sugar-free re-incubation. 
Figure 5.4.3.2. shows the production of a 71kD band, upon re-incubation of 
fructated lysozyme with native BSA, the intensity of which increases with the time 
of exposure of the BSA to the fructated lysozyme. The molecular weight of the 
71kD band is too low for a lysozyme-BSA heterodimer (67 + 14 = 81kD), but the 
band is, however, of remarkably similar molecular weight to a 72kD band 
produced when BSA is fructated on its own (figure 5.4.1.7. ). Contaminants of the 
lysozyme preparation of less than 10kD would have been removed by the 
ultrafiltration step (removal of unreacted sugar), therefore the 71kD band could be 
fructated lysozyme cross-linked to a contaminant of the BSA preparation, or a 
post-Heyns reactive intermediate that is derived from, but free of, the fructated 
lysozyme. 3-DOG (page 49 et sequa) has been proposed to be derived from 
Atriadori product and act as a free agent cross-link protein, thus it could be 3-DOG 
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that cross-links two contaminants of the BSA preparation. Alternatively 
compounds such as 3-DOG, or even fructose released from the fructated lysozyme, 
could react with the BSA, increasing its molecular weight. BSA was reported to 
form a stable structure at 7OkD upon glucation, the structure was proposed to be 
BSA with around 16 glucose residues attached [115]. 
Further investigation of post-Amadori or post-Heyns reactions using sugar-free 
re-incubation revealed that as little as 30 minutes fructation of lysozyme, followed 
by a rapid removal of free sugar and 7 days re-incubation with r3-lactoglobulin, 
produces a 32kD heterodimer (Fig. 5.4.3.4. ). The heterodimer bands produced in 
this experiment were, however, of poor contrast. Thus the experiment was 
modified using dialysis into bicarbonate buffer, rather than size exclusion 
chromatography and ultrafiltration, to remove free sugar; the results are shown in 
figures 5.4.3.5. to 5.4.3.7. 
Dialysis removes molecules smaller than the molecular weight cut-off of the 
dialysis membrane at a rate that is dependent on the concentration gradient. In the 
system used for experiments presented in this thesis, the volume of dialysis buffer 
was continually pumped across the membrane and samples, in a closed loop, such 
that an equilibrium between samples and dialysis buffer was reached. The final 
concentration of the small molecules (less than 6-8kD) in each change of buffer, 
and thus in the samples, was dependent on the volume of the samples, the dialysis 
buffer and the initial sugar concentrations. For the samples in figure 5.4.3.5. the 
dilution of small molecules was 100 fold for each change of buffer, thus in the first 
12 hours of dialysis, before the first change of buffer, the concentration of fructose 
in the dialysis buffer rose to 5mM. This meant that the sample that had up to that 
point been the sugar-free control, was exposed to an increasing concentration of 
fructose (up to 5mM) for up to 12 hours at 4°C in bicarbonate buffer. Therefore, 
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upon completion of dialysis this sample had been 'minimally fructated' (12 hours, 
5mM fructose, 4°C in bicarbonate buffer). So an aliquot of the same sample taken 
before dialysis, was used as the true sugar-free control for the rest of the 
experiment. Thus figure 5.4.3.5. illustrates the cross-linking of fructated lysozyme 
to native ß-lactoglobulin to form a 32kD heterodimer upon sugar-free re- 
incubation in bicarbonate buffer. The sample that contained lysozyme fructated for 
24 hours (right lane of L) shows a very clear heterodimer at 32kD, in a similar 
manner to figure 5.4.3.1., it can however be discerned in all of the samples, 
including the completely sugar-free control and the sample that was minimally 
fructated (right lanes of A and B respectively). 
The densitometry of the gel in figure 5.4.3.5. (Fig. 5.4.3.6. ), shows that the intensity 
of the heterodimer is proportional to the time that the lysozyme was initially 
fructated and therefore the amount of fructated lysozyme in the sample. The cross- 
linking observed in the true sugar-free control is probably due to in vivo glycation 
of the (3-lactoglobulin, which was purified from pasteurised skimmed milk; cows' 
milk contains the reducing disaccharide lactose at a concentration of about 0.13M 
[207]. The time lapsed between milking to the final lyophilisation of the purified (3- 
lactoglobulin was not available from Sigma, thus the degree of in vivo glycation 
will vary between batches of protein, thus this variable was removed from the 
experimental results presented. The densitometry and fluorescence are the net 
results due to in vitro fructation, i. e. the amount of heterodimer produced from in 
vivo glycation of ß-lactoglobulin (sugar-free control) has been subtracted. 
The increase in heterodimer formation in figures 5.4.3.5. and 5.4.3.6. is biphasic, 
there is an initial fast rate of production (up to 5 hours) which tapers off into a 
slower rate for the samples that contain more extensively fructated lysozyme. The 
change in rate of formation could be due to limitation of substrates; such as 
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available amino groups on the lysozyme during the initial fructation, or cross- 
linking sites on the ß-lactoglobulin. It is also conceivable that the heterodimer is a 
substrate for the production of a higher molecular weight AGE, but unless this 
AGE was only formed when a critical amount of its substrates were present, this 
would not account for the change in the rate of its formation. If the heterodimer 
was becoming part of a higher molecular weight protein it would be lost in a 
similar proportion in all the samples. 
The fluorescence of the samples used in the gel of figure 5.4.3.5. is illustrated in 
figure 5.4.3.7. The two lowest curves should, in theory, be almost the same, with 
perhaps some extra AGE formation in the samples that have been dialysed. The 
lower fluorescence of the samples after dialysis, compared to before, is probably 
due to quenching by the added ß-lactoglobulin. The upper curve is the 
fluorescence of ß-lactoglobulin and fructated lysozyme after 7 days sugar-free re- 
incubation. The fluorescence after re-incubation is dependent on the time of initial 
fructation. There is very little difference in the fluorescence of the samples 
containing lysozyme fructated for less than 3 hours, whereas samples containing 
lysozyme fructated for longer than 3 hours exhibit a fluorescence that is dependent 
on the time for which the lysozyme was fructated. This implies that a certain 
concentration of fructated lysozyme is necessary before fluorophores will form. 
Comparison of the cross-linking and fluorescence of the same re-incubated 
samples (Figs. 5.4.3.6. and 5.4.3.7. ) illustrates that at first cross-linking forms faster 
than the development of fluorescence. When the lysozyme has been fructated 
more extensively (four or more hours), however, the rates reverse. Highly 
fructated lysozyme produces more fluorescence than cross-links with 
(3-lactoglobulin. The threshold of the change from formation of cross-linked AGE 
to fluorescent AGE is when the lysozyme has been fructated for 4 to 5 hours. The 
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results suggest common post-Heyns compounds, that are intermediates in the 
production of cross-linked and fluorescent AGES. The concentration of these, and 
probably other post-Heyns (or post-Amadori if the reactions are analogous), is 
critical to the particular AGES formed; below a certain concentration cross-links 
are formed, above it fluorophores are formed. This conclusion is illustrated in the 
simple schematic diagram in figure 5.5.3.1. 
heterodimer 
flnorophore 
L= lysosyme 
H= hezose or sugar residue 
B= P-lactoglobulin 
+ 
t 
+ 
0 
2 
Fig. 5.5.3.1. A schematic diagram to illustrate that more extensively fructated 
lysozyme favours development of fluorescence rather than cross-linking with 
native ß-lactoglobulin. Note that the diagram is speculative; currently the number 
of moles of incorporated fructose per mole of protein at which development of 
fluorescence is preferred over cross-linking, is unknown; also, two covalently- 
linked sugar residues on a protein do not necessarily form a fluorophore. 
Sensi et al (1989) showed that in vitro glycated, powdered human glomerular 
basement membrane (10 days, 0.5M glucose, phosphate buffer) trapped more 
insulin, albumin, IgG and fibrinogen than the non-glycated control [181]. They 
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proposed that such trapping in vivo could exacerbate diabetic nephropathy. Indeed 
it would explain the increased deposition of albumin and fibronectin in diabetic 
kidney [191 and 2081. The in vitro studies carried out by Sensi et al (1989) have 
described glycated collagen trapping serum proteins [181]. The re-incubation 
experiments reported in this thesis are model systems that show that glycated 
proteins will form cross-links with other native proteins long after the removal of 
the monosaccharide. The results lend weight to the theory that the deposition of 
serum proteins onto the proteins of structural tissues, such as glomerular basement 
membrane, is via AGE-cross-links. Such AGE-cross-linking of serum proteins to 
structural proteins can be initiated by glycation of either or both of these two types 
of protein. 
The 'minimally fructated' sample (Figs. 5.4.3.5. to 5.4.3.7. ) indicates that the 
proportion of glycated protein in relation to the native form need only be small for 
AGEs to be formed and detected. The low concentrations of fructose found in 
human circulation combined with the non-detection of fructated protein, has led to 
the general assumption that dietary fructose has an insignificant effect on 
deterioration of health [209]. The results in this thesis show that both short 
exposure times of protein to high concentrations of fructose and long exposure 
times to low concentrations of fructose can, after removal of the free sugar, form 
AGES. The results indicate that dietary fructose could in vivo fructate enough 
protein to contribute to the development of diabetic secondary complications and 
thus also to the same diseases that occur in old age. 
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5.6. Summary 
Fructation of the proteins lysozyme, (3-lactoglobulin, and BSA in isolation, 
gives rise to dimers and trimers in the case of the first two proteins and a 72kD 
protein in the third. 
2. Fructation of lysozyme and ß-lactoglobulin together produces a 32kD 
heterodimer. 
3. Formation of cross-linked and fluorescent AGES is inhibited by fructation in 
HEPES buffer, or by inclusion of aminoguanidine or DTPA in phosphate 
buffer. The inhibition indicates a role for carbonyl intermediates and metal 
catalysed oxidation in AGE formation. 
4. The incomplete inhibition of AGE formation by aminoguanidine and DTPA 
indicates that some routes to AGE formation are independent of carbonyl 
intermediates and metal catalysed oxidation. The inhibitors also suggest 
different routes to formation of some non-fluorescent, cross-linked and 
fluorescent AGEs. 
5. Lysozyme that has been minimally fructated (12 hours, 5mM fructose, 4°C in 
bicarbonate buffer) produces a heterodimer with ß-lactoglobulin upon sugar- 
free re-incubation. Thus it is possible that even the low concentrations of serum 
fructose from the diet could cause significant levels of glycation in vivo, 
contributing to the progression of diabetic secondary complications and 
ageing. 
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6. The post-Amadori or post-Heyns production of non-fluorescent, cross-linked 
and fluorescent AGES may be independent, although they may share common 
post-Amadori or post-Heyns intermediates. 
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6. Overall Discussion 
The purpose of this chapter is to provide an overview of the results presented in 
this thesis, to correlate those results and discuss the contribution of fructose to the 
Maillard reaction in vivo. It is also an opportunity to discuss the contribution of 
fructation to progression of diabetic secondary complications and the same 
diseases that occur as a result of old age. The similarity of fructose and glucose 
chemistry makes it difficult to determine the relative contribution of each sugar to 
the formation of AGES present in diabetic secondary complications. Conversely 
the slight difference in the chemistry of glucose and fructose means that the assays 
designed to detect glucation, underestimate fructation [2091. The underestimation 
of fructation is compounded by the low concentration of fructose in the blood. 
Dietary fructose is an important part of our diet; one of the questions to be raised 
is one of whether dietary fructose could significantly contribute to progression of 
diabetic secondary complications and the same diseases that occur in old age. 
Before the turn of the century, fructose was only available in the western diet from 
natural sources, e. g. fruits and honey. At the turn of the century sucrose became 
widely used and its consumption has increased dramatically since then. Over the 
past 20 years the increased consumption of convenience foods (soft drinks, dairy 
products, canned, baked, and processed foods) has further increased our exposure 
to fructose. Initially sucrose was the predominant calorific sweetener in these 
foods, but this has been superseded by sweeter, high fructose corn syrups (HFCS). 
HFCS can contain up to 90% fructose by weight, but the majority (58%) that are 
used contain 55% fructose by weight (HFCS-55) [90 and 2131. Fructose is also used 
extensively in foods recommended for diabetics, this is because it has little effect 
on blood glucose concentration. The development of diabetic secondary 
complications is now widely appreciated to be a result of hyperglycaemia. What is 
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not quite so widely recognised is that other dietary sugars can also undergo the 
Maillard reaction, thus in theory contribute to diabetic long term complications 
and probably the same diseases that occur in the general population during old 
age. Our health throughout life is determined by our diet, dieticians have 
maintained for many years that a balanced diet is essential for a high quality of 
life. Fats are now widely recognised as important to the development of heart 
disease. I would like to see more research carried out on the role of 
monosaccharides in the development of such diseases, especially since diabetics 
suffer from them at an earlier age. 
Fructose is also produced by the sorbitol pathway, which in certain tissues is an 
important route for metabolism of intracellular glucose during hyperglycaemia. 
The disruptive osmotic effect of sorbitol accumulation on crystallin fibres of the 
lens is one of the theories put forward to explain diabetic cataract. The end- 
product of the sorbitol pathway, fructose, has however been largely ignored. 
McPherson et al (1988) reported that 10 to 20% of hexose incorporated into human 
ocular lens formed the same derivative, upon assay, as fructose. The fructose that 
formed the fructated protein was suggested to originate from the sorbitol 
pathway; especially since the concentration of fructated protein was higher in 
diabetic lenses than those from non-diabetics. Interestingly the presence or lack of 
cataract did not effect the results; the small number of lenses assayed meant that 
no firm conclusions could be drawn, but the experiment does warrant further 
exploration with more lenses. If the results withstand statistical scrutiny they 
suggest that there is no connection between cataract formation and fructation [88]. 
It is difficult to justify the presence of fructose in the lens since it would be 
metabolically expensive for the endothelial cells of the lens to export fructose into 
the lens, unless it had reached a toxic concentration within the cells. Here toxicity 
is defined as osmotic pressure or formation of fructated protein or amino acids at a 
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rate that the cell is unable to cope with. It is however clear from McPherson et al 
(1988) that fructated protein is present in the lens; the fructose presumably being 
released from the epithelial layer of cells that surround the lens. 
It has been known for a number of years that in vitro glycation by fructose 
proceeds in haemoglobin at a faster rate than glucose and similarly, that in vitro 
AGE-fluorescence develops at a faster rate during fructation than glucation [83 
and 141. The rate of in vitro incorporation of fructose or loss of free amino groups 
has, however, been reported to be equal or lower than that of glucose [88 and 14]. I 
have shown that in vitro fructose is incorporated into three different proteins at a 
faster rate than glucose and that this is reflected by their fluorescence. A higher 
rate of incorporation of fructose into protein would explain the faster development 
of AGES upon fructation than glucation. Conversely, if glucose and fructose were 
incorporated at similar rates it would suggest that fructose produces more AGEs 
per mole of hexose than glucose. If more time had been available I would have 
liked to have further studied fructose incorporation into HSA. At 0.1M, fructose 
and glucose appear to be incorporated into HSA at very similar ratesfor periods of 
glycation up to 3 days (Fig. 3.4.1.1. ). This result is possibly an error in the 
experiment but it would be worth checking; especially considering that the shorter 
incubation times are more physiological than a week of incubation using 0.1M 
hexose. I would also like to have investigated incorporation of hexose at 
concentrations much closer to those found in vivo. 
The lack of assays for fructation has meant that fluorescence has been used as the 
standard method of its measurement throughout this thesis. Fluorescence is, 
however, a non-quantitative technique and caution must be used when comparing 
the results of experiments that use different proteins, buffers and sugar 
concentrations. With this in mind, when experiments are conducted under 
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identical conditions, the fluorescence is consistently higher upon fructation than 
glucation. Another consistent finding is that the fluorescence is inhibited by the 
metal chelator DTPA and the hydrazine aminoguanidine. 
In chapter 3. I presented a histogram of the fluorescence of HSA and BSA 
developed over a week of fructation in various buffers (Fig. 3.4.2.1. ). Current 
theories hold that post-Amadori and post-Heyns reactions are largely dependent 
on MCO. Bicarbonate buffer contains at least twice as much free metal than 
phosphate buffer, yet BSA developed much greater fluorescence in the latter. 
Delipidated, essentially globulin free, HSA did develop more fluorescence in 
bicarbonate, but it is likely that this protein has been oxidatively modified by its 
purification. There is therefore something in the phosphate buffer, other than free 
metal, affecting AGE formation. It is possible that inorganic phosphate catalyses 
Amadori or Heyns rearrangement. This opens an avenue of research into the effect 
of different anions on AGE formation. If more time had been available it would 
have been interesting to investigate the effect of different preparations of a variety 
of buffers on AGE formation. 
The DNPH assay was developed to assess glycation by all sugars, specifically to 
quantify fructation. The assay does indicate enhanced rates of fructation and AGE 
formation when compared to glucation. Such a comparison does, however, need to 
be treated with caution because it relies on the assumption that products of 
glucation and fructation present the same proportion of reactive carbonyl groups. 
Since glucose and fructose themselves have very different percentages of acyclic 
aldehyde and ketone forms this assumption is likely to be wrong. Thus the above 
conclusion, that fructation and AGE formation from it proceeds at a faster rate 
than glucation, is drawn in combination with other assays of the Maillard reaction. 
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The investigation of the reaction of DNPH with intermediates and or products of 
the Maillard reaction was also useful for another reason. DNPH and 
aminoguanidine are both hydrazines that probably react with the same 
compounds. The production of DNPH positive material (protein-bound carbonyls) 
is inhibited by delipidation and chelation of free metal, as is fluorescence, whilst 
formation of Amadori product is unaffected. This indicates that the effect of metal 
catalysed oxidation and the action of lipid on the Maillard reaction is post- 
Amadori or post-Heyns and thus DNPH detects post-Amadori or post-Heyns 
compounds. The material detected by DNPH is not an advanced glycation end- 
products; as sugar-free re-incubation of fructated BSA results in a decrease in 
protein-bound carbonyl, whilst fluorescence increases as a function of time of re- 
incubation. Thus if the actions of DNPH and aminoguanidine are similar, a 
significant part of the action of aminoguanidine will be on this new class of post- 
Amadori or post-Heyns compounds. The inhibition of development of 
fluorescence by aminoguanidine indicates that the compounds detected by DNPH 
are intermediates or precursors in the formation of fluorescent AGEs. This 
conclusion is further supported by analysis of periodate, DNPH and fluorescence 
assays of protein glycated in the presence of aminoguanidine. Amadori product is 
unaffected or even promoted by the presence of aminoguanidine which is 
concomitant with it blocking after this point in the Maillard reaction, rather than, 
for example, on free sugar. Production of protein-bound carbonyl is partially 
inhibited and fluorescence is completely inhibited by aminoguanidine. If DNPH 
and aminoguanidine react with the same compounds, the partial inhibition of 
DNPH positive material can be explained by the chemistry of the hydrazones; the 
aminoguanidine hydrazone is probably hydrolysed by the acid used to solvate 
DNPH, the parent carbonyl is released and available for reaction with DNPH with 
some competition by aminoguanidine. Thus aminoguanidine blocks at the same 
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site detected by DNPH so preventing further AGE formation along this route, e. g. 
fluorescence. The lack of inhibition of Amadori product production by 
aminoguanidine is in agreement with the results reported by Requena et al (1993) 
and Fu et al (1994); the former article hypothesised that the main action of 
aminoguanidine was by sequestration of free monosaccharide; the latter article 
presents evidence similar to the contents of this thesis, i. e. blocking after Amadori 
product and hence its slight build up as a result [168 and 179]. 
Figure 5.4.2.2. illustrates that aminoguanidine only partially inhibits cross-linking 
yet the fluorescence has not increased (Fig. 5.4.2.3. ). Two possible explanations for 
this result are; 1) there is a route to non-fluorescent Maillard cross-links that does 
not involve carbonyl formation. 2) the cross-links themselves, or their derivatives, 
present a carbonyl group and sequestration of this carbonyl group by 
aminoguanidine blocks its further part in the Maillard reaction, such as 
development of fluorescence. 
The re-incubation of minimally fructated lysozyme with native ß-lactoglobulin 
revealed that although cross-linking developed from lysozyme fructated for any 
amount of time, fluorescence only developed if the lysozyme was fructated for at 
least 3 hours (0.5M fructose at 37°C in phosphate buffer). This result indicates that 
cross-linking preceded fluorescence in the time scale of development of AGEs. It 
may be that some cross-links may themselves become fluorescent with time 
Figure 6.1. is a modification of the schematic diagram of figure 5.5.2.1. produced 
using the conclusions of this thesis. The figure illustrates an area prior to 
production of protein-bound carbonyl groups that is dependent on metal catalysed 
oxidation, however, the results indicate that there is some AGE formation even 
when the metal content of the buffer is chelated or of very low concentration (as in 
HEPES). Metal ions chelated to compounds such as DTPA are still able to take part 
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in oxidation reactions; HEPES buffer is also not completely free of metal, nor is the 
water or labware used to make it. The low level of MCO could be responsible for 
AGE formation in HEPES or in the presence of DTPA, but an alternative 
explanation is that there could be routes to AGE formation that are independent of 
metal-catalysed oxidation. 
time 
Fig. 6.1. Schematic diagram of post-Amadori or post-Heyns reactions. The 
boxed areas represent families or groups of compounds defined by their 
properties, thus overlapping boxes represent groups with both properties. 
In vivo Maillard-cross-links are probably responsible for initiation and propagation 
of a multitude of degenerative diseases of old age and those associated with 
diabetic secondary complications. The majority of published studies of Maillard- 
cross-linking have concentrated on a protein in isolation (or a tissue rich in a single 
protein) such as collagen, this is because structural proteins such as collagen are 
associated with the majority of diabetic secondary complications. The mechanism 
and effects of deposition of serum proteins into basement membranes (other than 
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mere observation of deposition) has received little attention. Deposition of serum 
protein into a structural matrix bestows abnormal function to the basement 
membrane; e. g. immunoglobulins could initiate autoimmune disease [reviewed in 
214]. The release of cytokines by macrophages attracted to AGE, or oxdatively, 
modified basement membranes could be responsible for the thickening of the 
membrane [215]. 
Chapter 5. of this thesis describes a model system for the study of cross-linking of 
a glycated protein with a different native protein upon incubation under 
conditions free of sugar. It provides a model to illustrate how a protein that is 
glycated in one part of the body can cross-link to another non-glycated protein 
somewhere else. This is especially important for dietary fructose which does not 
normally cause especially high concentrations of fructose in general circulation. 
Blood proteins are only normally exposed to elevated concentrations of dietary 
fructose in the blood between the small intestine and the liver (hepatic portal 
vein), for short times during absorption of an ingested meal. Thus proteins 
fructated in the blood of the hepatic portal vein are distributed throughout the 
body. Such glycated proteins are likely to have altered receptor mediated uptake 
and, as AGES develop, become more resistant to enzymatic degradation by 
formation of intra-molecular cross-links. Fructated proteins in circulation have the 
potential to cross-link to structural proteins such as those in basement membranes. 
Such deposition would alter the properties of the basement membrane, as outlined 
in the paragraph above. 
Chapter 5. also illustrates that the time of exposure of a protein to fructose need 
only be short, or at low concentration for 12 hours, for enough protein to be 
glycated such that cross-linking can be observed upon sugar-free re-incubation 
with a different native protein. Thus the model of minimal fructation mimics the 
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effect of dietary fructose in vivo; i. e. short periods of elevated fructose 
concentration (up to a few mM), and thus fructation, in the hepatic portal vein 
followed by a return to basal levels after absorption has finished, whereupon 
development of AGES can occur unabated. 
The results presented in this thesis do indicate a role for in vivo fructation derived 
from both dietary intake and the sorbitol pathway. The reactivity of fructose 
indicates that the sorbitol pathway is not a benign curiosity but is probably a 
serious contributor to diabetic secondary complications, thus is yet another reason 
for diabetics to maintain euglycaemia. The increased consumption of fructose in 
the west is probably contributing to the deterioration of health during old age. 
This deterioration could be reduced by avoidance of convenience foods and 
drinks; such advice is particularly relevant to diabetics who are already producing 
AGEs at elevated rates. The degree of contribution of fructose to diseases of old 
age and diabetic secondary complications is open to debate, it is likely to vary 
between individuals and their lifestyles. Lifestyle is a very important factor 
because the Maillard reaction is very slow in comparison to enzymatic reactions in 
vivo, the reaction and levels of its products are enhanced and or inhibited by other 
factors throughout the life of the subject. The body has the capacity for self repair, 
thus as long as this mechanism is not overstretched a healthy lifestyle will reduce 
any damage accumulated through life. 
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7. Suggestions for further study 
The experiments investigating incorporation of hexose into protein could be taken 
further. The similar rates of incorporation of glucose and fructose into HSA over 
the first 3 days of glycation (Fig. 3.4.1.1. ) need to be checked. The incorporation of 
physiological concentrations of sugars would help build up the picture of AGES 
produced in vivo. 
The effect of metal catalysed oxidation on development of AGES could be 
investigated further using phosphate buffer prepared from a range of salts with 
different hydrations. The higher the hydration of the stock salt, the greater the 
contamination by free metal, thus a range of buffers could be prepared with 
equivalent physiological concentrations and pH but with an increasing amount of 
free metal contamination. This sort of experiment would eliminate variations in 
anion concentration, which may also affect the Maillard reaction. 
A conclusive test of whether DNPH and aminoguanidine compete for carbonyl 
groups during the DNPH assay could be made by assaying for protein-bound 
carbonyl groups using different concentrations of DNPH. If the DNPH assay is 
detecting all the available carbonyl groups on a glycated protein, increasing the 
concentration of DNPH should have little effect on the results. Protein fructated in 
the presence of aminoguanidine could be assayed for protein-bound carbonyl 
groups using a DNPH assay with an increasing concentration range of DNPH. If 
the yeild of protein-bound carbonyl increases as a function of the DNPH 
concentration then the hypothesis; the aminoguanidine-protein hydrazone is 
hydrolysed by the acid used to solubilise DNPH and, subsequently, free 
aminoguanidine and DNPH compete for the same carbonyl groups; is true. 
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The experiments investigating the minimum conditions of fructose necessary to 
produce AGE formation could be taken further. Size exclusion chromatography 
combined with ultrafiltration is a quicker method for removal of free sugar than 
dialysis. If the time of exposure of protein to fructose is to be reduced further than 
reported in this thesis the time required to remove free sugar is crucial; this is 
because the Maillard reaction is continuing during this time. Quick removal of free 
sugar would ensure that the fructated protein had the least amount of time to form 
AGES with itself and more glycated protein was available for cross-linking with a 
different protein. 
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